10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________________ to _________________

Commission File No.: 333-167960

IZEA, INC.

(Exact name of registrant as specified in its charter)

Nevada	37-1530765
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1000 Legion Place, Suite 1600 Orlando, Florida	32801
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:   (407) 674-6911

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes   x  No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  o		Accelerated filer  o
Non-accelerated filer  o	(Do not check if a smaller reporting company)	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.  Yes    o   No   x

 As of November 1, 2013, there were 22,389,331 shares of our common stock outstanding.

Quarterly Report on Form 10-Q for the period ended September 30, 2013

Table of Contents

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012	3
Unaudited Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012	4
Unaudited Consolidated Statement of Stockholders’ Deficit for the nine months ended September 30, 2013	5
Unaudited Consolidated Statements of Cash Flows for the nine months ended September 30, 2013 and 2012	6
Notes to the Unaudited Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3. Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.  Controls and Procedures	33
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	35
Item 1A. Risk Factors	35
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 3. Defaults Upon Senior Securities	38
Item 4. Mine Safety Disclosures	38
Item 5. Other Information	38
Item 6. Exhibits	39
Signatures	41

PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

IZEA, Inc.

Consolidated Balance Sheets

	September 30, 2013		December 31, 2012
	(Unaudited)
Assets
Current:
Cash and cash equivalents	$	1,663,688	$	657,946
Accounts receivable	1,163,664		426,818
Prepaid expenses	127,508		162,565
Prepaid equity financing costs	—		—
Deferred finance costs, net of accumulated amortization of $46,059 and $25,923	13,042		1,877
Other current assets	23,099		11,627
Total current assets	2,991,001		1,260,833
Property and equipment, net	147,813		113,757
Intangible assets, net of accumulated amortization of $72,776 and $59,276	4,500		18,000
Software development costs	244,878		—
Security deposits	7,951		9,048
Total assets	$	3,396,143	$	1,401,638

Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable	$	741,517		$	1,163,307
Accrued expenses	472,025			187,868
Unearned revenue	1,260,919			1,140,140
Compound embedded derivative	—			11,817
Current portion of capital lease obligations	40,126			17,638
Current portion of notes payable	—			75,000
Total current liabilities	2,514,587			2,595,770
Capital lease obligations, less current portion	30,194			10,212
Notes payable, less current portion	—			106,355
Warrant liability	2,139,967			2,750
Total liabilities	4,684,748			2,715,087
Stockholders’ deficit:
Series A convertible preferred stock; $.0001 par value; 240 shares authorized; 5 shares issued and outstanding	—			—
Common stock, $.0001 par value; 100,000,000 shares authorized; 22,335,543 and 6,186,997 issued and outstanding	2,234			619
Additional paid-in capital	24,265,185			21,489,354
Accumulated deficit	(25,556,024		)	(22,803,422		)
Total stockholders’ deficit	(1,288,605		)	(1,313,449		)
Total liabilities and stockholders’ deficit	$	3,396,143		$	1,401,638

See accompanying notes to the unaudited consolidated financial statements.

3

IZEA, Inc.

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Revenue	$	1,565,851		$	1,058,836		$	4,666,399		$	3,876,508
Cost of sales	499,127			434,019			1,846,130			1,593,790
Gross profit	1,066,724			624,817			2,820,269			2,282,718
Operating expenses:
General and administrative	1,655,727			1,335,858			4,594,888			4,807,610
Sales and marketing	63,436			219,584			272,695			985,466
Total operating expenses	1,719,163			1,555,442			4,867,583			5,793,076
Loss from operations	(652,439		)	(930,625		)	(2,047,314		)	(3,510,358		)
Other income (expense):
Interest expense	(14,439		)	(33,495		)	(52,435		)	(77,762		)
Loss on exchange of warrants and debt	(93,482		)	(37,610		)	(94,214		)	(802,123		)
Change in fair value of derivatives and notes payable carried at fair value, net	(215,092		)	50,160			(558,869		)	681,639
Other income (expense), net	150			—			230			455
Total other income (expense)	(322,863		)	(20,945		)	(705,288		)	(197,791		)
Net loss	$	(975,302	)	$	(951,570	)	$	(2,752,602	)	$	(3,708,149	)
Weighted average common shares outstanding – basic and diluted	12,996,717			2,265,222			9,034,361			2,266,524
Loss per common share – basic and diluted	$	(0.08	)	$	(0.42	)	$	(0.30	)	$	(1.64	)

See accompanying notes to the unaudited consolidated financial statements.

4

IZEA, Inc.

Consolidated Statement of Stockholders’ Deficit

(Unaudited)

	Series A Convertible Preferred Stock			Common Stock			Additional Paid-In		Accumulated			Total Stockholders’
	Shares	Amount		Shares	Amount		Capital		Deficit			Deficit
Balance, December 31, 2012	5	$	—	6,186,997	$	619	$	21,489,354	$	(22,803,422	)	$	(1,313,449	)
Sale of common stock and conversion of notes payable, net of offering costs	—	—		14,236,472	1,424		1,910,820		—			1,912,244
Conversion of notes payable into common stock	—	—		773,983	77		124,534		—			124,611
Exchange of warrants for common stock	—	—		5,001	1		731		—			732
Fair value of warrants issued	—	—		—	—		7,209		—			7,209
Stock issued for payment of services	—	—		1,133,090	113		373,286		—			373,399
Stock-based compensation	—	—		—	—		359,251		—			359,251
Net loss	—	—		—	—		—		(2,752,602		)	(2,752,602		)
Balance, September 30, 2013	5	$	—	22,335,543	$	2,234	$	24,265,185	$	(25,556,024	)	$	(1,288,605	)

See accompanying notes to the unaudited consolidated financial statements.

5

IZEA, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended September 30,
	2013			2012
Cash flows from operating activities:
Net loss	$	(2,752,602	)	$	(3,708,149	)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation and amortization	70,013			87,422
Stock-based compensation	359,251			150,878
Stock issued for payment of services	384,088			668,415
Loss on exchange of warrants and debt	94,214			802,123
Change in fair value of derivatives and notes payable carried at fair value, net	558,869			(681,639		)
Bad debt expense	24,018			—
Cash provided by (used for):
Accounts receivable, net	(760,864		)	(2,119		)
Prepaid expenses and other current assets	(231,982		)	109,998
Accounts payable	(421,790		)	(28,615		)
Accrued expenses	310,561			22,149
Unearned revenue	120,779			102,607
Deferred rent	—			(8,500		)
Net cash used for operating activities	(2,245,445		)	(2,485,430		)
Cash flows from investing activities:
Purchase of equipment	(15,064		)	(9,009		)
Security deposits	1,097			3,650
Net cash used for investing activities	(13,967		)	(5,359		)
Cash flows from financing activities:
Proceeds from issuance of notes payable, net	1,439,798			543,700
Proceeds from issuance of common stock and warrants, net	2,032,145			3,045,899
Proceeds from exercise of stock options	—			1,099
Payments on notes payable and capital leases	(206,789		)	(21,174		)
Net cash provided by financing activities	3,265,154			3,569,524
Net increase in cash and cash equivalents	1,005,742			1,078,735
Cash and cash equivalents, beginning of year	657,946			225,277
Cash and cash equivalents, end of period	$	1,663,688		$	1,304,012
Supplemental cash flow information:
Cash paid during period for interest	$	9,902		$	6,222
Non-cash financing and investing activities:
Fair value of compound embedded derivative in promissory notes	$	—		$	27,776
Fair value of common stock issued for future services	$	—		$	64,619
Fair value of warrants issued	$	2,352,108		$	49,170
Conversion of notes into common stock	$	1,501,229		$	—
Acquisition of assets through capital lease	$	55,369		$	—

See accompanying notes to the unaudited consolidated financial statements.

6

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

NOTE 1.       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Unaudited Interim Financial Information

The accompanying consolidated balance sheet as of September 30, 2013, the consolidated statements of operations for the three and nine months ended September 30, 2013 and 2012, the consolidated statement of stockholders' deficit for the nine months ended September 30, 2013 and the consolidated statements of cash flows for the nine months ended September 30, 2013 and 2012 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of our financial position at such dates and our results of operations and cash flows for the periods then ended in conformity with U.S. generally accepted accounting principles (“US GAAP”). The consolidated balance sheet as of December 31, 2012 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the United States Securities and Exchange Commission ("SEC"), does not include all of the information and notes required by US GAAP for complete financial statements. Operating results for the nine months ended September 30, 2013 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2012 included in the Company's Annual Report on Form 10-K filed with the SEC on March 29, 2013.

Nature of Business and Reverse Merger and Recapitalization

IZEA, Inc. (the "Company"), formerly known as IZEA Holdings, Inc. and before that, Rapid Holdings, Inc., was incorporated in Nevada on March 22, 2010.  On May 12, 2011, the Company completed a share exchange pursuant to which it acquired all of the capital stock of IZEA Innovations, Inc. ("IZEA"), which became its wholly owned subsidiary.  IZEA was incorporated in the state of Florida in February 2006 and was later reincorporated in the state of Delaware in September 2006 and changed its name to IZEA, Inc. from PayPerPost, Inc. on November 2, 2007. In connection with the share exchange, the Company discontinued its former business and continued the social sponsorship business of IZEA as its sole line of business. The Company's headquarters are in Orlando, FL.

The Company is a leading company in the social sponsorship space. The Company currently operates multiple online properties including its premiere platforms, SocialSpark and SponsoredTweets, as well as its legacy platform PayPerPost. In 2012, the Company launched a new platform called Staree and a display-advertising network to use within its platforms called IZEAMedia. Social sponsorship is when a company compensates a social media publisher or influencer such as a blogger or tweeter ("creators") to share sponsored content with their social network audience. This sponsored content is shared within the body of a content stream, a practice known as “native advertising.” The Company generates its revenue primarily through the sale of sponsorship campaigns to its advertisers. The Company fulfills these campaigns through its platforms by utilizing its creators to complete sponsorship opportunities for its advertisers. The Company also generates revenue from the posting of targeted display advertising and from various service fees.

Reverse Stock Split

On July 30, 2012, the Company filed a Certificate of Change with the Secretary of State of Nevada to effect a reverse stock split of the issued and outstanding shares of its common stock at a ratio of one share for every 40 shares outstanding prior to the effective date of the reverse stock split. Additionally, the Company's total authorized shares of common stock were decreased from 500,000,000 shares to 12,500,000 shares and subsequently increased to 100,000,000 shares in February 2013. All current and historical information contained herein related to the share and per share information for the Company's common stock or stock equivalents issued on or after May 12, 2011 reflects the 1-for-40 reverse stock split of the Company's outstanding shares of common stock that became market effective on August 1, 2012.

Principles of Consolidation

The consolidated financial statements include the accounts of IZEA, Inc. as of the date of the reverse merger, and its wholly owned subsidiary, IZEA Innovations, Inc. (collectively, the "Company"). All significant intercompany balances and transactions have been eliminated in consolidation.

Going Concern and Management’s Plans

The opinion of the Company's independent registered public accounting firm on the audited financial statements as of and for the year ended December 31, 2012 contains an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.

The Company has incurred significant losses from operations since inception and has an accumulated deficit of $25,556,024 as of September 30, 2013.  Net losses for the nine months ended September 30, 2013 and for the year ended December 31, 2012 were $2,752,602 and $4,672,638, respectively. The Company's ability to continue as a going concern is dependent upon raising

7

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

capital from financing transactions. The Company’s financial statements have been prepared on the basis that it is a going concern, which assumes continuity of operations and the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments that might result if the Company was forced to discontinue its operations.

From August 15, 2013 through September 23, 2013, the Company raised $2,182,500 in cash through the sale of 8,730,000 shares of its common stock at a price of $0.25 per share in a 2013 Private Placement (see Note 4). Additionally, as discussed in Note 2, the Company converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of its common stock at an effective price of $0.25 per share. The Company also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes.

On September 30, 2013, the Company entered into an agreement pursuant to which it issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services.

The 2013 Private Placement and payment of services with shares of restricted stock provided us with a positive working capital balance and cash reserves for future periods. However, revenues and cash generated from our operations are not presently sufficient to sustain our operations for more than one year.

The Company's continued operations are dependent on its ability to provide positive cash flow from operations and its ability to raise additional capital from financing transactions. Financing transactions may include the issuance of equity or convertible debt securities, obtaining credit facilities, or other financing alternatives. The volatility and sharp decline in the trading price of the Company's common stock over the past two years could make it more difficult to obtain financing through the issuance of equity or convertible debt securities. There can be no assurance that the Company will be successful in any future financing or that it will be available on terms that are acceptable to us.

Future financings through equity investments are likely to be dilutive to existing stockholders. Also, the terms of securities the Company may issue in future capital transactions may be more favorable for the new investors. Newly issued securities, warrants and restricted stock awards may include preferences, superior voting rights and privileges senior to those of existing holders. Further, the Company may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, legal and accounting fees, printing and distribution expenses and other costs. The Company may also be required to recognize non-cash expenses in connection with certain securities it may issue, such as convertible notes and warrants, which will adversely impact our financial condition. Future financings may be impaired by such factors as the overall level of activity in the capital markets and the Company's history of losses, which could impact the availability or cost of future financings. If the amount of capital the Company is able to raise from financing activities, together with its cash from operations, is not sufficient to satisfy the Company's capital needs, the Company may have to curtail its marketing and development plans and possibly limit operations.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

Accounts Receivable and Concentration of Credit Risk

Accounts receivable are customer obligations due under normal trade terms. Uncollectability of accounts receivable is not significant since most customers are bound by contract and are required to fund the Company for all the costs of an “opportunity,” defined as an order created by an advertiser for a publisher to write about the advertiser’s product. If a portion of the account balance is deemed uncollectible, the Company will either write-off the amount owed or provide a reserve based on the uncollectible portion of the account. Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. The Company does not have a reserve for doubtful accounts as of September 30, 2013 and December 31, 2012. Management believes that this estimate is reasonable, but there can be no assurance that the estimate will not change as a result of a change in economic conditions or business conditions within the industry, the individual customers or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. Bad debt expense was less than 1% of revenue for the nine months ended September 30, 2013 and 2012.

Concentrations of credit risk with respect to accounts receivable are typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. The Company also controls credit risk through credit approvals, credit limits and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. At September 30, 2013, two customers accounted for

8

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

38% of total accounts receivable in the aggregate, each of which accounted for more than 10% of the Company’s accounts receivable. At December 31, 2012, the Company had two customers which accounted for 46% of total accounts receivable in the aggregate. The Company had two and one customers that accounted for 33% and 13% of its revenue during the three and nine months ended September 30, 2013, respectively. The Company had no customers that accounted for more than 10% of its revenue during the three and nine months ended September 30, 2012.

Property and Equipment

Depreciation and amortization is computed using the straight-line method and half-year convention over the estimated useful lives of the assets as follows:

Equipment	3 years
Furniture and fixtures	5 - 10 years
Software	3 years
Leasehold improvements	3 years

Major additions and improvements are capitalized, while replacements, maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed as incurred. When assets are retired or otherwise disposed of, related costs and accumulated depreciation and amortization are removed and any gain or loss is reported as other income or expense.

Software Costs

The Company is in the process of developing a new platform called the Native Ad Exchange (NAX). This platform will be utilized both internally and externally to facilitate native advertising campaigns on a greater scale. In accordance with ASC 350-40, Internal Use Software and ASC 985-730, Computer Software Research and Development, research phase costs should be expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs may be capitalized. The Company determined that on April 15, 2013, the project became technologically feasible and the development phase began. The Company capitalized $146,031 and $244,878 in payroll and benefit costs to software development costs in the consolidated balance sheet during the three and nine months ended September 30, 2013, respectively. The platform is expected to be fully implemented in the first quarter of 2014.

Revenue Recognition

The Company derives its revenue from three sources: revenue from an advertiser for the use of the Company's network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators ("Service Fee Revenue"). Sponsored revenue is recognized and considered earned after an advertiser's opportunity is posted on the Company's online platform and their request was completed and content listed, as applicable, by the Company's creators for a requisite period of time. The requisite period ranges from 3 days for an action or tweet to 30 days for a blog. Advertisers may prepay for services by placing a deposit in their account with the Company.  The deposits are typically paid by the advertiser via check, wire transfer or credit card. Deposits are recorded as unearned revenue until earned as described above. Media Revenue is recognized and considered earned when the Company's creators place targeted display advertising in blogs. Service fees charged to advertisers are primarily related to inactivity fees for dormant accounts and fees for additional services outside of sponsored revenue. Service fees charged to creators include upgrade account fees for obtaining greater visibility to advertisers in advertiser searches in our platforms, early cash-out fees if a creator wishes to take proceeds earned for services from their account when the account balance is below certain minimum balance thresholds and inactivity fees for dormant accounts. Service fees are recognized immediately when the maintenance or enhancement service is performed for an advertiser or publisher.   All of the Company's revenue is generated through the rendering of services and is recognized under the general guidelines of SAB Topic 13 A.1 which states that revenue will be recognized when it is realized or realizable and earned. The Company considers its revenue as generally realized or realizable and earned once (i) persuasive evidence of an arrangement exists, (ii) services have been rendered, (iii) the price to the advertiser or customer is fixed (required to be paid at a set amount that is not subject to refund or adjustment) and determinable, and (iv) collectability is reasonably assured. The Company records revenue on the gross amount earned since it generally is the primary obligor in the arrangement, establishes the pricing and determines the service specifications.

Advertising Costs

Advertising costs are charged to expense as they are incurred, including payments to contact creators to promote the Company.  Advertising expense charged to operations for the three months ended September 30, 2013 and 2012 were approximately $12,000 and $60,000, respectively. Advertising expense charged to operations for the nine months ended September 30, 2013 and 2012 were approximately $56,000 and $359,000, respectively. Advertising costs are included in sales and marketing expense in the accompanying consolidated statements of operations.

9

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Income Taxes

The Company has not recorded current income tax expense due to the generation of net operating losses. Deferred income taxes are accounted for using the balance sheet approach which requires recognition of deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the tax basis of assets and liabilities. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.

The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more-likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company’s tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the date of filing.

Convertible Preferred Stock

The Company accounts for its convertible preferred stock under the provisions of Accounting Standards Codification ("ASC") on DistinguishingLiabilities from Equity, which sets forth the standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. The ASC requires an issuer to classify a financial instrument that is within the scope of the ASC as a liability if such financial instrument embodies an unconditional obligation to redeem the instrument at a specified date and/or upon an event certain to occur. The Series A Convertible Preferred Stock of the Company issued in May 2011 does not have a redemption feature. Future changes in the certainty of the Company’s obligation to redeem these instruments could result in a change in classification.

Derivative Financial Instruments

Derivative financial instruments are defined as financial instruments or other contracts that contain a notional amount and one or more underlying (e.g., interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. The Company accounts for derivative instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and equity instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

The Company records a beneficial conversion feature (“BCF”) related to the issuance of convertible debt and equity instruments that have conversion features at fixed rates that are in-the-money when issued, and the fair value of warrants issued in connection with those instruments. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds to warrants, based on their relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature. The discounts recorded in connection with the BCF and warrant valuation are recognized (a) for convertible debt as interest expense over the term of the debt, using the effective interest method or (b) for preferred stock as dividends at the time the stock first becomes convertible.

Fair Value of Financial Instruments

The Company’s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:

• Level 1 – Valuation based on quoted market prices in active markets for identical assets and liabilities.

• Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

10

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

• Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The Company does not have any Level 1 or 2 financial assets or liabilities. The Company’s Level 3 financial liabilities measured at fair value consisted of certain notes payable and the warrant liability as of September 30, 2013 (see Note 3).

Significant unobservable inputs used in the fair value measurement of the warrants include the estimated term. Significant increases (decreases) in the estimated remaining period to exercise would result in a significantly higher (lower) fair value measurement.

In developing our credit risk assumption, consideration was made of publicly available bond rates and US Treasury Yields. However, since the Company does not have a formal credit-standing, management estimated its standing among various reported levels and grades for use in the model. During all periods, management estimated that the Company's standing was in the speculative to high-risk grades (BB- to CCC in the Standard and Poor's Rating). A significant increase (decrease) in the risk-adjusted interest rate could result in a significantly lower (higher) fair value measurement.

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. Unless otherwise disclosed, the fair value of the Company’s notes payable and capital lease obligations approximate their carrying value based upon current rates available to the Company.

Certain convertible promissory notes are recorded at the fair value of the hybrid instrument as a whole and are recorded at their common stock equivalent value. Significant unobservable inputs used in the fair value of the hybrid instruments include the estimated number of common shares underlying the promissory notes and the fair value of the common stock to be issued upon conversion. Generally, an increase (decrease) in the estimated number of shares underlying the promissory notes or the fair value of the common stock to be issued upon conversion would result in a (higher) lower fair value measurement.

Stock-Based Compensation

Stock-based compensation cost related to stock options granted under the May 2011 Equity Incentive Plan and August 2011 B Equity Incentive Plan (together, the "2011 Equity Incentive Plans") (see Note 4) is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option-pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock as quoted in the OTCQB marketplace on the date of the agreement.  Prior to April 1, 2012, due to limited trading history and volume, the Company estimated the fair value of its common stock using recent independent valuations or the value paid in equity financing transactions. The Company estimates the volatility of its common stock at the date of grant based on the volatility of comparable peer companies that are publicly traded and have had a longer trading history than itself. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and post-vesting forfeitures. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The Company used the following assumptions for options granted under the 2011 Equity Incentive Plans during the three and nine months ended September 30, 2013 and 2012:

	Three Months Ended		Nine Months Ended
2011 Equity Incentive Plans Assumptions	September 30, 2013	September 30, 2012	September 30, 2013	September 30, 2012
Expected term	10 years	5 years	9 years	5 years
Weighted average volatility	51.72%	54.46%	52.02%	54.90%
Weighted average risk free interest rate	2.74%	0.65%	2.27%	0.75%
Expected dividends	—	—	—	—

The Company estimates forfeitures when recognizing compensation expense and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates.  Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and also impact the amount of unamortized compensation expense to be recognized in future periods.  Current average expected forfeiture rates were 50.21% during the three and nine months ended September 30, 2013 and 2012.

11

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Non-Employee Stock-Based Compensation

The Company's accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505, “Equity-Based Payments to Non-Employees.” The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. The fair value of equity instruments issued to consultants that vest immediately is expensed when issued. The fair value of equity instruments issued to consultants that have future vesting and are subject to forfeiture if performance does not occur is recognized as expense over the vesting period. Fair values for the unvested portion of issued instruments are adjusted each reporting period. The change in fair value is recorded to additional paid-in capital. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or the fair value of the services, whichever is more readily determinable.

Segment Information

The Company does not identify separate operating segments for management reporting purposes. The results of operations are the basis on which management evaluates operations and makes business decisions.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Recent Accounting Pronouncements

There are several new accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") which are not yet effective.  Management does not believe any of these accounting pronouncements will have a material impact on the Company's financial position or operating results.

Reclassifications

Certain items have been reclassified in the 2012 financial statements to conform to the 2013 presentation.

NOTE 2.      NOTES PAYABLE

Notes Payable – Related Parties

On February 3, 2012, the Company issued a senior secured promissory note in the principal amount of $550,000 with an original issuance discount of $50,000, plus $3,500 in lender fees to two of its existing shareholders.  In connection with the note, the Company incurred expenses of $21,800 for legal and other fees. Accordingly, net cash proceeds from the note amounted to $474,700. The holders were permitted to convert the outstanding principal amount of the note at a conversion price of 90% of the closing price of the Company's common stock, subject to further adjustment in the case of stock splits, reclassifications, reorganizations, certain issuances at less than the conversion price and the like, without limitation on the number of shares that could potentially be issued. From October 2012 through December 2012, the holders of this promissory note converted $437,850 of note value into 2,069,439 shares of common stock at an average conversion rate of $.21 per share. On February 4, 2013, the Company satisfied all of its remaining obligations under this note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share.

Proceeds from the note financings were allocated first to the embedded conversion option (see Note 3) that required bifurcation and recognition as a liability at fair value and then to the carrying value of the notes. The carrying value of the notes is subject to amortization, through charges to interest expense, over the term to maturity or conversion using the effective interest method.

On May 4, 2012, the Company issued an unsecured 30-day promissory note to two of its existing shareholders in the principal amount of $75,000, incurring $6,000 in expenses for legal fees, which resulted in net proceeds of $69,000. In June 2012, the note was extended until December 4, 2012 and the parties agreed that the noteholders could convert the note at any time on or before the maturity date into shares of common stock at a conversion price equal to the lower of (i) $5.00 per share or (ii) 90% of the then market price based on a volume weighted average price per share of the Company's common stock for the ten trading days prior to the conversion date. The note bore interest at a rate of 8% per annum. The noteholders did not elect to convert this note and the Company was not able to pay the balance owed upon its maturity on December 4, 2012. Therefore, the conversion feature expired and the note was in default bearing interest at the default rate of 18% per annum. On August 15, 2013, the noteholders converted the $75,000 in principal, plus $12,366 of accrued interest into 3.5 investment units (349,464 shares of common stock

12

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

and like number of warrants) on the same terms and conditions as other investors in our 2013 Private Placement discussed in Note 4. The Company recorded a $93,482 loss on the exchange of the promissory note for shares in the Company's consolidated statements of operations during the three months ended September 30, 2013.

Bridge Bank Credit Agreement

On March 1, 2013, the Company entered into a secured credit facility agreement with Bridge Bank, N.A. of San Jose, California. Pursuant to this agreement, the Company may submit requests for funding up to 80% of its eligible accounts receivable up to a maximum total outstanding advanced amount of $1.5 million. This agreement is secured by the Company's accounts receivable and substantially all of the Company's other assets. The agreement requires the Company to pay an annual facility fee of $7,500 (0.5% of the credit facility) and an annual due diligence fee of $1,000. Interest accrues on the advances at the prime rate plus 2% per annum. The default rate of interest is prime plus 7%. If the agreement is terminated prior to March 1, 2014, then the Company will be required to pay a termination fee of $18,750 (1% of the credit limit divided by 80%). The Company incurred $31,301 in costs related to this loan acquisition. These costs have been capitalized in the Company's consolidated balance sheet as deferred finance costs and are being amortized to interest expense over one year. As of September 30, 2013, the Company had no outstanding balance under this agreement.

Brian Brady Promissory Notes

On April 11, 2013 and May 22, 2013, the Company entered into unsecured loan agreements with Brian W. Brady, a director of the Company. Pursuant to these agreements, the Company received short-term loans totaling $750,000 due on May 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. On May 31, 2013, the Company signed an extension and conversion agreement that extended the due date to August 31, 2013. Additionally, the parties agreed to allow these notes and all accrued interest thereon to be converted into equity upon closing of the next private placement on the same terms and conditions that will be applicable to other investors in the private placement. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company. Upon modification of these loans on May 31, 2013, the Company elected that the notes should be recorded at fair value as discussed further in Note 3.

On June 7, June 14, July 25, and August 12, 2013, the Company entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, the Company received short-term loans totaling $520,000 due on August 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year.

On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest, into 5,157,008 shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement discussed in Note 4.

The proceeds from the loans from Mr. Brady were used to pay off the outstanding balance on the Bridge Bank facility and to pay for operating expenses. The Board determined that the terms of the agreements were consistent or better than the terms of other note agreements that the Company had issued in its recent history. The note issuances and the modification were approved by the disinterested members of the Company's Board of Directors.

During the three months ended September 30, 2013 and 2012, interest expense on all the notes amounted to $3,998 and $24,138, respectively. During the nine months ended September 30, 2013 and 2012, interest expense on all the notes amounted to $22,397 and $52,840, respectively. Direct finance costs allocated to the embedded derivatives were expensed in full upon issuance of the notes. Direct finance costs allocated to the notes are subject to amortization, through charges to interest expense, using the effective interest method. During the three months ended September 30, 2013 and 2012, interest expense related to the amortization of finance costs amounted to $7,826 and $7,666, respectively. During the nine months ended September 30, 2013 and 2012, interest expense related to the amortization of finance costs amounted to $20,137 and $18,700, respectively.

NOTE 3.     DERIVATIVE FINANCIAL INSTRUMENTS

The Company entered into financing transactions that gave rise to derivative liabilities, which are accounted for at fair value, in the Company's financial statements. Changes in the fair value of derivative financial instruments are required to be recorded in other income in the period of change, and are reflected in the Company's consolidated statements of operations as "loss on exchange of warrants and debt" or as "change in fair value of derivatives and notes payable carried at fair value."

13

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Warrant Liability

2012 Activity:

The Company determined that 153,882 warrant shares issued in its May 2011 Offering, 110,000 warrant shares issued in its September 2012 public offering and 250 warrant shares issued in July 2011 for a customer list acquisition, require classification as a liability due to certain registration rights and listing requirements in the agreements.

In May and June 2012, pursuant to separate private transactions with nineteen warrant holders, the Company redeemed warrants to purchase an aggregate of 123,052 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemptions were treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the carrying value of the warrants received in the exchange is recorded in the Company's consolidated statements of operations in other income under loss on exchange and change in fair value of derivatives. As a result of the exchange, the Company recognized a loss on the exchange of these warrants in the amount of $802,123 during the three and nine months ended September 30, 2012.

2013 Activity:

In February 2013, pursuant to a private transaction with a warrant holder, the Company redeemed a warrant to purchase 5,001 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemption was treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the zero carrying value of the warrant received in the exchange. As a result, the Company recognized a loss on exchange of warrants in the amount of $732 during the three months ended March 31, 2013.

From August 15, 2013 through September 23, 2013, the Company issued warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share pursuant to the terms of the Securities Purchase Agreements signed in its 2013 Private Placement (Note 4). The Company determined that these warrants require classification as a liability due to certain registration rights in the agreements that require the Company to file a registration statement with the SEC for purposes of registering the resale of the shares underlying these warrants by January 23, 2014 and use its commercially reasonable efforts to have it declared effective no later than March 23, 2014. The Company determined the fair value of these warrants on their issuance date to be $2,344,899.

During the three months ended September 30, 2013 and 2012, the Company recorded income of $207,462 and $10,903, respectively, due to the change in the fair value of its warrant liability. During the nine months ended September 30, 2013 and 2012, the Company recorded income of $207,682 and $738,628, respectively, due to the change in the fair value of its warrant liability.

The following table summarizes the Company's activity and fair value calculations of its derivative warrants for the nine months ended September 30, 2013:

	Linked Common Shares to Derivative Warrants		Warrant Liability
Balance, December 31, 2012	128,350		$	2,750
Issuance of warrants to investors in 2013 Private Placement	14,236,472		2,344,899
Exchange of warrants for common stock	(4,546	)	—
Change in fair value of derivatives	—		(207,682		)
Balance, September 30, 2013	14,360,276		$	2,139,967

The Company's warrants were valued on the applicable dates using a Binomial Lattice Option Valuation Technique (“Binomial”). Significant inputs into this technique as of December 31, 2012, May 31, 2013, August 15, 2013 - September 23, 2013 and September 30, 2013 are as follows:

14

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Binomial Assumptions	December 31, 2012	May 31, 2013	August 15, 2013 - September 23, 2013	September 30, 2013
Fair market value of asset (1)	$0.22	$0.20	$0.28-$0.37	$0.33
Exercise price	$1.25	$0.25-$0.50	$0.25-$0.50	$0.25-$1.25
Term (2)	4.7 years	5.0 years	5.0 years	3.9 years - 4.9 years
Implied expected life (3)	4.6 years	5.0 years	5.0 years	3.9 years - 4.9 years
Volatility range of inputs (4)	45.82%--84.21%	50.14%--83.49%	48.46%--81.72%	50.38%--80.40%
Equivalent volatility (3)	60.20%	59.15%	56.57%--57.55%	54.84%--56.50%
Risk-free interest rate range of inputs (5)	0.11%--0.72%	1.07%--1.05%	0.04%--1.72%	0.02%--1.39%
Equivalent risk-free interest rate (3)	0.32%	0.43%	0.56%--0.69%	0.32%--0.52%

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the binomial.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2), above.

(5)  The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (2), above.

Convertible Notes-Carried At Fair Value

$750,000 Notes Payable:

On May 31, 2013, the Company signed a loan extension and conversion agreement with Brian W. Brady, a director of the Company, that extended the due date on its $750,000 notes payable to August 31, 2013 and added a conversion feature in which the notes and all accrued interest thereon will be converted into equity upon the closing of the next private placement on the same terms and conditions that will be applicable to other investors in the future financing. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company.

The Company concluded that since the modification resulted in the addition of a conversion feature, the notes no longer met the definition of being indexed to the Company's own stock in accordance with ASC 815, Derivatives and Hedging. Accordingly, the modification of these loans on May 31, 2013 resulted in a change that required either bifurcation of the embedded conversion feature or the Company could choose to record the entire fair value of the convertible notes at fair value. Management chose to record the promissory notes  at their fair value using a common stock equivalent approach, with changes in fair value being reported as “Change in the fair value of derivatives and notes payable carried at fair value, net” in the accompanying consolidated statements of operations.

As discussed in Note 2, on August 15, 2013, Mr. Brady converted the $750,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The $750,000 convertible notes payable had a fair value of $820,202 on May 31, 2013 (the modification date) and $1,586,109 on August 15, 2013 (the conversion date). This change in fair value resulted in an expense of $422,554 and $765,907 during the three and nine months ended September 30, 2013, respectively.

Since the Company was currently negotiating a future financing at the time of modification, management believed there was a high probability that the future financing would occur, the common stock equivalent value of the notes was based on the negotiated terms of the future financing.

15

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

The newly-issued warrant, indexed to 1,000,000 shares of common stock, met the conditions for equity classification and the fair value of $88,000 was recorded in the Company's consolidated balance sheet as additional paid-in capital during the three months ended June 30, 2013. The value of the additional warrant and the restricted stock units to be issued upon the occurrence of the future financing were also recorded in additional paid-in capital. The additional warrant was valued at $280,500, using a binomial lattice option valuation technique and the restricted stock units were valued at $337,500 based on the Company's current market prices.

The modification added a substantial conversion feature so the debt instruments were considered “substantially” different after the modification and extinguishment accounting was applicable. Since the modification triggered debt extinguishment accounting, the fair value of the additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share and the additional 1,687,500 restricted stock units were considered in the determination of the amount of extinguishment loss. However, since Mr. Brady is a board member and shareholder, the transaction is considered to be with a related party and thus, the extinguishment is in essence a capital transaction. As such, the difference between the carrying amount of the original notes of $755,227 was compared to the fair value of the modified notes plus the fair value of the warrants issued on May 31, 2013, plus the warrants and restricted stock to be issued in the future, which equaled $1,526,202. The difference of $770,975 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

As of the date of modification, May 31, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,021,000	$	0.200	604,200
Warrants - $0.25 exercise price	1,510,500	$	0.088	132,924
Warrants - $0.50 exercise price	1,510,500	$	0.055	83,078
Common stock equivalent value				820,202

On the conversion date of August 15, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,064,944	$	0.350	1,072,730
Warrants - $0.25 exercise price	1,532,472	$	0.199	304,962
Warrants - $0.50 exercise price	1,532,472	$	0.136	208,417
Common stock equivalent value				1,586,109

The following table summarizes the Company's activity and fair value calculations of its derivative notes payable for the nine months ended September 30, 2013:

	Linked Common Shares to Convertible Notes Payable		Bifurcated Compound Embedded Derivatives			Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	537,146		$	11,817		$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	6,042,000		—			820,202
Conversion of notes into common stock	(6,903,872	)	(12,461		)	(1,586,109		)
Change in fair value of derivatives	324,726		644			765,907
Balance, September 30, 2013	—		$	—		$	—

The common stock was valued at the trading market price on the date of the valuation. The warrants were valued using a Binomial model using inputs as detailed above under the Binomial Assumptions table.

$520,000 Notes Payable:

On June 7, June 14, July 25, and August 12, 2013, the Company entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, the Company received short-term loans totaling $520,000 due on August 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. Although the notes did not contain a

16

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

conversion feature, the Company permitted Mr. Brady to convert the $520,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The difference between the carrying amount of the original notes and accrued interest of $523,016 was compared to the $1,082,642 fair value of the 2,092,064 shares of common stock and 2,092,064 warrants received on August 15, 2013 and since the transaction is considered to be with a related party, the difference of $559,626 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

Fair value measurements

Assets and liabilities that are recorded at fair value on a recurring basis are measured in accordance with ASC 820-10-05, Fair Value Measurements. The Brian Brady Promissory Notes originally issued April 11, 2013 and May 22, 2013 and modified on May 31, 2013 to extend the term and add a conversion feature are classified within Level 3 of the fair value hierarchy as they were valued using unobservable inputs including significant assumptions of the Company and other market participants.

The reconciliation of our derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2013 is as follows:

	Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	820,202
Total loss included in earnings	765,907
Balance upon conversion, August 15, 2013	$	1,586,109

Compound Embedded Derivative

The Company concluded that the compound embedded derivative in its $550,000 senior secured promissory note issued on February 3, 2012 and its $75,000 convertible promissory note as modified on June 6, 2012 (see Note 2) required bifurcation and liability classification as derivative financial instruments because they were not considered indexed to the Company's own stock as defined in ASC 815, Derivatives and Hedging. The noteholders did not elect to convert the $75,000 convertible promissory note prior its maturity date on December 4, 2012. Therefore, the conversion feature expired and no further derivative valuation is required. On February 4, 2013, the Company satisfied all of its remaining obligations under its $550,000 senior secured promissory note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share. The Company recorded the $12,461 value of the compound embedded derivative on the conversion date as a charge to additional paid-in capital. As of February 4, 2013, all convertible notes in which the conversion feature had been bifurcated and recorded at fair value, had been converted. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the nine months ended September 30, 2013 in the amount of $644. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the three and nine months ended September 30, 2012 in the amount of $39,257 and $56,989, respectively.

The Monte Carlo Simulation (“MCS”) technique was used to calculate the fair value of the compound embedded derivatives because it provides for the necessary assumptions and inputs. The MCS technique, which is an option-based model, is a generally accepted valuation technique for valuing embedded conversion features in hybrid convertible notes, because it is an open-ended valuation model that embodies all significant assumption types, and ranges of assumption inputs that the Company agrees would likely be considered in connection with the arms-length negotiation related to the transference of the instrument by market participants. In addition to the typical assumptions in a closed-end option model, such as volatility and a risk free rate, MCS incorporates assumptions for interest risk, credit risk and redemption behavior. In addition, MCS breaks down the time to expiration into potentially a large population of time intervals and steps. However, there may be other circumstances or considerations, other than those addressed herein, that relate to both internal and external factors that would be considered by market participants as it relates specifically to the Company and the subject financial instruments. The effects, if any, of these considerations cannot be reasonably measured, quantified or qualified.

The following table shows the summary calculations arriving at the compound embedded derivative value as of December 31, 2012 and on the final conversion date of February 4, 2013. See the assumption details for the composition of these calculations.

17

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Compound Embedded Derivative	December 31, 2012		February 4, 2013
Notional amount	$	106,355	$	112,150
Conversion price	0.198		0.145
Linked common shares (1)	537,146		773,983
MCS value per linked common share (2)	0.022		0.016
Total	$	11,817	$	12,461

(1) The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares increased as the trading market price decreased and decreased as the trading market price increased.

(2) The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.

The significant inputs into the Monte Carlo Simulation used to calculate the compound embedded derivative values as of December 31, 2012 and on the final conversion date of February 4, 2013 are as follows:

Monte Carlo Assumptions	December 31, 2012	February 4, 2013 (7)
Fair market value of asset (1)	$0.22	$0.16
Conversion price	$0.20	$0.14
Term (2)	0.09 years	n/a
Implied expected life (3)	0.09 years	n/a
Volatility range of inputs (4)	16.12%--40.17%	n/a
Equivalent volatility (3)	30.7%	n/a
Risk adjusted interest rate range of inputs (5)	10.00%	n/a
Equivalent risk-adjusted interest rate (3)	10.00%	n/a
Credit risk-adjusted interest rate (6)	15.63%	n/a

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2) above.

(5) CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument.

(6) The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

18

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

(7) Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

NOTE 4.       STOCKHOLDERS' DEFICIT

On February 6, 2013, the Company's Board of Directors and holders of a majority of the outstanding shares of common stock of the Company approved an increase in the number of authorized shares of common stock of the Company from 12,500,000 shares to 100,000,000 shares (the “Share Increase”). The Company amended its Articles of Incorporation to effect the Share Increase by filing a Certificate of Amendment with the Nevada Secretary of State on February 11, 2013. The Company has authorized 10,000,000 shares of preferred stock with a par value of $0.0001 of which 240 shares were designated as Series A Convertible Preferred Stock on May 25, 2011.

2013 Private Placement

From August 15, 2013 through September 23, 2013, the Company raised $2,182,500 in cash through the sale of 8,730,000 shares of its common stock at a price of $0.25 per share in its 2013 Private Placement. Additionally, as discussed in Note 2, the Company converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of its common stock at an effective price of $0.25 per share. The Company also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes. The Company determined that the initial fair value of these warrants on their issuance dates total $2,344,899. Total costs of the private placement were $1,646,874 which included $150,355 in cash expenses, $2,344,899 related to the investor warrants noted above, less $848,380 related to change in fair value of Brady debt and loss on exchange of other convertible notes prior to conversion. As a result of the above transactions related to the private placement, the Company reported $1,912,244 as an increase in common stock and additional paid-in capital on the statement of stockholders deficit.

Pursuant to the terms of the Securities Purchase Agreements issued in the 2013 Private Placement, the Company agreed to file a registration statement with the SEC for purposes of registering the resale of these shares of common stock and the shares underlying the warrants within four months after the final closing date (by January 23, 2014) and use its commercially reasonable efforts to have it declared effective no later than six months after the final closing date (by March 23, 2014). The Company filed a registration statement on Form S-1 with the SEC on October 16, 2013, as amended on Form S-1/A filed on October 31, 2013.

Convertible Securities

From October 2012 through December 2012, the holders of the Company's $550,000 senior secured promissory note converted $437,850 of note value into 2,069,439 shares of common stock at an average conversion rate of $.21 per share. The Company recorded the related $83,663 value of the compound embedded derivative on the converted portion as a charge to additional paid-in capital. On February 4, 2013, the Company satisfied all of its remaining obligations under its $550,000 senior secured promissory note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share. The Company recorded the $12,461 value of the compound embedded derivative on the conversion date as a charge to additional paid-in capital.

Additional Warrant Transactions

During the nine months ended September 30, 2013, pursuant to private transactions with warrant holders, the Company redeemed warrants to purchase 5,001 shares of common stock for the same number of shares without the Company receiving any further cash consideration. As a result of the exchange, the Company recognized a loss on the exchange of the warrants in the amount $732 during the nine months ended September 30, 2013.

On March 1, 2013, the Company entered into a $1.5 million secured credit facility agreement with Bridge Bank, N.A. of San Jose, California. In connection with this agreement, the Company issued a warrant with an expiration date after 5 years to purchase up to 58,139 shares of common stock for $15,000 ($.258 per share). This warrant met the conditions for equity classification and the fair value of $7,209, as determined using a binomial lattice option valuation technique, was recorded in the Company's consolidated balance sheet as an increase in deferred finance costs and paid-in capital.

On May 31, 2013, the Company signed a loan extension and conversion agreement with Brian W. Brady, a director of the Company, that extended the due date on its $750,000 notes payable to August 31, 2013. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement, completed on August 15, 2013, it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock

19

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company. These warrants and restricted stock units met the conditions for equity classification and the fair value of $706,000, as determined using a binomial lattice option valuation technique, was recorded in the Company's consolidated balance sheet as an increase in additional paid-in capital.

Stock Options

On May 12, 2011, the Company adopted the 2011 Equity Incentive Plan (the “May 2011 Plan”) that authorizes, subsequent to the latest amendment on February 6, 2013, 11,613,715 shares of common stock to be granted for future stock awards to employees, directors or contractors. As of September 30, 2013, the Company had 4,728,955 shares of common stock available for future grants under the May 2011 Plan.

On August 22, 2011, the Company adopted the 2011 B Equity Incentive Plan (the “August 2011 Plan”) reserving for issuance an aggregate of 87,500 shares of common stock under the August 2011 Plan. As of September 30, 2013, the Company had 50,000 shares of common stock available for future grants under the August 2011 Plan.

Under both the May 2011 Plan and the August 2011 Plan (together, the "2011 Equity Incentive Plans"), the Board of Directors determines the exercise price to be paid for the shares, the period within which each option may be exercised, and the terms and conditions of each option. The exercise price of the incentive and non-qualified stock options may not be less than 100% of the fair market value per share of the Company’s common stock on the grant date. If an individual owns stock representing more than 10% of the outstanding shares, the price of each share of an incentive stock option must be equal to or exceed 110% of fair market value. Unless otherwise determined by the board of directors at the time of grant, the right to purchase shares covered by any options under the 2011 Equity Incentive Plans typically vest over the requisite service period as follows: 25% of options shall vest one year from the date of grant and the remaining options shall vest monthly, in equal increments over the following three years. The term of the options is up to ten years. The Company issues new shares to the optionee for any stock awards or options exercised pursuant to its equity incentive plans.

A summary of option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

Options Outstanding	Common Shares		Weighted Average Exercise Price		Weighted Average Remaining Life (Years)
Outstanding at December 31, 2011	114,445		$	17.61	4.4
Granted	378,293		5.74
Exercised	(551	)	2.00
Forfeited	(100,210	)	18.81
Outstanding at December 31, 2012	391,977		$	5.87	4.3
Granted	7,640,062		0.25
Exercised	—		—
Forfeited	(1,111,013	)	0.45
Outstanding at September 30, 2013	6,921,026		$	0.54	8.8
Exercisable at September 30, 2013	1,611,198		$	0.89	8.8

During the year ended December 31, 2012, options were exercised into 551 shares of the Company's common stock for cash proceeds of $1,099. The intrinsic value of these options was $5,769. During the three and nine months ended September 30, 2013, no options were exercised. There is no aggregate intrinsic value on the outstanding or exercisable options as of September 30, 2013 since the weighted average exercise price per share exceeded the fair value on such date.

A summary of the nonvested stock option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

20

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

Nonvested Options	Common Shares		Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest
Nonvested at December 31, 2011	57,516		$	2.73	2.5
Granted	378,293		2.17
Vested	(83,429	)	2.26
Forfeited	(43,753	)	2.78
Nonvested at December 31, 2012	308,627		$	2.17	2.9
Granted	7,640,062		0.20
Vested	(1,541,284	)	0.37
Forfeited	(1,097,577	)	0.21
Nonvested at September 30, 2013	5,309,828		$	0.27	3.6

Stock-based compensation cost related to stock options granted under the 2011 Equity Incentive Plans is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option-pricing model that uses the assumptions stated in Note 1. Total stock-based compensation expense recognized on awards outstanding during the three months ended September 30, 2013 and 2012 was $190,877 and $31,894, respectively. Total stock-based compensation expense recognized on awards outstanding during the nine months ended September 30, 2013 and 2012 was $359,251 and $150,878, respectively. Stock-based compensation expense is recorded as a general and administrative expense in the Company's consolidated statements of operations. Future compensation related to nonvested awards expected to vest of $696,167 is estimated to be recognized over the weighted-average vesting period of three years.

Restricted Stock Issued for Services

In May 2012 and July 2012, the Company entered into seven agreements for celebrity endorsements of the Company's platforms whereby the Company paid cash of $100,000 and issued a total of 135,521 shares of restricted common stock. In the majority of the agreements, the restricted stock vested 25% immediately upon the signing of the agreements and then vests 6.25% per month over the following twelve months during the term of the agreements.

On June 12, 2012, the Company issued 1,200 shares of restricted common stock to its investors' counsel in order to pay for legal services totaling $6,000 related to the issuance of the $75,000 convertible promissory note.

On July 2, 2012, the Company issued 71,221 shares of restricted common stock to its former legal counsel in order to pay for general legal services totaling $356,103.

In August and September 2012, the Company issued 35,000 and 69,445 respective shares of restricted common stock as a result of a stock subscription agreement with its director, Brian Brady.

On January 3, 2013, the Company issued 60,000 shares of restricted stock pursuant to a twelve-month compensation arrangement with Mitchel J. Laskey for his service as a director and Chairman of the Company's Board of Directors.

On January 3, 2013, the Company issued 20,000 shares of restricted stock valued at $4,820 in order to pay for a small asset purchase.

Effective January 3, 2013, the Company entered into a twelve-month agreement to pay $4,000 per month beginning January 2013 to a firm who would provide investor relations services. In accordance with the agreement, the Company issued 100,000 shares of restricted common stock on January 15, 2013 and agreed to issue an additional 100,000 restricted shares on or before July 15, 2013. This agreement was mutually terminated on May 1, 2013 for no further cash consideration with the Company agreeing to issue the final installment of 100,000 shares of restricted common stock upon the termination of the agreement.

On May 16, 2013, the Company issued 30,000 shares of restricted common stock valued at $6,000 to settle an outstanding balance with a vendor.

On September 30, 2013, the Company entered into an agreement pursuant to which it issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services.

21

IZEA, Inc.

Notes to the Unaudited Consolidated Financial Statements

The following tables contain summarized information about nonvested restricted stock outstanding at September 30, 2013:

Restricted Stock	Common Shares
Nonvested at December 31, 2011	—
Granted	312,387
Vested	(263,805	)
Forfeited	—
Nonvested at December 31, 2012	48,582
Granted	1,133,090
Vested	(1,181,672	)
Forfeited	—
Nonvested at September 30, 2013	—

Total stock-based compensation expense recognized for restricted awards issued for services during the three months ended September 30, 2013 was $289,303 of which $1,222 is included in sales and marketing expense and $288,081 is included in general and administrative expense in the consolidated statements of operations. Total stock-based compensation expense recognized for restricted awards issued for services during the nine months ended September 30, 2013 was $384,088 of which $14,027 is included in sales and marketing expense and $370,061 is included in general and administrative expense in the consolidated statements of operations. The fair value of the services are based on the value of the Company's common stock over the term of service. The fair value of the restricted stock issued during the three and nine months ended September 30, 2013 was $288,081 and $366,301, respectively, and the change in the fair value of the issued but nonvested shares was $266 and $7,098, respectively.

NOTE 5.    LOSS PER COMMON SHARE

Net losses were reported during the three and nine months ended September 30, 2013 and 2012.  As such, the Company excluded the following items from the computation of diluted loss per common share as their effect would be anti-dilutive:

	Three and Nine Months Ended
	September 30, 2013	September 30, 2012
Stock options	6,921,026	393,494
Warrants	18,605,999	128,434
Restricted stock units	1,819,400	—
Potential conversion of Series A convertible preferred stock	3,788	3,788
Potential conversion of promissory notes payable	—	789,142
Total excluded shares	27,350,213	1,314,858

NOTE 6.     RELATED PARTY TRANSACTIONS

On December 26, 2012, Mitchel J. Laskey was elected to the Company's Board of Directors. He was then appointed as the Chairman of the Board, Chairman of the Audit Committee and as a member of the Compensation and Nominating Committees. Upon his appointment, the Board approved a twelve-month compensation arrangement whereby Mr. Laskey would receive $10,000 cash per month, 60,000 restricted stock units in January 2013, 60,000 restricted stock units in June 2013 and up to 120,000 in additional restricted stock units to be issued at the discretion of the disinterested members of the compensation committee for Mr. Laskey's service as Chairman of the Board. Mr. Laskey resigned from the Company's Board of Directors and all his related positions on April 24, 2013. Upon his resignation, he forfeited the right to receive any further cash or stock compensation.

As discussed in Notes 2 and 3, from April 2013 through August 2013, the Company entered into several unsecured loan agreements with Brian W. Brady, a director of the Company. Pursuant to these agreements, the Company received short-term loans totaling $1,270,000 due on August 31, 2013, as amended. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360 day year. On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest, into 5,157,008 shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement.

22

In connection with the 2013 Private Placement, the Board awarded to Edward Murphy, our President and CEO, a bonus of $50,000 and granted him a stock option to purchase 4,398,978 shares of common stock at an exercise price of $0.25 per share, expiring ten years from the issuance date.

NOTE 7.  COMMITMENTS & CONTINGENCIES

From time to time, the Company may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is, however, subject to inherent uncertainties, and an adverse result in these or other matters may harm the Company's business.

On October 17, 2012, Blue Calypso, Inc. filed a complaint against the Company in the U.S. District Court for the Eastern District of Texas accusing us ofinfringing patents related to peer-to-peer advertising between mobile communication devices seeking unspecified damages. The Company made a request that the Texascourt transfer the matter to the Middle District of Florida, but no ruling has yet been made on that motion. On October 4, 2013, Blue Calypso, the Company and the other defendants submitted to the Texas court a joint claim construction and prehearing statement containing each parties’ position with regard to the meaning of the disputed claim terms of the patents.  The court has also yet to rule on this matter. At this stage, the Company does not have an estimate of thelikelihood or the amount of any potential exposure to it. The Company believes that there is no merit to this suit and intends to vigorously defend itself.

The Company is currently not aware of any other legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on its operations or financial position.

NOTE 8.  SUBSEQUENT EVENTS

No material events have occurred since September 30, 2013 that require recognition or disclosure in the financial statements.

23

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Special Note Regarding Forward-Looking Information

The following discussion and analysis is provided to increase the understanding of, and should be read in conjunction with, our consolidated financial statements and related notes included elsewhere in this report. Historical results and percentage relationships among any amounts in these financial statements are not necessarily indicative of trends in operating results for any future period. This report contains “forward-looking statements.” The statements, which are not historical facts contained in this report, including this Management's Discussion and Analysis of Financial Condition and Results of Operations, and notes to our consolidated financial statements, particularly those that utilize terminology such as “may” “will,” “should,” “expects,” “anticipates,” “estimates,” “believes,” or “plans” or comparable terminology are forward-looking statements. Such statements are based on currently available operating, financial and competitive information, and are subject to various risks and uncertainties. Future events and our actual results may differ materially from the results reflected in these forward-looking statements. Factors that might cause such a difference include, but are not limited to, our ability to raise additional funding, our ability to maintain and grow our business, variability of operating results, our ability to maintain and enhance our brand, our development and introduction of new products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the service requirements of our clients, our ability to protect our intellectual property, the potential liability with respect to actions taken by our existing and past employees, risks associated with international sales, and other risks described herein and in our other filings with the Securities and Exchange Commission.

The safe harbor for forward-looking statements provided by Section 21E of the Securities Exchange Act of 1934 excludes issuers of “penny stock” (as defined in Rule 3a51-1 under the Securities Exchange Act of 1934). Our common stock currently falls within that definition. All forward-looking statements in this document are based on information currently available to us as of the date of this report, and we assume no obligation to update any forward-looking statements.  Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

Company History

IZEA, Inc., formerly known as IZEA Holdings, Inc., and before that Rapid Holdings, Inc., was incorporated in Nevada on March 22, 2010.  On May 12, 2011, we completed a share exchange pursuant to which we acquired all of the capital stock of IZEA Innovations, Inc. ("IZEA"), which became our wholly owned subsidiary.  IZEA was incorporated in the state of Florida in February 2006 and was later reincorporated in the state of Delaware in September 2006 and changed its name to IZEA, Inc. from PayPerPost, Inc. on November 2, 2007. In connection with the share exchange, we discontinued our former business and continued the social sponsorship business of IZEA as our sole line of business. 

On July 30, 2012, we filed a Certificate of Change with the Secretary of State of Nevada to effect a reverse stock split of the issued and outstanding shares of our common stock at a ratio of one share for every 40 shares outstanding prior to the effective date of the reverse stock split. Additionally, our total authorized shares of common stock were decreased from 500,000,000 shares to 12,500,000 shares and subsequently increased to 100,000,000 shares in February 2013. All current and historical information contained herein related to the share and per share information for our common stock or stock equivalents issued on or after May 12, 2011 reflects the 1-for-40 reverse stock split of our outstanding shares of common stock that became market effective on August 1, 2012.

Company Overview

We are a leading company in the social sponsorship space. We currently operate multiple online properties including our premiere platforms, SocialSpark and SponsoredTweets, as well as our legacy platform PayPerPost. In 2012, we launched a new platform called Staree and a display-advertising network to use within our platforms called IZEAMedia. Social sponsorship is when a company compensates a social media publisher or influencer such as a blogger or tweeter ("creators") to share sponsored content with their social network audience. This sponsored content is shared within the body of a content stream, a practice known as “native advertising.” We generate our revenue primarily through the sale of sponsorship campaigns to our advertisers. We fulfill these campaigns through our platforms by utilizing our creators to complete sponsorship opportunities for our advertisers. We also generate revenue from the posting of targeted display advertising and from various service fees.

24

Results of Operations for the Three Months EndedSeptember 30, 2013 Compared to the Three Months EndedSeptember 30, 2012

	Unaudited
	Three Months Ended
	September 30, 2013			September 30, 2012			$ Change			% Change
Revenue	$	1,565,851		$	1,058,836		$	507,015		47.9	%
Cost of sales	499,127			434,019			65,108			15.0	%
Gross profit	1,066,724			624,817			441,907			70.7	%
Operating expenses:
General and administrative	1,655,727			1,335,858			319,869			23.9	%
Sales and marketing	63,436			219,584			(156,148		)	(71.1	)%
Total operating expenses	1,719,163			1,555,442			163,721			10.5	%
Loss from operations	(652,439		)	(930,625		)	278,186			29.9	%
Other income (expense):
Interest expense	(14,439		)	(33,495		)	19,056			(56.9	)%
Loss on exchange of warrants and debt	(93,482		)	(37,610		)	(55,872		)	148.6	%
Change in fair value of derivatives and notes payable carried at fair value, net	(215,092		)	50,160			(265,252		)	(528.8	)%
Other income (expense), net	150			—			150			100.0	%
Total other income (expense)	(322,863		)	(20,945		)	(301,918		)	(1,441.5	)%
Net loss	$	(975,302	)	$	(951,570	)	$	(23,732	)	(2.5	)%

Revenues

We derive revenue from three sources: revenue from an advertiser for the use of our network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators for services, maintenance and enhancement of their accounts ("Service Fee Revenue").

Revenues for the three months ended September 30, 2013increased by $507,015, or 47.9%, compared to the same period in 2012. The increase was attributable to a $419,000 increase in our Sponsored Revenue, a $34,000 increase from Media Revenue and a $54,000 increase in Service Fee Revenue. In the three months ended September 30, 2013, Sponsored Revenue was 85%, Media Revenue was 7% and Service Fee Revenue was 8% of total revenue compared to Sponsored Revenue of 86%, Media Revenue of 7% and Service Fee Revenue of 7% of total revenue in the three months ended September 30, 2012. The increase in Sponsored Revenue was primarily attributable to our concentrated sales efforts toward larger IZEA managed campaigns and generating repeat business from existing customers. Media revenue increased primarily due to coupling of media sales with larger sponsorship campaigns. Service fees increased in the three months ended September 30, 2013 primarily due to fees received from inactive self-service advertisers.

Our net bookings for the three months ended September 30, 2013 are 69% higher than the comparable prior year quarter. We anticipate that our revenue will continue to exceed prior year quarters. Net bookings is a measure of sales and contracts minus any cancellations or refunds in a given period. Management uses net bookings as a leading indicator of future revenue recognition as revenue is typically recognized within 90 days of booking. We experienced higher bookings as a result of new customers, larger IZEA managed campaigns and an increase in repeat clients.

Cost of Sales and Gross Profit

Our cost of sales is comprised primarily of amounts paid to our social media content creators for fulfilling an advertiser’s sponsor request for a blog post, tweet, click or action.

Cost of sales for the three months ended September 30, 2013increased by $65,108, or 15.0%, compared to the same period in 2012.   Cost of sales increased as a direct result of the increase in our Sponsored Revenue and the direct creator costs to generate such revenue.

25

Gross profit for the three months ended September 30, 2013increased by $441,907, or 70.7%, compared to the same period in 2012.  Our gross margin improved by nine percentage points from 59% for the three months ended September 30, 2012 to 68% for the same period in 2013. The gross margin increase is primarily attributable to an increase in larger advertisers using our managed campaign services during the three months ended September 30, 2013 as compared to smaller and more self-service campaigns in 2012.

Operating Expenses

Operating expenses consist of general and administrative, and sales and marketing expenses.  Total operating expenses for the three months ended September 30, 2013increased by $163,721, or 10.5%, compared to the same period in 2012. The increase was primarily attributable to higher non-cash stock compensation and professional fees along with decreases in promotional marketing expenses.

General and administrative expenses consist primarily of payroll, general operating costs, public company costs, facilities costs, insurance, depreciation, professional fees, and investor relations fees.  General and administrative expenses for the three months ended September 30, 2013increased by $319,869 or 23.9%, compared to the same period in 2012. The increase was primarily attributable to increases in professional fees for legal and accounting services and an increase in non-cash stock compensation expense. During the three months ended September 30, 2013, legal fees increased by approximately $116,000 related to our patent litigation defense against Blue Calypso, as more fully described under "Legal Proceedings" below and accounting fees for financial consultants increased by approximately $49,000. In connection with the 2013 Private Placement, the Board awarded to Mr. Murphy, our President and CEO, a bonus of $50,000 and granted him a stock option to purchase 4,398,978 shares of common stock at an exercise price of $0.25 per share, expiring ten years from the issuance date. As a result of this option grant and others, our non-cash stock compensation expense increased nearly $159,000 in the three months ended September 30, 2013 compared to the same period in 2012. We are in the process of developing a new platform called the Native Ad Exchange (NAX). This platform will be utilized both internally and externally to facilitate native advertising campaigns on a greater scale. We have filed a patent application covering important features of this platform and have submitted a trademark application for “Native Ad Exchange,” which are currently pending approval. We capitalized $146,031 in payroll and benefit costs related to NAX to software development costs during the three months ended September 30, 2013.

Sales and marketing expenses consist primarily of compensation for sales and marketing and related support resources, sales commissions and trade show expenses. Sales and marketing expenses for the three months ended September 30, 2013decreased by $156,148 or 71.1%, compared to the same period in 2012.   The decrease was primarily attributable to lower promotional expenses related to the launch of new platforms and no expenses incurred for our WeRewards program that we discontinued in November 2012. During May and July 2012, we entered into seven agreements to issue a total of 135,548 shares of restricted common stock for celebrity endorsements of our platforms, primarily related to the launch of our new Staree platform. In the majority of the agreements, the restricted stock vested 25% immediately upon the signing of the agreements and then vests 6.25% per month over the following 12 months. In addition to the shares, we made cash payments of $100,000. We recorded a total of $1,222 in marketing expense for the value of cash payments earned and the restricted awards vested during the three months ended September 30, 2013 compared to a total of $100,838 in the three months ended September 30, 2012.

Other Income (Expense)

Other income (expense) consists primarily of interest expense, a loss on exchange of warrants and debt and the change in the fair value of derivatives and notes payable carried at fair value.

Interest expense during the three months ended September 30, 2013decreased by $19,056 compared to the same period in 2012 primarily due lower debt balances as a result of the conversion of all of our outstanding debt by August 15, 2013. The carrying value and the direct finance costs on the notes are subject to amortization, through charges to interest expense, over their terms to maturity using the effective interest method.

During the three months ended September 30, 2013 and 2012, we incurred a $93,482 and $37,610, respective loss on exchange when we exchanged our $75,000 notes payable for equity in 2013 and redeemed certain warrants to purchase an aggregate of 12,730 shares of common stock for the same number of shares of our common stock without receiving any cash consideration for the exchange in 2012.

We entered into financing transactions that gave rise to derivative liabilities. These financial instruments are carried as derivative liabilities, at fair value, in our financial statements. Changes in the fair value of derivative financial instruments

26

are required to be recorded in other income (expense) in the period of change. We recorded income of $207,462 and $10,903, resulting from the decrease in the fair value of certain warrants during the three months ended September 30, 2013 and 2012, respectively. Additionally, we recorded expense resulting from the increase in the fair value of the compound embedded derivatives during the three months ended September 30, 2013 and 2012 in the amount of $0 and $39,257, respectively, and expense resulting from the increase in fair value of certain notes payable of $422,554 during the three months ended September 30, 2013. The net effect of these changes in fair values resulted in expense of $215,092 and income of $50,160 during the three months ended September 30, 2013 and 2012, respectively. We have no control over the amount of change in the fair value of our derivative instruments as this is a factor based on fluctuating interest rates and stock prices and other market conditions outside of our control.

Net Loss

Net loss for the three months ended September 30, 2013 was $975,302 which increased from the net loss of $951,570 for the same period in 2012.  The increase was primarily due to the non-cash stock compensation expense, loss on exchange of debt and equity instruments and the change in fair market value of derivatives accounting for a total change of $499,451 for the period offset by the increase in gross profit margin.

Results of Operations for the Nine Months EndedSeptember 30, 2013 Compared to the Nine Months EndedSeptember 30, 2012

	Unaudited
	Nine Months Ended
	September 30, 2013			September 30, 2012			$ Change			% Change
Revenue	$	4,666,399		$	3,876,508		$	789,891		20.4	%
Cost of sales	1,846,130			1,593,790			252,340			15.8	%
Gross profit	2,820,269			2,282,718			537,551			23.5	%
Operating expenses:
General and administrative	4,594,888			4,807,610			(212,722		)	(4.4	)%
Sales and marketing	272,695			985,466			(712,771		)	(72.3	)%
Total operating expenses	4,867,583			5,793,076			(925,493		)	(16.0	)%
Loss from operations	(2,047,314		)	(3,510,358		)	1,463,044			41.7	%
Other income (expense):
Interest expense	(52,435		)	(77,762		)	25,327			(32.6	)%
Loss on exchange of warrants and debt	(94,214		)	(802,123		)	707,909			(88.3	)%
Change in fair value of derivatives and notes payable carried at fair value, net	(558,869		)	681,639			(1,240,508		)	(182.0	)%
Other income (expense), net	230			455			(225		)	(49.5	)%
Total other income (expense)	(705,288		)	(197,791		)	(507,497		)	(256.6	)%
Net loss	$	(2,752,602	)	$	(3,708,149	)	$	955,547		25.8	%

Revenues

We derive revenue from three sources: revenue from an advertiser for the use of our network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators for services, maintenance and enhancement of their accounts ("Service Fee Revenue").

Revenues for the nine months ended September 30, 2013increased by $789,891, or 20.4%, compared to the same period in 2012. The increase was attributable to a $716,000 increase in our Sponsored Revenue, a $73,000 increase from Media Revenue and a $1,000 increase in Service Fee Revenue. In the nine months ended September 30, 2013, Sponsored Revenue was 87%, Media Revenue was 6% and Service Fee Revenue was 7% of total revenue compared to Sponsored Revenue of 86%, Media Revenue of 5% and Service Fee Revenue of 9% of total revenue in the nine months ended September 30, 2012. The increase in Sponsored Revenue was primarily attributable to our concentrated sales efforts toward larger IZEA managed

27

campaigns and generating repeat business from existing customers. Media revenue increased primarily due to coupling of media sales with larger sponsorship campaigns. Service fees increased in the nine months ended September 30, 2013 due to additional fees received from inactive self-service advertisers.

Our net bookings for the nine months ended September 30, 2013 are 31% higher than the comparable prior year period. We received $5.1 million in net bookings during the first nine months of 2013, or $7.1 million on an annualized run-rate basis. Net bookings is a measure of sales and contracts minus any cancellations or refunds in a given period. Management uses net bookings as a leading indicator of future revenue recognition as revenue is typically recognized within 90 days of booking. We experienced higher bookings as a result of new customers, larger IZEA managed campaigns and an increase in repeat clients.

Cost of Sales and Gross Profit

Our cost of sales is comprised primarily of amounts paid to our social media content creators for fulfilling an advertiser’s sponsor request for a blog post, tweet, click or action.

Cost of sales for the nine months ended September 30, 2013increased by $252,340, or 15.8%, compared to the same period in 2012.   Cost of sales increased as a direct result of the decrease in our Sponsored Revenue and the direct creator costs to generate such revenue.

Gross profit for the nine months ended September 30, 2013increased by $537,551, or 23.5%, compared to the same period in 2012.  Additionally, our gross margin increased by one percentage point from 59% for the nine months ended September 30, 2012 to 60% for the same period in 2013. The gross margin increase is primarily attributable to an increase in larger advertisers using our managed campaign services during the nine months ended September 30, 2013 as compared to smaller and more self-service campaigns in 2012.

Operating Expenses

Operating expenses consist of general and administrative, and sales and marketing expenses.  Total operating expenses for the nine months ended September 30, 2013decreased by $925,493, or (16.0)%, compared to the same period in 2012. The decrease was primarily attributable to lower payroll, travel and rent expenses along with decreases in promotional marketing expenses.

General and administrative expenses consist primarily of payroll, general operating costs, public company costs, facilities costs, insurance, depreciation, professional fees, and investor relations fees.  General and administrative expenses for the nine months ended September 30, 2013decreased by $212,722 or (4.4)%, compared to the same period in 2012. The decrease was primarily attributable to a $151,000 decrease in rent and office related expense with the reduction of outside office locations in mid-2012 and the move of our corporate headquarters in December 2012, a $349,000 decrease in payroll, personnel and related benefit expenses due to fewer outside sales personnel and capitalized development costs, offset by an increase in non-cash stock compensation expense of $208,000 and public company related costs of $98,000. During the nine months ended September 30, 2013, we capitalized $244,878 in payroll and benefit costs to software development costs. We are in the process of developing a new platform called the Native Ad Exchange (NAX). This platform will be utilized both internally and externally to facilitate native advertising campaigns on a greater scale. We have filed a patent application covering important features of this platform and have submitted a trademark application for “Native Ad Exchange,” which are currently pending approval.

Sales and marketing expenses consist primarily of compensation for sales and marketing and related support resources, sales commissions and trade show expenses. Sales and marketing expenses for the nine months ended September 30, 2013decreased by $712,771 or (72.3)%, compared to the same period in 2012.   The decrease was primarily attributable to lower promotional expenses related to the launch of new platforms and no expenses incurred for our WeRewards program that we discontinued in November 2012. During May and July 2012, we entered into seven agreements to issue a total of 135,548 shares of restricted common stock for celebrity endorsements of our platforms, primarily related to the launch of our new Staree platform. In the majority of the agreements, the restricted stock vested 25% immediately upon the signing of the agreements and then vests 6.25% per month over the following 12 months. In addition to the shares, we made cash payments of $100,000. We recorded a total of $45,277 in marketing expense for the value of cash payments earned and the restricted awards vested during the nine months ended September 30, 2013 compared to a total of $355,061 in the nine months ended September 30, 2012.

28

Other Income (Expense)

Other income (expense) consists primarily of interest expense, a loss on exchange of warrants and debt and the change in the fair value of derivatives and notes payable carried at fair value.

Interest expense during the nine months ended September 30, 2013decreased by $25,327 compared to the same period in 2012 primarily due lower debt balances as a result of the conversion of our $550,000 senior secured promissory note from October 2012 through February 2013 and the conversion of all of our other outstanding debt by August 15, 2013. The carrying value and the direct finance costs on the notes are subject to amortization, through charges to interest expense, over their terms to maturity using the effective interest method.

During the nine months ended September 30, 2013, we recognized a $94,214 loss on exchange when we exchanged our $75,000 notes payable for equity in 2013 and redeemed certain warrants to purchase an aggregate of 5,001 shares of common stock for the same number of shares of our common stock without receiving any cash consideration for the exchange. During the nine months ended September 30, 2012, we recognized a $802,123 loss on exchange when we redeemed certain warrants to purchase an aggregate of 135,782 shares of common stock for the same number of shares of our common stock without receiving any cash consideration for the exchange.

We entered into financing transactions that gave rise to derivative liabilities. These financial instruments are carried as derivative liabilities, at fair value, in our financial statements. Changes in the fair value of derivative financial instruments are required to be recorded in other income (expense) in the period of change. We recorded income of $207,682 and $738,628, resulting from the decrease in the fair value of certain warrants during the nine months ended September 30, 2013 and 2012, respectively. Additionally, we recorded expense resulting from the increase in the fair value of the compound embedded derivatives during the nine months ended September 30, 2013 and 2012 in the amount of $644 and $56,989, respectively, and expense resulting from the increase in fair value of certain notes payable of $765,907 during the nine months ended September 30, 2013. The net effect of these changes in fair values resulted in expense of $558,869 and income of $681,639 during the nine months ended September 30, 2013 and 2012, respectively. We have no control over the amount of change in the fair value of our derivative instruments as this is a factor based on fluctuating interest rates and stock prices and other market conditions outside of our control.

Net Loss

Net loss for the nine months ended September 30, 2013 was $2,752,602 which decreased from the net loss of $3,708,149 for the same period in 2012.  We were able to reduce the overall net loss through our 16.0% reduction in operating costs as discussed above.

Liquidity and Capital Resources

Our cash position was $1,663,688 as of September 30, 2013 as compared to $657,946 as of December 31, 2012, an increase of $1,005,742 as a result of proceeds from a private placement we completed in September 2013.  We have incurred significant net losses and negative cash flow from operations since our inception. We incurred net losses of $2,752,602 and $4,672,638 for the nine months ended September 30, 2013 and the year ended December 31, 2012, respectively, and had an accumulated deficit of $25,556,024 as of September 30, 2013.   The opinion of our independent registered public accounting firm on our audited financial statements as of and for the year ended December 31, 2012 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon raising capital from financing transactions.

Cash used for operating activities was $2,245,445 during the nine months ended September 30, 2013 and was primarily a result of our net loss during the period of $2,752,602.  Cash provided by financing activities was $3,265,154 during the nine months ended September 30, 2013 and was primarily a result of proceeds of $1,270,000 in unsecured loans from Brian W. Brady, our director, and $169,798 received from the issuance of a secured credit facility agreement with Bridge Bank, N.A., along with proceeds, net of expenses, of $2,032,145 from the sale of our common stock, as further discussed below. Financing activities were reduced by principal payments of $206,789 on our notes and capital leases.

To date, we have financed our operations through internally generated revenue from operations, the sale of our equity and the issuance of notes and loans from shareholders.

29

On February 3, 2012, we issued a senior secured promissory note in the principal amount of $550,000 with an original issuance discount of $50,000, plus $3,500 in lender fees to two of our existing shareholders.  In connection with the note, we incurred expenses of $21,800 for legal and other fees. Accordingly, net cash proceeds from the note amounted to $474,700. The holders were permitted to convert the outstanding principal amount of the note at a conversion price of 90% of the closing price of our common stock. From October 2012 through December 2012, the holders of this promissory note converted $437,850 of note value into 2,069,439 shares of our common stock at an average conversion rate of $.21 per share. On February 4, 2013, we satisfied all of our remaining obligations under this note when the holders converted the final balance owed of $112,150 into 773,983 shares of our common stock at an average conversion rate of $.145 per share.

On January 3, 2013, we issued 60,000 shares of restricted stock pursuant to a twelve-month compensation arrangement with Mitchel J. Laskey for his service as a director and chairman of our Board of Directors. On January 3, 2013, we also issued 20,000 shares of restricted stock valued at $4,820 in order to pay for a small asset purchase.

Effective January 3, 2013, we entered into an agreement to pay $4,000 per month for twelve months beginning January 2013 to a firm who would provide investor relations services. In accordance with the agreement, we issued 100,000 shares of restricted common stock on January 15, 2013 and agreed to issue an additional 100,000 restricted shares on or before July 15, 2013. This agreement was mutually terminated on May 1, 2013 for no further cash consideration with our company agreeing to issue the final installment of 100,000 shares of restricted common stock upon the termination of the agreement.

On March 1, 2013, we entered into a secured credit facility agreement with Bridge Bank, N.A. of San Jose, California. Pursuant to this agreement, we may submit requests for funding up to 80% of our eligible accounts receivable up to a maximum total outstanding advanced amount of $1.5 million. This agreement is secured by our accounts receivable and substantially all of our other assets. The agreement requires us to pay an annual facility fee of $7,500 (0.5% of the credit facility) and an annual due diligence fee of $1,000. Interest accrues on the advances at the prime rate plus 2% per annum. The default rate of interest is prime plus 7%. If the agreement is terminated prior to March 1, 2014, then we will be required to pay a termination fee of $18,750 (1% of the credit limit divided by 80%). We incurred $31,301 in costs related to this loan acquisition. These costs have been capitalized in our consolidated balance sheet as deferred finance costs and are being amortized to interest expense over one year. As of September 30, 2013, there was no outstanding balance under this agreement.

On May 16, 2013, we issued 30,000 shares of restricted common stock valued at $6,000 to settle an outstanding balance with a vendor.

On April 11, 2013 and May 22, 2013, we entered into unsecured loan agreements with Brian W. Brady, a director of our company. Pursuant to these agreements,we received short-term loans totaling $750,000 due on May 31, 2013. The notes bear interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. On May 31, 2013,we signed an extension and conversion agreement that extended the due date to August 31, 2013. Additionally, we agreed to allow these notes and all accrued interest thereon to be converted into equity upon closing of the next private placement expected to occur in the third quarter of 2013 on the same terms and conditions that will be applicable to other investors in the private placement. In consideration for the extension and conversion agreement, we issued Mr. Brady a warrant to purchase 1,000,000 shares of our common stock at $0.25 per share for a period of five years. We also agreed that upon the first closing of our next private placement, we would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of our common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of our company.

On June 7, June 14, July 25, and August 12, 2013, we entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, we received short-term loans totaling $520,000 due on August 31, 2013. The notes bear interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. The note issuances and the modification were approved by the disinterested members of our Board of Directors.

On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest, into 51.57 Units (5,157,008 shares of common stock) on the same terms and conditions as were applicable to the other investors our 2013 Private Placement.

On May 4, 2012, we issued a 30-day promissory note to two of our existing shareholders in the principal amount of $75,000 incurring $6,000 in expenses for legal fees which resulted in net proceeds of $69,000. In June 2012, the note was extended until December 4, 2012. The note bore interest at a rate of 8% per annum. We were not able to pay the balance owed upon the maturity on December 4, 2012. Therefore, the conversion feature expired and the note was in default bearing interest at the default rate of 18% per annum. On August 15, 2013, the noteholders converted the $75,000 in principal, plus $12,366 of

30

accrued interest into 3.5 investment units (349,464 shares of common stock and a like number of warrants) on the same terms and conditions as other investors in our 2013 Private Placement.

From August 15, 2013 through September 23, 2013, we raised $2,182,500 in cash through the sale of 8,730,000 shares of our common stock at a price of $0.25 per share in our 2013 Private Placement. Additionally, as discussed above, we converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of our common stock at an effective price of $0.25 per share. We also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of our common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of our common stock at an exercise price of $0.50 per share. Pursuant to the terms of the Securities Purchase Agreements issued in the 2013 Private Placement, we agreed to file a registration statement with the SEC for purposes of registering the resale of these shares of common stock and the shares underlying the warrants within four months after the final closing date (by January 23, 2014) and use our commercially reasonable efforts to have it declared effective no later than six months after the final closing date (by March 23, 2014). The net proceeds received from the 2013 Private Placement are being used for general working capital purposes.

On September 30, 2013, we converted $288,081 in accounts payable owed for legal services into 823,090 shares of our common stock at an effective price of $0.35 per share. Under the terms of the agreement, we agreed to register these shares upon filing of our next registration statement.

On October 1, 2013, we issued 50,000 shares of restricted common stock for investor relations services.

The effect of the above transactions has provided us with a positive working capital balance and cash reserves for future periods. However, revenues and cash generated from our operations are not presently sufficient to sustain our operations for more than one year. Our ability to continue as a going concern is dependent upon raising additional capital from financing transactions, increasing revenue totals or keeping operating expenses at less than 50% of our revenue levels in order to achieve positive cash flows, none of which can be assured. If we achieve profitability, we may not be able to sustain it.

Financing transactions may include the issuance of equity or convertible debt securities, obtaining credit facilities, or other financing alternatives. The volatility and sharp decline in the trading price of our common stock over the past two years could make it more difficult to obtain financing through the issuance of equity or convertible debt securities. There can be no assurance that we will be successful in any future financing or that it will be available on terms that are acceptable to us.

Future financings through equity investments are likely to be dilutive to existing stockholders. Also, the terms of securities we may issue in future capital transactions may be more favorable for our new investors. Newly issued securities, warrants and restricted stock awards may include preferences, superior voting rights and privileges senior to those of existing holders. Further, we may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, legal and accounting fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible notes and warrants, which will adversely impact our financial condition. Future financings may be impaired by such factors as the overall level of activity in the capital markets and our history of losses, which could impact the availability or cost of future financings. If the amount of capital we are able to raise from financing activities, together with our cash from operations, is not sufficient to satisfy our capital needs, we may have to curtail our marketing and development plans and possibly limit operations.

Off-Balance Sheet Arrangements

We do not engage in any activities involving variable interest entities or off-balance sheet arrangements.

Critical Accounting Policies and Use of Estimates

The preparation of the accompanying financial statements and related disclosures in conformity with U.S. GAAP requires us to make judgments, assumptions and estimates that affect the amounts reported in the accompanying financial statements and the accompanying notes.  The preparation of these financial statements requires managements to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities.  When making these estimates and assumptions, we consider our historical experience, our knowledge of economic and market factors and various other factors that we believe to be reasonable under the circumstances.  Actual results could differ from these estimates.  The following critical accounting policies are significantly affected by judgments, assumptions and estimates used in the preparation of the financial statements.

31

Accounts receivable are customer obligations due under normal trade terms. Uncollectability of accounts receivable is not significant since most customers are bound by contract and are required to fund us for all the costs of an “opportunity,” defined as an order created by an advertiser for a publisher to write about the advertiser’s product. If a portion of the account balance is deemed uncollectible, we will either write-off the amount owed or provide a reserve based on the uncollectible portion of the account. Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. We do not have a reserve for doubtful accounts as of September 30, 2013. We believe that this estimate is reasonable, but there can be no assurance that the estimate will not change as a result of a change in economic conditions or business conditions within the industry, the individual customers or our company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. Bad debt expense was less than 1% of revenue for the nine months ended September 30, 2013 and 2012.

We derive revenue from three sources: revenue from an advertiser for the use of the our network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators ("Service Fee Revenue"). Sponsored revenue is recognized and considered earned after an advertiser's opportunity is posted on our online platform and their request was completed and content listed, as applicable, by our creators for a requisite period of time. The requisite period ranges from 3 days for an action or tweet to 30 days for a blog. Advertisers may prepay for services by placing a deposit in their account with us.  The deposits are typically paid by the advertiser via check, wire transfer or credit card. Deposits are recorded as unearned revenue until earned as described above. Media Revenue is recognized and considered earned when our creators place targeted display advertising in blogs. Service fees are recognized immediately when the maintenance, enhancement or other service is performed for an advertiser or creator.   Service fees charged to advertisers are primarily related to inactivity fees for dormant accounts and fees for additional services outside of sponsored revenue. Service fees charged to creators include upgrade account fees for obtaining greater visibility to advertisers in advertiser searches in our platforms, early cash-out fees if a creator wishes to take proceeds earned for services from their account when the account balance is below certain minimum balance thresholds and inactivity fees for dormant accounts. All of our revenue is generated through the rendering of services and is recognized under the general guidelines of SAB Topic 13 A.1 which states that revenue will be recognized when it is realized or realizable and earned. We consider our revenue as generally realized or realizable and earned once (i) persuasive evidence of an arrangement exists, (ii) services have been rendered, (iii) our price to the advertiser or customer is fixed (required to be paid at a set amount that is not subject to refund or adjustment) and determinable, and (iv) collectability is reasonably assured. We record revenue on the gross amount earned since we generally are the primary obligor in the arrangement, establish the pricing and determine the service specifications.

Stock-based compensation is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  We estimate the fair value of each stock option as of the date of grant using the Black-Scholes pricing model.  Options typically vest ratably over four years with one-fourth of options vesting one year from the date of grant and the remaining options vesting monthly, in equal increments over the remaining three-year period  and generally have five or ten-year contract lives.  We estimate the fair value of our common stock using the closing stock price of our common stock as quoted in the OTCQB marketplace on the date of the agreement.  Prior to April 1, 2012, due to limited trading history and volume, we estimated the fair value of our common stock using recent independent valuations or the value paid in equity financing transactions. We estimate the volatility of our common stock at the date of grant based on the volatility of comparable peer companies that are publicly traded and have had a longer trading history than us. We determine the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and post-vesting forfeitures. We use the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. We have never paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future. We estimate forfeitures when recognizing compensation expense and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change. Changes also impact the amount of unamortized compensation expense to be recognized in future periods.

The following table shows the number of options granted under our May 2011 and August 2011 Equity Incentive Plans and the assumptions used to determine the fair value of those options during the quarterly periods in 2012 and through September 30, 2013:

32

2011 Equity Incentive Plans - Options Granted

Period Ended	Total Options Granted	Weighted Average Fair Value of Common Stock	Weighted Average Expected Term	Weighted Average Volatility	Weighted Average Risk Free Interest Rate	Weighted Average Fair Value of Options Granted
March 31, 2012	2,751	$12.50	5 years	54.85%	0.82%	$3.36
June 30, 2012	347,667	$5.18	5 years	54.93%	0.76%	$2.26
September 30, 2012	26,625	$2.20	5 years	54.46%	0.65%	$1.03
December 31, 2012	1,250	$0.39	5 years	52.75%	0.65%	$0.18
March 31, 2013	2,170,834	$0.25	10 years	52.72%	1.91%	$0.16
June 30, 2013	975,250	$0.25	6 years	51.84%	0.91%	$0.12
September 30, 2013	4,493,978	$0.35	10 years	51.72%	2.74%	$0.24

There were 6,921,026 options outstanding as of September 30, 2013 with a weighted average exercise price of $0.54 per share.  There is no aggregate intrinsic value on the exercisable, outstanding options as of September 30, 2013 since the weighted average exercise price per share exceeded the market price of $0.33 of our common stock on such date.

We account for derivative instruments in accordance with ASC 815, Derivatives and Hedging , which requires additional disclosures about the our objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and equity instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

We record a beneficial conversion feature (“BCF”) related to the issuance of convertible debt and equity instruments that have conversion features at fixed rates that are in-the-money when issued, and the fair value of warrants issued in connection with those instruments. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds to warrants, based on their relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature. The discounts recorded in connection with the BCF and warrant valuation are recognized (a) for convertible debt as interest expense over the term of the debt, using the effective interest method or (b) for preferred stock as dividends at the time the stock first becomes convertible.

Recent Accounting Pronouncements

There are several new accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") which are not yet effective.  Management does not believe any of these accounting pronouncements will have a material impact on our financial position or operating results.

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required.

ITEM 4 – CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act

33

is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate to allow timely decisions regarding required disclosures.

In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Furthermore, controls and procedures could be circumvented by the individual acts of some persons, by collusion or two or more people or by management override of the control. Misstatements due to error or fraud may occur and not be detected on a timely basis.

Evaluation of Disclosure Controls and Procedures

In connection with the preparation of this quarterly report on Form 10-Q for the period ended September 30, 2013, an evaluation was performed under the supervision and with the participation of the Company's management including our Chief Executive Officer ("CEO") and Principal Financial Officer ("PFO"), who are the same person, to determine the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2013.  Based on this evaluation, our management concluded that our disclosure controls and procedures were effective as of September 30, 2013 to provide reasonable assurance that the information required to be disclosed by us in reports or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to management, including the Company's principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the Company’s transactions;

(ii) provide reasonable assurance that transactions are recorded as necessary for the preparation of our financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures are made only in accordance with authorizations of our management and directors; and

(iii) provide reasonable assurance regarding prevention or timely detection of any unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement misstatements. Also, projections of any evaluation of internal control effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

There were no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.     

34

PART II - OTHER INFORMATION

ITEM 1 – LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is, however, subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

On October 17, 2012, Blue Calypso, Inc. filed a complaint against us in the U.S. District Court for the Eastern District of Texas accusing us ofinfringing patents related to peer-to-peer advertising between mobile communication devices seeking unspecified damages. We made a request that the Texascourt transfer the matter to the Middle District of Florida, but no ruling has yet been made on that motion. On October 4, 2013, Blue Calypso, we and the other defendants submitted to the Texas court a joint claim construction and prehearing statement containing each parties’ position with regard to the meaning of the disputed claim terms of the patents.  The court has also yet to rule on this matter. At this stage, we do not have an estimate of thelikelihood or the amount of any potential exposure to us. We believe that there is no merit to this suit and intend to vigorously defend ourselves.

We are currently not aware of any other legal proceedings or claims that we believe would or could have, individually or in the aggregate, a material adverse effect on us.

ITEM 1A – RISK FACTORS

In addition to the information set forth under Item 1A of Part I to our Annual Report on Form 10-K for the year ended December 31, 2012, information at the beginning of Management's Discussion and Analysis entitled "Special Note Regarding Forward-Looking Information" and updates noted below, investors should consider that there are numerous and varied risks, known and unknown, that may prevent us from achieving our goals.  If any of these risks actually occur, our business, financial condition or results of operation may be materially adversely affected.  In such case, the trading price of our common stock could decline and investors could lose all or part of their investment.

Risks Related to our Business

We have a history of losses, expect future losses and cannot assure you that we will achieve profitability or obtain the financing necessary for future growth.

We have incurred significant net losses and negative cash flow from operations since our inception. We incurred net losses of $2,752,602 and $4,672,638 for the nine months ended September 30, 2013 and for the year ended December 31, 2012, respectively, and had an accumulated deficit of $25,556,024 as of September 30, 2013. Although our revenue has increased since inception, we have not achieved profitability and cannot be certain that we will be able to sustain these growth rates or realize sufficient revenue to achieve profitability. Our ability to continue as a going concern is dependent upon raising capital from financing transactions, increasing revenue and keeping operating expenses at less than 50% of our revenue levels in order to achieve positive cash flows, none of which can be assured. If we achieve profitability, we may not be able to sustain it.

As described under "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources," the 2013 Private Placement provided us with a positive working capital balance and cash reserves for future periods. However, revenues and cash generated from our operations are not presently sufficient to sustain our operations for more than one year. Our ability to continue as a going concern is dependent upon raising additional capital from financing transactions, increasing revenue totals or keeping operating expenses at less than 50% of our revenue levels in order to achieve positive cash flows, none of which can be assured. If we achieve profitability, we may not be able to sustain it.

We will need to obtain financing for future growth which may be difficult to obtain and may be highly dilutive.

Our continued operations are dependent on our ability to provide positive cash flow from operations and our ability to raise additional capital from financing transactions. Financing transactions may include the issuance of equity or convertible debt securities, obtaining credit facilities, or other financing alternatives. The volatility and sharp decline in the trading price of our common stock over the past two years could make it more difficult to obtain financing through the issuance of equity or convertible debt securities. There can be no assurance that we will be successful in any future financing or that it will be available on terms that are acceptable to us.

35

Future financings through equity investments are likely to be dilutive to existing stockholders. Also, the terms of securities we may issue in future capital transactions may be more favorable for our new investors. Newly issued securities, warrants and restricted stock awards may include preferences, superior voting rights and privileges senior to those of existing holders. Further, we may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, legal and accounting fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible notes and warrants, which will adversely impact our financial condition. Future financings may be impaired by such factors as the overall level of activity in the capital markets and our history of losses, which could impact the availability or cost of future financings. If the amount of capital we are able to raise from financing activities, together with our cash from operations, is not sufficient to satisfy our capital needs, we may have to curtail our marketing and development plans and possibly limit operations.

Our independent registered public accounting firm's report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern.

As of September 30, 2013, our total stockholders' deficit was $1,288,605. Primarily as a result of our losses and limited cash balances, our independent registered public accounting firm included in their report for the year ended December 31, 2012 an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. If we are not able to raise sufficient capital to generate positive cash flows that will sustain us for more than one year, our independent registered public accounting firm may be required to continue to include this explanatory paragraph expressing substantial doubt about our ability to continue as a going concern in their future reports. Such language in our independent registered public accounting firm's report could make it more difficult to obtain future financing.

Exercise of stock options, warrants and other convertible securities will dilute your percentage of ownership and could cause our stock price to fall.

As of November 1, 2013, we have outstanding stock options to purchase 6,921,026 shares of common stock at an average price of $0.54 per share, outstanding warrants to purchase 18,605,999 shares of common stock at an average price of $0.36 per share,1,511,718 shares of unvested restricted common stock and 318,652 shares of vested, yet unissued, shares of restricted common stock. Additionally, we have available shares to issue stock options, restricted stock or other awards to purchase up to 4,728,955 shares of common stock under our May 2011 Equity Incentive Plan and up to 50,000 shares of common stock under our August 2011 Equity Incentive Plan. In the future, we may grant additional stock options, warrants and convertible securities. The exercise, conversion or exchange of stock options, warrants or convertible securities will dilute the percentage ownership of our other stockholders. Sales of a substantial number of shares of our common stock could cause the price of our common stock to fall and could impair our ability to raise capital by selling additional securities.

We (and others) are currently defending a patent infringement claim related to peer-to-peer advertising between mobile communication devices seeking unspecified damages, which may materially impact our business.

On October 17, 2012, Blue Calypso, Inc. filed a complaint against us in the U.S. District Court for the Eastern District of Texas accusing us ofinfringing patents related to peer-to-peer advertising between mobile communication devices seeking unspecified damages. We made a request that the Texascourt transfer the matter to the Middle District of Florida, but no ruling has yet been made on that motion. On October 4, 2013, Blue Calypso, we and the other defendants submitted to the Texas court a joint claim construction and prehearing statement containing each parties’ position with regard to the meaning of the disputed claim terms of the patents.  The court has also yet to rule on this matter. At this stage, we do not have an estimate of thelikelihood or the amount of any potential exposure to us. Although we believe that there is no merit to this lawsuit, there can be no assurance that we will prevail in the suit.  In the event that a favorable outcome for us is not obtained, we could potentially be limited in certain ways in the use of our current social sponsorship platforms.  Even if the litigation is resolved in our favor, it is possible that the litigation will be protracted, resulting in substantial legal costs to defend against the action and the diversion of management's attention and other resources of our company.  In either event, the continuation of this action could have a material adverse effect on our business, financial condition and results of operations.

We are developing a new platform to process all of our existing business transactions and grow our operations, but cannot provide any assurance regarding its success.

We are currently developing a new platform called Native Ad Exchange (“NAX”). NAX is designed to provide a unified ecosystem that enables the creation of multiple types of content through a wide variety of social channels. NAX is a brand-new system, engineered from the ground-up to replace all of our current platforms with an integrated offering that is improved and more efficient for the company to operate. Our intention is to focus all of our engineering resources on the NAX

36

platform for the foreseeable future. We are spending a significant amount of time and resources on the development of this platform, but we cannot provide any assurances of its short or long-term success or growth. A portion of the proceeds of our 2013 Private Placement is being used for completion of the NAX platform. There is no assurance that the amount of money being allocated for the platform will be sufficient to complete it, or that such completion will result in significant revenues or profit for us. If our advertisers and creators do not perceive this platform to be of high value and quality, we may not be able to retain them or acquire new advertisers and creators. Additionally, if existing or future competitors develop or offer products or services that provide significant performance, price, creative or other advantages over this platform, demand for NAX may decrease and our business, prospects, results of operations and financial condition could be negatively affected.

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Private Placement

From August 15, 2013 through September 23, 2013, we entered into Securities Purchase Agreements with 26 investors, pursuant to which we raised $2,182,500 in cash through the private placement of 87.3 units, at a price of $25,000 per unit. Each unit consisted of 100,000 shares of our common stock, together with two warrants. The warrants were composed of one warrant to purchase 50,000 shares of common stock at an exercise price of $0.25 per share and another warrant to purchase 50,000 shares of common stock at an exercise price of $0.50 per share, in each case exercisable for cash at any time during the five years following the date of issuance.

Between April 2013 and August 2013, Brian W. Brady, a director of our company, loaned us $1,270,000 for working capital through several short-term, unsecured promissory notes. On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest under the notes, into 51.57 units (5,157,008 shares of common stock) on the same terms and conditions as were applicable to the other investors in our 2013 Private Placement. Two other unaffiliated noteholders converted $75,000 in principal, plus $12,366 of accrued interest, that we owed to them pursuant to an unsecured promissory note originally issued in May 2012, into 3.5 investment units (349,464 shares of common stock and a like number of warrants) on the same terms and conditions as other investors in our 2013 Private Placement.

As a result of the private placement and conversion of the notes, we issued 14,236,472 shares of our common stock, warrants to purchase 7,118,236 shares of our common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of our common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes.

Pursuant to the terms of the Securities Purchase Agreements issued in the 2013 Private Placement, we agreed to file a registration statement with the SEC for purposes of registering the resale of these shares of common stock and the shares underlying the warrants within four months after the final closing date (by January 23, 2014) and use our commercially reasonable efforts to have it declared effective no later than six months after the final closing date (by March 23, 2014). We filed a registration statement on Form S-1 with the SEC on October 16, 2013, as amended on Form S-1/A filed on October 31, 2013.

Mr. Brady provided us with a waiver of his registration rights under the Securities Purchase Agreement in this registration statement with respect to his 5,157,008 shares of common stock and like number of shares underlying warrants.  In exchange for such waiver, we agreed to grant to Mr. Brady “piggyback” registration rights to include his shares in future registrations of ours (other than on Forms S-4 and S-8) and up to four demand registration rights to compel registration of those shares for resale. Additionally, the unaffiliated noteholders received their securities as exempt from the registration requirements since they met the required holding period of one-year based on the original issuance date of the promissory note. Therefore, we are only required to register 8,730,000 of these shares of common stock that are currently issued and outstanding and 9,079,464 shares of common stock that the investors may receive if they exercise their warrants. Due to the large number of securities issued, we are only seeking current registration of 8,730,000 shares of common stock and 174,732 shares of common stock that the investors may receive if they exercise their warrants.

Other Restricted Share Issuance

On September 30, 2013, we entered into an agreement pursuant to which we issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services. Under the terms of the agreement, we agreed to register these shares upon filing of our next registration statement. Due to the large number of securities for which we are requesting registration, we are only seeking current registration for 411,545 of these shares. We

37

filed a registration statement on Form S-1 with the SEC on October 16, 2013, as amended on Form S-1/A filed on October 31, 2013.

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

NONE

ITEM 4 – MINE SAFETY DISCLOSURES

N/A

ITEM 5 - OTHER INFORMATION

NONE

38

ITEM 6 – EXHIBITS

3.1		Articles of Incorporation (Incorporated by reference to the Company’s registration statement on Form S-1 filed with the Securities and Exchange Commission on July 2, 2010).
3.2		Certificate of Amendment to the Articles of Incorporation (Incorporated by reference to the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on February 15, 2013).
3.3		Certificate of Amendment to the Articles of Incorporation (Incorporated by reference to the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on May 16, 2011).
3.4		Bylaws (Incorporated by reference to the Company’s registration statement on Form S-1 filed with the Securities and Exchange Commission on July 2, 2010).
3.5		Certificate of Designation (Incorporated by reference to the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2011).
3.6		Amendment to Certificate of Designation (Incorporated by reference to the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2011).
3.7		Certificate of Change of IZEA, Inc., filed with the Nevada Secretary of State on July 30, 2012 (Incorporated by reference to the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on August 1, 2012).
10.1		Agreement between the Company and Mitchel Laskey, dated December 26, 2012 (Incorporated by reference to Form 10-K, filed with the SEC on March 29, 2013).
10.2		Amended 2011 Equity Incentive Plan as of February 6, 2013 (Incorporated by reference to Form 10-K, filed with the SEC on March 29, 2013).
10.3		Financing Agreement between the Company and Bridge Bank, dated March 1, 2013 (Incorporated by reference to Form 10-K, filed with the SEC on March 29, 2013).
10.4		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated April 11, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2013).
10.5		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated May 22, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on May 28, 2013).
10.6		Loan Extension between IZEA, Inc. and Brian W. Brady dated May 31, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on June 3, 2013).
10.7		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated June 7, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on June 21, 2013).
10.8		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated June 14, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on June 21, 2013).
10.9		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated July 25, 2013 (Incorporated by reference to the Company's current report on Form 8-K filed with the Securities and Exchange Commission on July 30, 2013).
10.10		Loan Agreement and Promissory Note between IZEA, Inc. and Brian W. Brady dated August 12, 2013 (Incorporated by reference to the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2013).
10.11		Form of Securities Purchase Agreement executed by IZEA, Inc. and Investors in the 2013 Private Placement (Incorporated by reference to Form 8-K, filed with the SEC on August 21, 2013).
10.12		Form of Warrant to Purchase Common Stock of IZEA, Inc. issued to Investors in the 2013 Private Placement (Incorporated by reference to Form 8-K, filed with the SEC on August 21, 2013).
31.1	*	Section 302 Certification of Principal Executive Officer and Principal Financial Officer
32.1	**	Section 906 Certification of Principal Executive Officer and Principal Financial Officer
101	***	The following materials from IZEA, Inc.'s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2013 are formatted in XBRL (eXtensible Business Reporting Language):  (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statement of Stockholders' Deficit, (iv) the Consolidated Statements of Cash Flow, and (iv) Notes to the Consolidated Financial Statements.

* Filed herewith.

39

** In accordance with Item 601of Regulation S-K, this Exhibit is hereby furnished to the SEC as an accompanying document and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933.

***   In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	IZEA, Inc. a Nevada corporation
November 7, 2013	By:	/s/ Edward Murphy
		Edward Murphy President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer)

41

EX-31.1

EXHIBIT 31.1

Certification by Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002

I, Edward Murphy, certify that:

1. I have reviewed this report on Form 10-Q of IZEA, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  November 7, 2013

/s/ Edward Murphy

Edward Murphy

President and Chief Executive Officer

(Principal Executive Officer and Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of IZEA, Inc., a Nevada corporation (the “Company”), on Form 10-Q for the period ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward Murphy, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated:  November 7, 2013

/s/ Edward Murphy

Edward Murphy

President and Chief Executive Officer

(Principal Executive Officer and Principal Financial Officer)

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Derivative [Line Items]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

The reconciliation of our derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2013 is as follows:

	Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	820,202
Total loss included in earnings	765,907
Balance upon conversion, August 15, 2013	$	1,586,109

DERIVATIVE FINANCIAL INSTRUMENTS

The Company entered into financing transactions that gave rise to derivative liabilities, which are accounted for at fair value, in the Company's financial statements. Changes in the fair value of derivative financial instruments are required to be recorded in other income in the period of change, and are reflected in the Company's consolidated statements of operations as "loss on exchange of warrants and debt" or as "change in fair value of derivatives and notes payable carried at fair value."

Warrant Liability

2012 Activity:

The Company determined that 153,882 warrant shares issued in its May 2011 Offering, 110,000 warrant shares issued in its September 2012 public offering and 250 warrant shares issued in July 2011 for a customer list acquisition, require classification as a liability due to certain registration rights and listing requirements in the agreements.

In May and June 2012, pursuant to separate private transactions with nineteen warrant holders, the Company redeemed warrants to purchase an aggregate of 123,052 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemptions were treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the carrying value of the warrants received in the exchange is recorded in the Company's consolidated statements of operations in other income under loss on exchange and change in fair value of derivatives. As a result of the exchange, the Company recognized a loss on the exchange of these warrants in the amount of $802,123 during the three and nine months ended September 30, 2012.

2013 Activity:

In February 2013, pursuant to a private transaction with a warrant holder, the Company redeemed a warrant to purchase 5,001 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemption was treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the zero carrying value of the warrant received in the exchange. As a result, the Company recognized a loss on exchange of warrants in the amount of $732 during the three months ended March 31, 2013.

From August 15, 2013 through September 23, 2013, the Company issued warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share pursuant to the terms of the Securities Purchase Agreements signed in its 2013 Private Placement (Note 4). The Company determined that these warrants require classification as a liability due to certain registration rights in the agreements that require the Company to file a registration statement with the SEC for purposes of registering the resale of the shares underlying these warrants by January 23, 2014 and use its commercially reasonable efforts to have it declared effective no later than March 23, 2014. The Company determined the fair value of these warrants on their issuance date to be $2,344,899.

During the three months ended September 30, 2013 and 2012, the Company recorded income of $207,462 and $10,903, respectively, due to the change in the fair value of its warrant liability. During the nine months ended September 30, 2013 and 2012, the Company recorded income of $207,682 and $738,628, respectively, due to the change in the fair value of its warrant liability.

The following table summarizes the Company's activity and fair value calculations of its derivative warrants for the nine months ended September 30, 2013:

	Linked Common Shares to Derivative Warrants		Warrant Liability
Balance, December 31, 2012	128,350		$	2,750
Issuance of warrants to investors in 2013 Private Placement	14,236,472		2,344,899
Exchange of warrants for common stock	(4,546	)	—
Change in fair value of derivatives	—		(207,682		)
Balance, September 30, 2013	14,360,276		$	2,139,967

The Company's warrants were valued on the applicable dates using a Binomial Lattice Option Valuation Technique (“Binomial”). Significant inputs into this technique as of December 31, 2012, May 31, 2013, August 15, 2013 - September 23, 2013 and September 30, 2013 are as follows:

Binomial Assumptions	December 31, 2012	May 31, 2013	August 15, 2013 - September 23, 2013	September 30, 2013
Fair market value of asset (1)	$0.22	$0.20	$0.28-$0.37	$0.33
Exercise price	$1.25	$0.25-$0.50	$0.25-$0.50	$0.25-$1.25
Term (2)	4.7 years	5.0 years	5.0 years	3.9 years - 4.9 years
Implied expected life (3)	4.6 years	5.0 years	5.0 years	3.9 years - 4.9 years
Volatility range of inputs (4)	45.82%--84.21%	50.14%--83.49%	48.46%--81.72%	50.38%--80.40%
Equivalent volatility (3)	60.20%	59.15%	56.57%--57.55%	54.84%--56.50%
Risk-free interest rate range of inputs (5)	0.11%--0.72%	1.07%--1.05%	0.04%--1.72%	0.02%--1.39%
Equivalent risk-free interest rate (3)	0.32%	0.43%	0.56%--0.69%	0.32%--0.52%

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the binomial.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2), above.

(5)  The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (2), above.

Convertible Notes-Carried At Fair Value

$750,000 Notes Payable:

On May 31, 2013, the Company signed a loan extension and conversion agreement with Brian W. Brady, a director of the Company, that extended the due date on its $750,000 notes payable to August 31, 2013 and added a conversion feature in which the notes and all accrued interest thereon will be converted into equity upon the closing of the next private placement on the same terms and conditions that will be applicable to other investors in the future financing. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company.

The Company concluded that since the modification resulted in the addition of a conversion feature, the notes no longer met the definition of being indexed to the Company's own stock in accordance with ASC 815, Derivatives and Hedging. Accordingly, the modification of these loans on May 31, 2013 resulted in a change that required either bifurcation of the embedded conversion feature or the Company could choose to record the entire fair value of the convertible notes at fair value. Management chose to record the promissory notes  at their fair value using a common stock equivalent approach, with changes in fair value being reported as “Change in the fair value of derivatives and notes payable carried at fair value, net” in the accompanying consolidated statements of operations.

As discussed in Note 2, on August 15, 2013, Mr. Brady converted the $750,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The $750,000 convertible notes payable had a fair value of $820,202 on May 31, 2013 (the modification date) and $1,586,109 on August 15, 2013 (the conversion date). This change in fair value resulted in an expense of $422,554 and $765,907 during the three and nine months ended September 30, 2013, respectively.

Since the Company was currently negotiating a future financing at the time of modification, management believed there was a high probability that the future financing would occur, the common stock equivalent value of the notes was based on the negotiated terms of the future financing.

The newly-issued warrant, indexed to 1,000,000 shares of common stock, met the conditions for equity classification and the fair value of $88,000 was recorded in the Company's consolidated balance sheet as additional paid-in capital during the three months ended June 30, 2013. The value of the additional warrant and the restricted stock units to be issued upon the occurrence of the future financing were also recorded in additional paid-in capital. The additional warrant was valued at $280,500, using a binomial lattice option valuation technique and the restricted stock units were valued at $337,500 based on the Company's current market prices.

The modification added a substantial conversion feature so the debt instruments were considered “substantially” different after the modification and extinguishment accounting was applicable. Since the modification triggered debt extinguishment accounting, the fair value of the additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share and the additional 1,687,500 restricted stock units were considered in the determination of the amount of extinguishment loss. However, since Mr. Brady is a board member and shareholder, the transaction is considered to be with a related party and thus, the extinguishment is in essence a capital transaction. As such, the difference between the carrying amount of the original notes of $755,227 was compared to the fair value of the modified notes plus the fair value of the warrants issued on May 31, 2013, plus the warrants and restricted stock to be issued in the future, which equaled $1,526,202. The difference of $770,975 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

As of the date of modification, May 31, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,021,000	$	0.200	604,200
Warrants - $0.25 exercise price	1,510,500	$	0.088	132,924
Warrants - $0.50 exercise price	1,510,500	$	0.055	83,078
Common stock equivalent value				820,202

On the conversion date of August 15, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,064,944	$	0.350	1,072,730
Warrants - $0.25 exercise price	1,532,472	$	0.199	304,962
Warrants - $0.50 exercise price	1,532,472	$	0.136	208,417
Common stock equivalent value				1,586,109

The following table summarizes the Company's activity and fair value calculations of its derivative notes payable for the nine months ended September 30, 2013:

	Linked Common Shares to Convertible Notes Payable		Bifurcated Compound Embedded Derivatives			Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	537,146		$	11,817		$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	6,042,000		—			820,202
Conversion of notes into common stock	(6,903,872	)	(12,461		)	(1,586,109		)
Change in fair value of derivatives	324,726		644			765,907
Balance, September 30, 2013	—		$	—		$	—

The common stock was valued at the trading market price on the date of the valuation. The warrants were valued using a Binomial model using inputs as detailed above under the Binomial Assumptions table.

$520,000 Notes Payable:

On June 7, June 14, July 25, and August 12, 2013, the Company entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, the Company received short-term loans totaling $520,000 due on August 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. Although the notes did not contain a conversion feature, the Company permitted Mr. Brady to convert the $520,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The difference between the carrying amount of the original notes and accrued interest of $523,016 was compared to the $1,082,642 fair value of the 2,092,064 shares of common stock and 2,092,064 warrants received on August 15, 2013 and since the transaction is considered to be with a related party, the difference of $559,626 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

Fair value measurements

Assets and liabilities that are recorded at fair value on a recurring basis are measured in accordance with ASC 820-10-05, Fair Value Measurements. The Brian Brady Promissory Notes originally issued April 11, 2013 and May 22, 2013 and modified on May 31, 2013 to extend the term and add a conversion feature are classified within Level 3 of the fair value hierarchy as they were valued using unobservable inputs including significant assumptions of the Company and other market participants.

The reconciliation of our derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2013 is as follows:

	Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	820,202
Total loss included in earnings	765,907
Balance upon conversion, August 15, 2013	$	1,586,109

Compound Embedded Derivative

The Company concluded that the compound embedded derivative in its $550,000 senior secured promissory note issued on February 3, 2012 and its $75,000 convertible promissory note as modified on June 6, 2012 (see Note 2) required bifurcation and liability classification as derivative financial instruments because they were not considered indexed to the Company's own stock as defined in ASC 815, Derivatives and Hedging. The noteholders did not elect to convert the $75,000 convertible promissory note prior its maturity date on December 4, 2012. Therefore, the conversion feature expired and no further derivative valuation is required. On February 4, 2013, the Company satisfied all of its remaining obligations under its $550,000 senior secured promissory note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share. The Company recorded the $12,461 value of the compound embedded derivative on the conversion date as a charge to additional paid-in capital. As of February 4, 2013, all convertible notes in which the conversion feature had been bifurcated and recorded at fair value, had been converted. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the nine months ended September 30, 2013 in the amount of $644. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the three and nine months ended September 30, 2012 in the amount of $39,257 and $56,989, respectively.

The Monte Carlo Simulation (“MCS”) technique was used to calculate the fair value of the compound embedded derivatives because it provides for the necessary assumptions and inputs. The MCS technique, which is an option-based model, is a generally accepted valuation technique for valuing embedded conversion features in hybrid convertible notes, because it is an open-ended valuation model that embodies all significant assumption types, and ranges of assumption inputs that the Company agrees would likely be considered in connection with the arms-length negotiation related to the transference of the instrument by market participants. In addition to the typical assumptions in a closed-end option model, such as volatility and a risk free rate, MCS incorporates assumptions for interest risk, credit risk and redemption behavior. In addition, MCS breaks down the time to expiration into potentially a large population of time intervals and steps. However, there may be other circumstances or considerations, other than those addressed herein, that relate to both internal and external factors that would be considered by market participants as it relates specifically to the Company and the subject financial instruments. The effects, if any, of these considerations cannot be reasonably measured, quantified or qualified.

The following table shows the summary calculations arriving at the compound embedded derivative value as of December 31, 2012 and on the final conversion date of February 4, 2013. See the assumption details for the composition of these calculations.

Compound Embedded Derivative	December 31, 2012		February 4, 2013
Notional amount	$	106,355	$	112,150
Conversion price	0.198		0.145
Linked common shares (1)	537,146		773,983
MCS value per linked common share (2)	0.022		0.016
Total	$	11,817	$	12,461

(1) The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares increased as the trading market price decreased and decreased as the trading market price increased.

(2) The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.

The significant inputs into the Monte Carlo Simulation used to calculate the compound embedded derivative values as of December 31, 2012 and on the final conversion date of February 4, 2013 are as follows:

Monte Carlo Assumptions	December 31, 2012	February 4, 2013 (7)
Fair market value of asset (1)	$0.22	$0.16
Conversion price	$0.20	$0.14
Term (2)	0.09 years	n/a
Implied expected life (3)	0.09 years	n/a
Volatility range of inputs (4)	16.12%--40.17%	n/a
Equivalent volatility (3)	30.7%	n/a
Risk adjusted interest rate range of inputs (5)	10.00%	n/a
Equivalent risk-adjusted interest rate (3)	10.00%	n/a
Credit risk-adjusted interest rate (6)	15.63%	n/a

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2) above.

(5) CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument.

(6) The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

(7) Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

Schedule of Compound Embedded Derivative [Table Text Block]

The following table shows the summary calculations arriving at the compound embedded derivative value as of December 31, 2012 and on the final conversion date of February 4, 2013. See the assumption details for the composition of these calculations.

Compound Embedded Derivative	December 31, 2012		February 4, 2013
Notional amount	$	106,355	$	112,150
Conversion price	0.198		0.145
Linked common shares (1)	537,146		773,983
MCS value per linked common share (2)	0.022		0.016
Total	$	11,817	$	12,461

(1) The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares increased as the trading market price decreased and decreased as the trading market price increased.

(2) The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.

Binomial Lattice Option Valuation Technique [Member]

Derivative [Line Items]

Schedule of Price Risk Derivatives [Table Text Block]

The Company's warrants were valued on the applicable dates using a Binomial Lattice Option Valuation Technique (“Binomial”). Significant inputs into this technique as of December 31, 2012, May 31, 2013, August 15, 2013 - September 23, 2013 and September 30, 2013 are as follows:

Binomial Assumptions	December 31, 2012	May 31, 2013	August 15, 2013 - September 23, 2013	September 30, 2013
Fair market value of asset (1)	$0.22	$0.20	$0.28-$0.37	$0.33
Exercise price	$1.25	$0.25-$0.50	$0.25-$0.50	$0.25-$1.25
Term (2)	4.7 years	5.0 years	5.0 years	3.9 years - 4.9 years
Implied expected life (3)	4.6 years	5.0 years	5.0 years	3.9 years - 4.9 years
Volatility range of inputs (4)	45.82%--84.21%	50.14%--83.49%	48.46%--81.72%	50.38%--80.40%
Equivalent volatility (3)	60.20%	59.15%	56.57%--57.55%	54.84%--56.50%
Risk-free interest rate range of inputs (5)	0.11%--0.72%	1.07%--1.05%	0.04%--1.72%	0.02%--1.39%
Equivalent risk-free interest rate (3)	0.32%	0.43%	0.56%--0.69%	0.32%--0.52%

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the binomial.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2), above.

(5)  The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (2), above.

Common Stock Indexed Fair Value Based on Calculated Indexed Shares [Text Block]

As of the date of modification, May 31, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,021,000	$	0.200	604,200
Warrants - $0.25 exercise price	1,510,500	$	0.088	132,924
Warrants - $0.50 exercise price	1,510,500	$	0.055	83,078
Common stock equivalent value				820,202

On the conversion date of August 15, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,064,944	$	0.350	1,072,730
Warrants - $0.25 exercise price	1,532,472	$	0.199	304,962
Warrants - $0.50 exercise price	1,532,472	$	0.136	208,417
Common stock equivalent value				1,586,109

Monte Carlo Simulation Technique [Member]

Derivative [Line Items]

Schedule of Price Risk Derivatives [Table Text Block]

The significant inputs into the Monte Carlo Simulation used to calculate the compound embedded derivative values as of December 31, 2012 and on the final conversion date of February 4, 2013 are as follows:

Monte Carlo Assumptions	December 31, 2012	February 4, 2013 (7)
Fair market value of asset (1)	$0.22	$0.16
Conversion price	$0.20	$0.14
Term (2)	0.09 years	n/a
Implied expected life (3)	0.09 years	n/a
Volatility range of inputs (4)	16.12%--40.17%	n/a
Equivalent volatility (3)	30.7%	n/a
Risk adjusted interest rate range of inputs (5)	10.00%	n/a
Equivalent risk-adjusted interest rate (3)	10.00%	n/a
Credit risk-adjusted interest rate (6)	15.63%	n/a

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2) above.

(5) CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument.

(6) The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

(7) Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

Warrant [Member]

Derivative [Line Items]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The following table summarizes the Company's activity and fair value calculations of its derivative warrants for the nine months ended September 30, 2013:

	Linked Common Shares to Derivative Warrants		Warrant Liability
Balance, December 31, 2012	128,350		$	2,750
Issuance of warrants to investors in 2013 Private Placement	14,236,472		2,344,899
Exchange of warrants for common stock	(4,546	)	—
Change in fair value of derivatives	—		(207,682		)
Balance, September 30, 2013	14,360,276		$	2,139,967

Debt [Member]

Derivative [Line Items]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The following table summarizes the Company's activity and fair value calculations of its derivative notes payable for the nine months ended September 30, 2013:

	Linked Common Shares to Convertible Notes Payable		Bifurcated Compound Embedded Derivatives			Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	537,146		$	11,817		$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	6,042,000		—			820,202
Conversion of notes into common stock	(6,903,872	)	(12,461		)	(1,586,109		)
Change in fair value of derivatives	324,726		644			765,907
Balance, September 30, 2013	—		$	—		$	—

XML

Consolidated Unaudited Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Revenue	$ 1,565,851	$ 1,058,836	$ 4,666,399	$ 3,876,508
Cost of sales	499,127	434,019	1,846,130	1,593,790
Gross profit	1,066,724	624,817	2,820,269	2,282,718
Operating expenses:
General and administrative	1,655,727	1,335,858	4,594,888	4,807,610
Sales and marketing	63,436	219,584	272,695	985,466
Total operating expenses	1,719,163	1,555,442	4,867,583	5,793,076
Loss from operations	(652,439)	(930,625)	(2,047,314)	(3,510,358)
Other income (expense):
Interest expense	(14,439)	(33,495)	(52,435)	(77,762)
Loss on exchange of warrants and debt	(93,482)	(37,610)	(94,214)	(802,123)
Change in fair value of derivatives and notes payable carried at fair value, net	(215,092)	50,160	(558,869)	681,639
Other income (expense), net	150	0	230	455
Total other income (expense)	(322,863)	(20,945)	(705,288)	(197,791)
Net loss	$ (975,302)	$ (951,570)	$ (2,752,602)	$ (3,708,149)
Weighted average common shares outstanding – basic and diluted (shares)	12,996,717	2,265,222	9,034,361	2,266,524
Loss per common share – basic and diluted (per share)	$ (0.08)	$ (0.42)	$ (0.30)	$ (1.64)

XML

Stockholders' Deficit

9 Months Ended

Sep. 30, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

STOCKHOLDERS' DEFICIT

On February 6, 2013, the Company's Board of Directors and holders of a majority of the outstanding shares of common stock of the Company approved an increase in the number of authorized shares of common stock of the Company from 12,500,000 shares to 100,000,000 shares (the “Share Increase”). The Company amended its Articles of Incorporation to effect the Share Increase by filing a Certificate of Amendment with the Nevada Secretary of State on February 11, 2013. The Company has authorized 10,000,000 shares of preferred stock with a par value of $0.0001 of which 240 shares were designated as Series A Convertible Preferred Stock on May 25, 2011.

2013 Private Placement

From August 15, 2013 through September 23, 2013, the Company raised $2,182,500 in cash through the sale of 8,730,000 shares of its common stock at a price of $0.25 per share in its 2013 Private Placement. Additionally, as discussed in Note 2, the Company converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of its common stock at an effective price of $0.25 per share. The Company also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes. The Company determined that the initial fair value of these warrants on their issuance dates total $2,344,899. Total costs of the private placement were $1,646,874 which included $150,355 in cash expenses, $2,344,899 related to the investor warrants noted above, less $848,380 related to change in fair value of Brady debt and loss on exchange of other convertible notes prior to conversion. As a result of the above transactions related to the private placement, the Company reported $1,912,244 as an increase in common stock and additional paid-in capital on the statement of stockholders deficit.

Pursuant to the terms of the Securities Purchase Agreements issued in the 2013 Private Placement, the Company agreed to file a registration statement with the SEC for purposes of registering the resale of these shares of common stock and the shares underlying the warrants within four months after the final closing date (by January 23, 2014) and use its commercially reasonable efforts to have it declared effective no later than six months after the final closing date (by March 23, 2014). The Company filed a registration statement on Form S-1 with the SEC on October 16, 2013, as amended on Form S-1/A filed on October 31, 2013.

Convertible Securities

From October 2012 through December 2012, the holders of the Company's $550,000 senior secured promissory note converted $437,850 of note value into 2,069,439 shares of common stock at an average conversion rate of $.21 per share. The Company recorded the related $83,663 value of the compound embedded derivative on the converted portion as a charge to additional paid-in capital. On February 4, 2013, the Company satisfied all of its remaining obligations under its $550,000 senior secured promissory note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share. The Company recorded the $12,461 value of the compound embedded derivative on the conversion date as a charge to additional paid-in capital.

Additional Warrant Transactions

During the nine months ended September 30, 2013, pursuant to private transactions with warrant holders, the Company redeemed warrants to purchase 5,001 shares of common stock for the same number of shares without the Company receiving any further cash consideration. As a result of the exchange, the Company recognized a loss on the exchange of the warrants in the amount $732 during the nine months ended September 30, 2013.

On March 1, 2013, the Company entered into a $1.5 million secured credit facility agreement with Bridge Bank, N.A. of San Jose, California. In connection with this agreement, the Company issued a warrant with an expiration date after 5 years to purchase up to 58,139 shares of common stock for $15,000 ($.258 per share). This warrant met the conditions for equity classification and the fair value of $7,209, as determined using a binomial lattice option valuation technique, was recorded in the Company's consolidated balance sheet as an increase in deferred finance costs and paid-in capital.

On May 31, 2013, the Company signed a loan extension and conversion agreement with Brian W. Brady, a director of the Company, that extended the due date on its $750,000 notes payable to August 31, 2013. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement, completed on August 15, 2013, it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company. These warrants and restricted stock units met the conditions for equity classification and the fair value of $706,000, as determined using a binomial lattice option valuation technique, was recorded in the Company's consolidated balance sheet as an increase in additional paid-in capital.

Stock Options

On May 12, 2011, the Company adopted the 2011 Equity Incentive Plan (the “May 2011 Plan”) that authorizes, subsequent to the latest amendment on February 6, 2013, 11,613,715 shares of common stock to be granted for future stock awards to employees, directors or contractors. As of September 30, 2013, the Company had 4,728,955 shares of common stock available for future grants under the May 2011 Plan.

On August 22, 2011, the Company adopted the 2011 B Equity Incentive Plan (the “August 2011 Plan”) reserving for issuance an aggregate of 87,500 shares of common stock under the August 2011 Plan. As of September 30, 2013, the Company had 50,000 shares of common stock available for future grants under the August 2011 Plan.

Under both the May 2011 Plan and the August 2011 Plan (together, the "2011 Equity Incentive Plans"), the Board of Directors determines the exercise price to be paid for the shares, the period within which each option may be exercised, and the terms and conditions of each option. The exercise price of the incentive and non-qualified stock options may not be less than 100% of the fair market value per share of the Company’s common stock on the grant date. If an individual owns stock representing more than 10% of the outstanding shares, the price of each share of an incentive stock option must be equal to or exceed 110% of fair market value. Unless otherwise determined by the board of directors at the time of grant, the right to purchase shares covered by any options under the 2011 Equity Incentive Plans typically vest over the requisite service period as follows: 25% of options shall vest one year from the date of grant and the remaining options shall vest monthly, in equal increments over the following three years. The term of the options is up to ten years. The Company issues new shares to the optionee for any stock awards or options exercised pursuant to its equity incentive plans.

A summary of option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

Options Outstanding	Common Shares		Weighted Average Exercise Price		Weighted Average Remaining Life (Years)
Outstanding at December 31, 2011	114,445		$	17.61	4.4
Granted	378,293		5.74
Exercised	(551	)	2.00
Forfeited	(100,210	)	18.81
Outstanding at December 31, 2012	391,977		$	5.87	4.3
Granted	7,640,062		0.25
Exercised	—		—
Forfeited	(1,111,013	)	0.45
Outstanding at September 30, 2013	6,921,026		$	0.54	8.8
Exercisable at September 30, 2013	1,611,198		$	0.89	8.8

During the year ended December 31, 2012, options were exercised into 551 shares of the Company's common stock for cash proceeds of $1,099. The intrinsic value of these options was $5,769. During the three and nine months ended September 30, 2013, no options were exercised. There is no aggregate intrinsic value on the outstanding or exercisable options as of September 30, 2013 since the weighted average exercise price per share exceeded the fair value on such date.

A summary of the nonvested stock option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

Nonvested Options	Common Shares		Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest
Nonvested at December 31, 2011	57,516		$	2.73	2.5
Granted	378,293		2.17
Vested	(83,429	)	2.26
Forfeited	(43,753	)	2.78
Nonvested at December 31, 2012	308,627		$	2.17	2.9
Granted	7,640,062		0.20
Vested	(1,541,284	)	0.37
Forfeited	(1,097,577	)	0.21
Nonvested at September 30, 2013	5,309,828		$	0.27	3.6

Stock-based compensation cost related to stock options granted under the 2011 Equity Incentive Plans is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option-pricing model that uses the assumptions stated in Note 1. Total stock-based compensation expense recognized on awards outstanding during the three months ended September 30, 2013 and 2012 was $190,877 and $31,894, respectively. Total stock-based compensation expense recognized on awards outstanding during the nine months ended September 30, 2013 and 2012 was $359,251 and $150,878, respectively. Stock-based compensation expense is recorded as a general and administrative expense in the Company's consolidated statements of operations. Future compensation related to nonvested awards expected to vest of $696,167 is estimated to be recognized over the weighted-average vesting period of three years.

Restricted Stock Issued for Services

In May 2012 and July 2012, the Company entered into seven agreements for celebrity endorsements of the Company's platforms whereby the Company paid cash of $100,000 and issued a total of 135,521 shares of restricted common stock. In the majority of the agreements, the restricted stock vested 25% immediately upon the signing of the agreements and then vests 6.25% per month over the following twelve months during the term of the agreements.

On June 12, 2012, the Company issued 1,200 shares of restricted common stock to its investors' counsel in order to pay for legal services totaling $6,000 related to the issuance of the $75,000 convertible promissory note.

On July 2, 2012, the Company issued 71,221 shares of restricted common stock to its former legal counsel in order to pay for general legal services totaling $356,103.

In August and September 2012, the Company issued 35,000 and 69,445 respective shares of restricted common stock as a result of a stock subscription agreement with its director, Brian Brady.

On January 3, 2013, the Company issued 60,000 shares of restricted stock pursuant to a twelve-month compensation arrangement with Mitchel J. Laskey for his service as a director and Chairman of the Company's Board of Directors.

On January 3, 2013, the Company issued 20,000 shares of restricted stock valued at $4,820 in order to pay for a small asset purchase.

Effective January 3, 2013, the Company entered into a twelve-month agreement to pay $4,000 per month beginning January 2013 to a firm who would provide investor relations services. In accordance with the agreement, the Company issued 100,000 shares of restricted common stock on January 15, 2013 and agreed to issue an additional 100,000 restricted shares on or before July 15, 2013. This agreement was mutually terminated on May 1, 2013 for no further cash consideration with the Company agreeing to issue the final installment of 100,000 shares of restricted common stock upon the termination of the agreement.

On May 16, 2013, the Company issued 30,000 shares of restricted common stock valued at $6,000 to settle an outstanding balance with a vendor.

On September 30, 2013, the Company entered into an agreement pursuant to which it issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services.

The following tables contain summarized information about nonvested restricted stock outstanding at September 30, 2013:

Restricted Stock	Common Shares
Nonvested at December 31, 2011	—
Granted	312,387
Vested	(263,805	)
Forfeited	—
Nonvested at December 31, 2012	48,582
Granted	1,133,090
Vested	(1,181,672	)
Forfeited	—
Nonvested at September 30, 2013	—

Total stock-based compensation expense recognized for restricted awards issued for services during the three months ended September 30, 2013 was $289,303 of which $1,222 is included in sales and marketing expense and $288,081 is included in general and administrative expense in the consolidated statements of operations. Total stock-based compensation expense recognized for restricted awards issued for services during the nine months ended September 30, 2013 was $384,088 of which $14,027 is included in sales and marketing expense and $370,061 is included in general and administrative expense in the consolidated statements of operations. The fair value of the services are based on the value of the Company's common stock over the term of service. The fair value of the restricted stock issued during the three and nine months ended September 30, 2013 was $288,081 and $366,301, respectively, and the change in the fair value of the issued but nonvested shares was $266 and $7,098, respectively.

XML

Summary of Significant Accounting Policies - Software Costs (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Accounting Policies [Abstract]
Software development costs	$ 146,031	$ 244,878

XML

Stockholders' Deficit (Tables)

9 Months Ended

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

Options Outstanding	Common Shares		Weighted Average Exercise Price		Weighted Average Remaining Life (Years)
Outstanding at December 31, 2011	114,445		$	17.61	4.4
Granted	378,293		5.74
Exercised	(551	)	2.00
Forfeited	(100,210	)	18.81
Outstanding at December 31, 2012	391,977		$	5.87	4.3
Granted	7,640,062		0.25
Exercised	—		—
Forfeited	(1,111,013	)	0.45
Outstanding at September 30, 2013	6,921,026		$	0.54	8.8
Exercisable at September 30, 2013	1,611,198		$	0.89	8.8

Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity [Table Text Block]

A summary of the nonvested stock option activity under the 2011 Equity Incentive Plans for the year ended December 31, 2012 and the nine months ended September 30, 2013 is presented below:

Nonvested Options	Common Shares		Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest
Nonvested at December 31, 2011	57,516		$	2.73	2.5
Granted	378,293		2.17
Vested	(83,429	)	2.26
Forfeited	(43,753	)	2.78
Nonvested at December 31, 2012	308,627		$	2.17	2.9
Granted	7,640,062		0.20
Vested	(1,541,284	)	0.37
Forfeited	(1,097,577	)	0.21
Nonvested at September 30, 2013	5,309,828		$	0.27	3.6

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity [Table Text Block]

The following tables contain summarized information about nonvested restricted stock outstanding at September 30, 2013:

Restricted Stock	Common Shares
Nonvested at December 31, 2011	—
Granted	312,387
Vested	(263,805	)
Forfeited	—
Nonvested at December 31, 2012	48,582
Granted	1,133,090
Vested	(1,181,672	)
Forfeited	—
Nonvested at September 30, 2013	—

XML

Loss Per Common Share (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	27,350,213	1,314,858	27,350,213	1,314,858
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	6,921,026	393,494	6,921,026	393,494
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	18,605,999	128,434	18,605,999	128,434
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	1,819,400		1,819,400
Potential conversion of series A convertible preferred [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	3,788	3,788	3,788	3,788
Potential conversion of promissory note payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	0	789,142	0	789,142

XML

Derivative Financial Instruments - Compound Embedded Derivative - Monte Carlo Assumption (Details) (Monte Carlo Simulation Technique [Member], Compound Embedded Derivative [Member], USD $)	0 Months Ended		12 Months Ended
	Feb. 04, 2013		Dec. 31, 2012
Derivative [Line Items]
Fair market value of asset (per share)	$ 0.16	[1],[2]	$ 0.22	[1]
Conversion price (per share)	$ 0.145	[2]	$ 0.198
Term (in years)			0 years 1 month 1 day	[3]
Implied expected life (in years)			0 years 1 month 1 day	[4]
Equivalent volatility (percentage)			30.70%	[4]
Risk adjusted interest rate range of inputs (percentage)			10.00%	[5]
Equivalent risk-adjusted interest rate (percentage)			10.00%	[4]
Credit risk-adjusted interest rate (percentage)			15.63%	[6]
Minimum [Member]
Derivative [Line Items]
Volatility range of inputs (percentage)			16.12%	[7]
Maximum [Member]
Derivative [Line Items]
Volatility range of inputs (percentage)			40.17%	[7]

[1] The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

[2] Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

[3] The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

[4] The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS.

[5] CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument.

[6] The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

[7] The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2) above.

XML

Summary of Significant Accounting Policies - Stock-Based Compensation (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Significant Accounting Policies [Line Items]
Current average expected forfeiture rate (percentage)	50.21%		50.21%
Equity Incentive 2011 Plan [Member]
Significant Accounting Policies [Line Items]
Expected term (in years)	10 years	5 years	9 years	5 years
Weighted average volatility (percentage)	51.72%	54.46%	52.02%	54.90%
Weighted average risk free interest rate (percentage)	2.74%	0.65%	2.27%	0.75%
Expected dividends	0.00%	0.00%	0.00%	0.00%

XML

Summary of Significant Accounting Policies - Advertising Costs (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Accounting Policies [Abstract]
Advertising expense	$ 12,000	$ 60,000	$ 56,000	$ 359,000

XML

Stockholders' Deficit - Restricted Stock Issued for Services (Details) (USD $)	0 Months Ended			1 Months Ended			0 Months Ended				3 Months Ended	9 Months Ended	1 Months Ended		0 Months Ended	1 Months Ended	9 Months Ended	0 Months Ended		3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Jan. 03, 2013	Jun. 12, 2012	Sep. 30, 2012	Aug. 31, 2012	May 31, 2012	Sep. 30, 2013 Restricted Stock [Member]	May 16, 2013 Restricted Stock [Member]	Jan. 03, 2013 Restricted Stock [Member]	Jul. 02, 2012 Restricted Stock [Member]	Sep. 30, 2013 Restricted Stock [Member]	Sep. 30, 2013 Restricted Stock [Member]	May 31, 2012 Immediately following signed agreements [Member] Restricted Stock [Member]	May 31, 2012 Each month for 12 months [Member] Restricted Stock [Member]	May 04, 2012 Convertible Promissory Note [Member]	Jan. 31, 2013 Board of Directors Chairman [Member] Restricted Stock Units (RSUs) [Member]	Sep. 30, 2013 Board of Directors Chairman [Member] Restricted Stock Units (RSUs) [Member]	Jan. 03, 2013 Investor Relations Services [Member]	Jan. 03, 2013 Investor Relations Services [Member] Restricted Stock [Member]	Sep. 30, 2013 Selling and Marketing Expense [Member] Restricted Stock [Member]	Sep. 30, 2013 Selling and Marketing Expense [Member] Restricted Stock [Member]	Sep. 30, 2013 General and Administrative Expense [Member] Restricted Stock [Member]	Sep. 30, 2013 General and Administrative Expense [Member] Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash paid For celebrity endorsements						$ 100,000
Restricted shares issued for celebrity endorsements						135,521
Share-based compensation arrangement by share-based payment award, equity instruments other than options, percentage vested													25.00%	6.25%
Stock Issued during period, value, restricted stock award, gross			1,200	69,445	35,000
Debt issuance cost															6,000
Debt instrument, face amount (in dollars)															75,000
Stock Issued during period, shares, issued for services							823,090	30,000	20,000	71,221									100,000
Stock issued during period, value, issued for services								6,000		356,103
Share-based compensation arrangement by share-based payment award, shares issued in period																60,000	60,000
Stock issued during period, value, purchase of assets		4,820
Payments for professional services																		4,000
Shares reserved for future issuance																			100,000
Share-based compensation, requisite service period recognition											289,303	384,088								1,222	14,027	288,081	370,061
Share Price, Restricted Stock Granted for Services, Per Share							$ 0.35				$ 0.35	$ 0.35
Legal Fees Reduction, Settled by Issuance of Restricted Stock	288,081
Fair value of stock issued during period											288,081	366,301
Change in fair value of stock issued during period											$ 266	$ 7,098

XML

Derivative Financial Instruments - Binomial Assumptions (Details) (Warrant [Member], Binomial Lattice Option Valuation Technique [Member], USD $)	0 Months Ended		1 Months Ended		9 Months Ended		12 Months Ended
	May 31, 2013		Sep. 23, 2013		Sep. 30, 2013		Dec. 31, 2012
Derivative [Line Items]
Fair market value of asset (per share)	$ 0.20	[1]			$ 0.33		$ 0.22	[1]
Exercise price (per share)							$ 1.25
Term (in years)	5 years 0 months	[2]	5 years 0 months	[2]			4 years 8 months	[2]
Implied expected life (in years)	5 years 0 months	[3]	5 years 0 months	[3]			4 years 7 months	[3]
Equivalent volatility (percentage)	59.15%	[3]					60.20%	[3]
Equivalent risk-free interest rate (percentage)	0.43%	[3]					0.32%	[3]
Minimum [Member]
Derivative [Line Items]
Fair market value of asset (per share)			$ 0.28	[1]
Exercise price (per share)	$ 0.25		$ 0.25		$ 0.25
Term (in years)					3 years 10 months 24 days	[2]
Implied expected life (in years)					3 years 10 months 24 days	[3]
Volatility range of inputs (percentage)	50.14%	[4]	56.57%	[3]	54.84%	[3]	45.82%	[4]
Equivalent volatility (percentage)			48.46%	[4]	50.38%	[4]
Risk-free interest rate range of inputs (percentage)	1.05%	[5]	0.04%	[5]	0.02%	[5]	0.11%	[5]
Equivalent risk-free interest rate (percentage)			0.56%	[3]	0.32%	[3]
Maximum [Member]
Derivative [Line Items]
Fair market value of asset (per share)			$ 0.37	[1]
Exercise price (per share)	$ 0.50		$ 0.50		$ 1.25
Term (in years)					4 years 10 months 24 days	[2]
Implied expected life (in years)					4 years 10 months 24 days	[3]
Volatility range of inputs (percentage)	83.49%	[4]	57.55%	[3]	56.50%	[3]	84.21%	[4]
Equivalent volatility (percentage)			81.72%	[4]	80.40%	[4]
Risk-free interest rate range of inputs (percentage)	1.07%	[5]	1.72%	[5]	1.39%	[5]	0.72%	[5]
Equivalent risk-free interest rate (percentage)			0.69%	[3]	0.52%	[3]

[1] The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

[2] The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

[3] The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the binomial.

[4] The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2), above.

[5] The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (2), above.

XML

Stockholders' Deficit - Private Placement (Details) (USD $)	1 Months Ended	9 Months Ended		1 Months Ended	0 Months Ended		1 Months Ended
	Sep. 23, 2013	Sep. 30, 2013	Aug. 15, 2013	Sep. 23, 2013 Common Stock [Member]	Aug. 15, 2013 Warrants - $0.25 exercise price [Member]	May 31, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.50 exercise price [Member]
Class of Warrant or Right [Line Items]
Share Price				$ 0.25
Class of Warrant or Right, Expiration Period					5 years	5 years	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			349,464				7,118,236	7,118,236
Class of Warrant or Right, Exercise Price of Warrants or Rights							0.25	0.50
Warrants, Fair Value at Issuance			$ 2,344,899
Payments of Stock Issuance Costs	1,646,874
Payments of Stock Issuance Costs, Cash	150,355
Payments of Stock Issuance Costs, Warrants	2,344,899
Income (Loss) in Fair Value of Debt and Exchange of Convertible Notes	848,380
Stock Issued During Period, Value, Increase to Common Stock and Additional Paid in Capital		1,912,244
Proceeds from Issuance of Private Placement	2,182,500
Stock Issued During Period, Shares, New Issues				8,730,000
Debt conversion, converted instrument, amount (in dollars)				$ 1,376,618
Stock Issued During Period, Shares, Conversion of Convertible Securities				5,506,472
Period After Final Closing Date of Private Placement that Registration Statement Must Be Filed	4 months
Period After Final Closing Date of Private Placement that Registration Statement Must Be Made Effective	6 months

XML

Related Party Transactions (Details) (USD $)			1 Months Ended		0 Months Ended	1 Months Ended	9 Months Ended		1 Months Ended
	Aug. 12, 2013 Unsecured Debt [Member]	May 22, 2013 Unsecured Debt [Member]	Sep. 23, 2013 President and Chief Executive Officer [Member]	Sep. 23, 2013 President and Chief Executive Officer [Member] Stock Options [Member]	Dec. 26, 2012 Board of Directors Chairman [Member]	Jan. 31, 2013 Board of Directors Chairman [Member] Restricted Stock Units (RSUs) [Member]	Sep. 30, 2013 Board of Directors Chairman [Member] Restricted Stock Units (RSUs) [Member]	Mar. 31, 2013 Board of Directors Chairman [Member] Restricted Stock Units (RSUs) [Member]	Sep. 23, 2013 Common Stock [Member]
Related Party Transaction [Line Items]
Officers' Compensation			$ 50,000		$ 10,000
Share-based compensation arrangement by share-based payment award, shares issued in period						60,000	60,000
Common stock, capital shares reserved for future issuance (shares)								120,000
Short-term loan	520,000	750,000
Debt instrument, interest rate, stated percentage (percentage)	7.00%
Debt instrument, default interest rate (percentage)	12.00%
Debt conversion, converted instrument, amount (in dollars)									$ 1,376,618
Stock Issued During Period, Shares, Conversion of Convertible Securities									5,506,472
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			4,398,978
Weighted average exercise price, granted			$ 0.25
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award				P10Y

XML

Notes Payable (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Debt Disclosure [Abstract]
Interest Expense, Notes Payable	$ 3,998	$ 24,138	$ 22,397	$ 52,840
Amortization of Financing Costs	$ 7,826	$ 7,666	$ 20,137	$ 18,700

XML

Stockholders' Deficit - Stock Options (Details) (USD $)	9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended				0 Months Ended	12 Months Ended	0 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Stock Options [Member]	Sep. 30, 2012 Stock Options [Member]	Sep. 30, 2013 Stock Options [Member]	Sep. 30, 2012 Stock Options [Member]	Sep. 30, 2013 Equity Incentive 2011 Plan [Member]	Sep. 30, 2012 Equity Incentive 2011 Plan [Member]	Sep. 30, 2013 Equity Incentive 2011 Plan [Member]	Sep. 30, 2012 Equity Incentive 2011 Plan [Member]	Dec. 31, 2012 Equity Incentive 2011 Plan [Member]	May 12, 2011 Equity Incentive 2011 Plan [Member]	Sep. 30, 2013 Equity Incentive B 2011 Plan [Member]	Aug. 22, 2011 Equity Incentive B 2011 Plan [Member]	Aug. 22, 2011 May 2011 and August 2011 Equity Incentive Plans [Member]	Dec. 31, 2012 May 2011 and August 2011 Equity Incentive Plans [Member]	Aug. 22, 2011 May 2011 and August 2011 Equity Incentive Plans [Member] Stock Options [Member]	Aug. 22, 2011 Individual Stock Ownership in Excess of 10 Percent [Member] May 2011 and August 2011 Equity Incentive Plans [Member]	Aug. 22, 2011 Twelve Months After Grant Date [Member] May 2011 and August 2011 Equity Incentive Plans [Member]	Aug. 22, 2011 Monthly in equal installments [Member] May 2011 and August 2011 Equity Incentive Plans [Member] Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, shares authorized (shares)												11,613,715		87,500
Common stock, capital shares reserved for future issuance (shares)							4,728,955		4,728,955				50,000
Fair market value of incentive stock options (percentage)															100.00%			110.00%
Share-based compensation arrangement by share-based payment award, equity instruments options, percentage vested (pecentage)																			25.00%
Share-based compensation arrangement by share-based payment award, award vesting period (in years)																				3 years
Expected term (in years)							10 years	5 years	9 years	5 years							10 years
Common shares, exercises									0		551					551
Proceeds from exercise of stock options	$ 0	$ 1,099														$ 1,099
Share-based compensation arrangement by share-based payment award, options, exercises in period, total intrinsic value (shares)																5,769
Share-based compensation, requisite service period recognition			190,877	31,894	359,251	150,878
Nonvested awards, total compensation cost not yet recognized			$ 696,167		$ 696,167
Nonvested awards, total compensation cost not yet recognized, period for recognition (in years)					3 years

XML

Summary of Significant Accounting Policies - Revenue Recognition (Details)	9 Months Ended
	Sep. 30, 2013
Minimum [Member]
Significant Accounting Policies [Line Items]
Revenue recognition requisite period (in days)	3 days
Maximum [Member]
Significant Accounting Policies [Line Items]
Revenue recognition requisite period (in days)	30 days

XML

Consolidated Unaudited Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flow from operating activites: [Abstract]
Net loss	$ (2,752,602)	$ (3,708,149)
Adjustments to rconcile net loss to net cash used for operating activities: [Abstract]
Depreciation and amortization	70,013	87,422
Stock-based compensation	359,251	150,878
Stock issued for payment of services	384,088	668,415
Loss on exchange of warrants and debt	94,214	802,123
Change in fair value of derivatives and notes payable carried at fair value, net	558,869	(681,639)
Bad debt expense	24,018	0
Cash provided by (used for): [Abstract]
Accounts receivable, net	(760,864)	(2,119)
Prepaid expense and other current assets	(231,982)	109,998
Accounts payable	(421,790)	(28,615)
Accrued expenses	310,561	22,149
Unearned revenue	120,779	102,607
Deferred rent	0	(8,500)
Net cash used for operating activities	(2,245,445)	(2,485,430)
Cash flows from investing activities: [Abstract]
Purchase of equipment	(15,064)	(9,009)
Security deposits	1,097	3,650
Net cash used for investing activities	(13,967)	(5,359)
Cash flows from financing activities: [Abstract]
Proceeds from issuance of notes payable, net	1,439,798	543,700
Proceeds from issuance of common stock and warrants, net	2,032,145	3,045,899
Proceeds from exercise of stock options	0	1,099
Payments on notes payable and capital leases	(206,789)	(21,174)
Net cash provided financing activities	3,265,154	3,569,524
Net increase in cash and cash equivalents	1,005,742	1,078,735
Cash and cash equivalents, beginning of year	657,946	225,277
Cash and cash equivalents, end of year	1,663,688	1,304,012
Supplemental cash flow information: [Abstract]
Cash paid during period for interest	9,902	6,222
Non-cash financing and investing activities:
Fair value of compound embedded derivative in promissory notes	0	27,776
Fair value of common stock issued for future services	0	64,619
Fair value of warrants issued	2,352,108	49,170
Conversion of notes to common stock	1,501,229	0
Acquisition of assets through capital lease	$ 55,369	$ 0

XML

Notes Payable

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

NOTES PAYABLE

Notes Payable – Related Parties

On February 3, 2012, the Company issued a senior secured promissory note in the principal amount of $550,000 with an original issuance discount of $50,000, plus $3,500 in lender fees to two of its existing shareholders.  In connection with the note, the Company incurred expenses of $21,800 for legal and other fees. Accordingly, net cash proceeds from the note amounted to $474,700. The holders were permitted to convert the outstanding principal amount of the note at a conversion price of 90% of the closing price of the Company's common stock, subject to further adjustment in the case of stock splits, reclassifications, reorganizations, certain issuances at less than the conversion price and the like, without limitation on the number of shares that could potentially be issued. From October 2012 through December 2012, the holders of this promissory note converted $437,850 of note value into 2,069,439 shares of common stock at an average conversion rate of $.21 per share. On February 4, 2013, the Company satisfied all of its remaining obligations under this note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share.

Proceeds from the note financings were allocated first to the embedded conversion option (see Note 3) that required bifurcation and recognition as a liability at fair value and then to the carrying value of the notes. The carrying value of the notes is subject to amortization, through charges to interest expense, over the term to maturity or conversion using the effective interest method.

On May 4, 2012, the Company issued an unsecured 30-day promissory note to two of its existing shareholders in the principal amount of $75,000, incurring $6,000 in expenses for legal fees, which resulted in net proceeds of $69,000. In June 2012, the note was extended until December 4, 2012 and the parties agreed that the noteholders could convert the note at any time on or before the maturity date into shares of common stock at a conversion price equal to the lower of (i) $5.00 per share or (ii) 90% of the then market price based on a volume weighted average price per share of the Company's common stock for the ten trading days prior to the conversion date. The note bore interest at a rate of 8% per annum. The noteholders did not elect to convert this note and the Company was not able to pay the balance owed upon its maturity on December 4, 2012. Therefore, the conversion feature expired and the note was in default bearing interest at the default rate of 18% per annum. On August 15, 2013, the noteholders converted the $75,000 in principal, plus $12,366 of accrued interest into 3.5 investment units (349,464 shares of common stock and like number of warrants) on the same terms and conditions as other investors in our 2013 Private Placement discussed in Note 4. The Company recorded a $93,482 loss on the exchange of the promissory note for shares in the Company's consolidated statements of operations during the three months ended September 30, 2013.

Bridge Bank Credit Agreement

On March 1, 2013, the Company entered into a secured credit facility agreement with Bridge Bank, N.A. of San Jose, California. Pursuant to this agreement, the Company may submit requests for funding up to 80% of its eligible accounts receivable up to a maximum total outstanding advanced amount of $1.5 million. This agreement is secured by the Company's accounts receivable and substantially all of the Company's other assets. The agreement requires the Company to pay an annual facility fee of $7,500 (0.5% of the credit facility) and an annual due diligence fee of $1,000. Interest accrues on the advances at the prime rate plus 2% per annum. The default rate of interest is prime plus 7%. If the agreement is terminated prior to March 1, 2014, then the Company will be required to pay a termination fee of $18,750 (1% of the credit limit divided by 80%). The Company incurred $31,301 in costs related to this loan acquisition. These costs have been capitalized in the Company's consolidated balance sheet as deferred finance costs and are being amortized to interest expense over one year. As of September 30, 2013, the Company had no outstanding balance under this agreement.

Brian Brady Promissory Notes

On April 11, 2013 and May 22, 2013, the Company entered into unsecured loan agreements with Brian W. Brady, a director of the Company. Pursuant to these agreements, the Company received short-term loans totaling $750,000 due on May 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. On May 31, 2013, the Company signed an extension and conversion agreement that extended the due date to August 31, 2013. Additionally, the parties agreed to allow these notes and all accrued interest thereon to be converted into equity upon closing of the next private placement on the same terms and conditions that will be applicable to other investors in the private placement. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company. Upon modification of these loans on May 31, 2013, the Company elected that the notes should be recorded at fair value as discussed further in Note 3.

On June 7, June 14, July 25, and August 12, 2013, the Company entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, the Company received short-term loans totaling $520,000 due on August 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year.

On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest, into 5,157,008 shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement discussed in Note 4.

The proceeds from the loans from Mr. Brady were used to pay off the outstanding balance on the Bridge Bank facility and to pay for operating expenses. The Board determined that the terms of the agreements were consistent or better than the terms of other note agreements that the Company had issued in its recent history. The note issuances and the modification were approved by the disinterested members of the Company's Board of Directors.

During the three months ended September 30, 2013 and 2012, interest expense on all the notes amounted to $3,998 and $24,138, respectively. During the nine months ended September 30, 2013 and 2012, interest expense on all the notes amounted to $22,397 and $52,840, respectively. Direct finance costs allocated to the embedded derivatives were expensed in full upon issuance of the notes. Direct finance costs allocated to the notes are subject to amortization, through charges to interest expense, using the effective interest method. During the three months ended September 30, 2013 and 2012, interest expense related to the amortization of finance costs amounted to $7,826 and $7,666, respectively. During the nine months ended September 30, 2013 and 2012, interest expense related to the amortization of finance costs amounted to $20,137 and $18,700, respectively.

XML

Loss Per Common Share

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

LOSS PER COMMON SHARE

Net losses were reported during the three and nine months ended September 30, 2013 and 2012.  As such, the Company excluded the following items from the computation of diluted loss per common share as their effect would be anti-dilutive:

	Three and Nine Months Ended
	September 30, 2013	September 30, 2012
Stock options	6,921,026	393,494
Warrants	18,605,999	128,434
Restricted stock units	1,819,400	—
Potential conversion of Series A convertible preferred stock	3,788	3,788
Potential conversion of promissory notes payable	—	789,142
Total excluded shares	27,350,213	1,314,858

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

The reconciliation of our derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2013 is as follows:

	Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	820,202
Total loss included in earnings	765,907
Balance upon conversion, August 15, 2013	$	1,586,109

DERIVATIVE FINANCIAL INSTRUMENTS

The Company entered into financing transactions that gave rise to derivative liabilities, which are accounted for at fair value, in the Company's financial statements. Changes in the fair value of derivative financial instruments are required to be recorded in other income in the period of change, and are reflected in the Company's consolidated statements of operations as "loss on exchange of warrants and debt" or as "change in fair value of derivatives and notes payable carried at fair value."

Warrant Liability

2012 Activity:

The Company determined that 153,882 warrant shares issued in its May 2011 Offering, 110,000 warrant shares issued in its September 2012 public offering and 250 warrant shares issued in July 2011 for a customer list acquisition, require classification as a liability due to certain registration rights and listing requirements in the agreements.

In May and June 2012, pursuant to separate private transactions with nineteen warrant holders, the Company redeemed warrants to purchase an aggregate of 123,052 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemptions were treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the carrying value of the warrants received in the exchange is recorded in the Company's consolidated statements of operations in other income under loss on exchange and change in fair value of derivatives. As a result of the exchange, the Company recognized a loss on the exchange of these warrants in the amount of $802,123 during the three and nine months ended September 30, 2012.

2013 Activity:

In February 2013, pursuant to a private transaction with a warrant holder, the Company redeemed a warrant to purchase 5,001 shares of common stock for the same number of shares without the Company receiving any further cash consideration. The redemption was treated as an exchange wherein the fair value of the newly issued common stock was recorded and the difference between that and the zero carrying value of the warrant received in the exchange. As a result, the Company recognized a loss on exchange of warrants in the amount of $732 during the three months ended March 31, 2013.

From August 15, 2013 through September 23, 2013, the Company issued warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share pursuant to the terms of the Securities Purchase Agreements signed in its 2013 Private Placement (Note 4). The Company determined that these warrants require classification as a liability due to certain registration rights in the agreements that require the Company to file a registration statement with the SEC for purposes of registering the resale of the shares underlying these warrants by January 23, 2014 and use its commercially reasonable efforts to have it declared effective no later than March 23, 2014. The Company determined the fair value of these warrants on their issuance date to be $2,344,899.

During the three months ended September 30, 2013 and 2012, the Company recorded income of $207,462 and $10,903, respectively, due to the change in the fair value of its warrant liability. During the nine months ended September 30, 2013 and 2012, the Company recorded income of $207,682 and $738,628, respectively, due to the change in the fair value of its warrant liability.

The following table summarizes the Company's activity and fair value calculations of its derivative warrants for the nine months ended September 30, 2013:

	Linked Common Shares to Derivative Warrants		Warrant Liability
Balance, December 31, 2012	128,350		$	2,750
Issuance of warrants to investors in 2013 Private Placement	14,236,472		2,344,899
Exchange of warrants for common stock	(4,546	)	—
Change in fair value of derivatives	—		(207,682		)
Balance, September 30, 2013	14,360,276		$	2,139,967

The Company's warrants were valued on the applicable dates using a Binomial Lattice Option Valuation Technique (“Binomial”). Significant inputs into this technique as of December 31, 2012, May 31, 2013, August 15, 2013 - September 23, 2013 and September 30, 2013 are as follows:

Binomial Assumptions	December 31, 2012	May 31, 2013	August 15, 2013 - September 23, 2013	September 30, 2013
Fair market value of asset (1)	$0.22	$0.20	$0.28-$0.37	$0.33
Exercise price	$1.25	$0.25-$0.50	$0.25-$0.50	$0.25-$1.25
Term (2)	4.7 years	5.0 years	5.0 years	3.9 years - 4.9 years
Implied expected life (3)	4.6 years	5.0 years	5.0 years	3.9 years - 4.9 years
Volatility range of inputs (4)	45.82%--84.21%	50.14%--83.49%	48.46%--81.72%	50.38%--80.40%
Equivalent volatility (3)	60.20%	59.15%	56.57%--57.55%	54.84%--56.50%
Risk-free interest rate range of inputs (5)	0.11%--0.72%	1.07%--1.05%	0.04%--1.72%	0.02%--1.39%
Equivalent risk-free interest rate (3)	0.32%	0.43%	0.56%--0.69%	0.32%--0.52%

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the binomial.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2), above.

(5)  The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (2), above.

Convertible Notes-Carried At Fair Value

$750,000 Notes Payable:

On May 31, 2013, the Company signed a loan extension and conversion agreement with Brian W. Brady, a director of the Company, that extended the due date on its $750,000 notes payable to August 31, 2013 and added a conversion feature in which the notes and all accrued interest thereon will be converted into equity upon the closing of the next private placement on the same terms and conditions that will be applicable to other investors in the future financing. In consideration for the extension and conversion agreement, the Company issued Mr. Brady a warrant to purchase 1,000,000 shares of the Company's common stock at $0.25 per share for a period of five years. The Company also agreed that upon the first closing of its next private placement it would issue Mr. Brady an additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share for a period of five years and 1,687,500 restricted stock units which vest upon the earlier of two years after issuance or completion of a transaction resulting in a change of control of the Company.

The Company concluded that since the modification resulted in the addition of a conversion feature, the notes no longer met the definition of being indexed to the Company's own stock in accordance with ASC 815, Derivatives and Hedging. Accordingly, the modification of these loans on May 31, 2013 resulted in a change that required either bifurcation of the embedded conversion feature or the Company could choose to record the entire fair value of the convertible notes at fair value. Management chose to record the promissory notes  at their fair value using a common stock equivalent approach, with changes in fair value being reported as “Change in the fair value of derivatives and notes payable carried at fair value, net” in the accompanying consolidated statements of operations.

As discussed in Note 2, on August 15, 2013, Mr. Brady converted the $750,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The $750,000 convertible notes payable had a fair value of $820,202 on May 31, 2013 (the modification date) and $1,586,109 on August 15, 2013 (the conversion date). This change in fair value resulted in an expense of $422,554 and $765,907 during the three and nine months ended September 30, 2013, respectively.

Since the Company was currently negotiating a future financing at the time of modification, management believed there was a high probability that the future financing would occur, the common stock equivalent value of the notes was based on the negotiated terms of the future financing.

The newly-issued warrant, indexed to 1,000,000 shares of common stock, met the conditions for equity classification and the fair value of $88,000 was recorded in the Company's consolidated balance sheet as additional paid-in capital during the three months ended June 30, 2013. The value of the additional warrant and the restricted stock units to be issued upon the occurrence of the future financing were also recorded in additional paid-in capital. The additional warrant was valued at $280,500, using a binomial lattice option valuation technique and the restricted stock units were valued at $337,500 based on the Company's current market prices.

The modification added a substantial conversion feature so the debt instruments were considered “substantially” different after the modification and extinguishment accounting was applicable. Since the modification triggered debt extinguishment accounting, the fair value of the additional warrant to purchase 3,187,500 shares of the Company's common stock at $0.25 per share and the additional 1,687,500 restricted stock units were considered in the determination of the amount of extinguishment loss. However, since Mr. Brady is a board member and shareholder, the transaction is considered to be with a related party and thus, the extinguishment is in essence a capital transaction. As such, the difference between the carrying amount of the original notes of $755,227 was compared to the fair value of the modified notes plus the fair value of the warrants issued on May 31, 2013, plus the warrants and restricted stock to be issued in the future, which equaled $1,526,202. The difference of $770,975 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

As of the date of modification, May 31, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,021,000	$	0.200	604,200
Warrants - $0.25 exercise price	1,510,500	$	0.088	132,924
Warrants - $0.50 exercise price	1,510,500	$	0.055	83,078
Common stock equivalent value				820,202

On the conversion date of August 15, 2013, the common stock equivalent value was estimated as follows:

	Indexed Shares	Fair Value per Share		Estimated Fair Value
Common stock	3,064,944	$	0.350	1,072,730
Warrants - $0.25 exercise price	1,532,472	$	0.199	304,962
Warrants - $0.50 exercise price	1,532,472	$	0.136	208,417
Common stock equivalent value				1,586,109

The following table summarizes the Company's activity and fair value calculations of its derivative notes payable for the nine months ended September 30, 2013:

	Linked Common Shares to Convertible Notes Payable		Bifurcated Compound Embedded Derivatives			Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	537,146		$	11,817		$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	6,042,000		—			820,202
Conversion of notes into common stock	(6,903,872	)	(12,461		)	(1,586,109		)
Change in fair value of derivatives	324,726		644			765,907
Balance, September 30, 2013	—		$	—		$	—

The common stock was valued at the trading market price on the date of the valuation. The warrants were valued using a Binomial model using inputs as detailed above under the Binomial Assumptions table.

$520,000 Notes Payable:

On June 7, June 14, July 25, and August 12, 2013, the Company entered into additional unsecured loan agreements with Mr. Brady. Pursuant to these agreements, the Company received short-term loans totaling $520,000 due on August 31, 2013. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360-day year. Although the notes did not contain a conversion feature, the Company permitted Mr. Brady to convert the $520,000 principal into shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement. The difference between the carrying amount of the original notes and accrued interest of $523,016 was compared to the $1,082,642 fair value of the 2,092,064 shares of common stock and 2,092,064 warrants received on August 15, 2013 and since the transaction is considered to be with a related party, the difference of $559,626 was treated as a capital transaction and is included in additional paid-in capital as of September 30, 2013. The common stock equivalent value was based on the calculated indexed shares, the fair value of the common stock on the valuation date, and the fair value of the warrants using a binomial lattice model.

Fair value measurements

Assets and liabilities that are recorded at fair value on a recurring basis are measured in accordance with ASC 820-10-05, Fair Value Measurements. The Brian Brady Promissory Notes originally issued April 11, 2013 and May 22, 2013 and modified on May 31, 2013 to extend the term and add a conversion feature are classified within Level 3 of the fair value hierarchy as they were valued using unobservable inputs including significant assumptions of the Company and other market participants.

The reconciliation of our derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2013 is as follows:

	Convertible Notes Payable, Carried at Fair Value
Balance, December 31, 2012	$	—
Issuance of $750,000 promissory note with compound embedded derivative - May 31, 2013	820,202
Total loss included in earnings	765,907
Balance upon conversion, August 15, 2013	$	1,586,109

Compound Embedded Derivative

The Company concluded that the compound embedded derivative in its $550,000 senior secured promissory note issued on February 3, 2012 and its $75,000 convertible promissory note as modified on June 6, 2012 (see Note 2) required bifurcation and liability classification as derivative financial instruments because they were not considered indexed to the Company's own stock as defined in ASC 815, Derivatives and Hedging. The noteholders did not elect to convert the $75,000 convertible promissory note prior its maturity date on December 4, 2012. Therefore, the conversion feature expired and no further derivative valuation is required. On February 4, 2013, the Company satisfied all of its remaining obligations under its $550,000 senior secured promissory note when the noteholders converted the final balance owed of $112,150 into 773,983 shares of common stock at an average conversion rate of $.145 per share. The Company recorded the $12,461 value of the compound embedded derivative on the conversion date as a charge to additional paid-in capital. As of February 4, 2013, all convertible notes in which the conversion feature had been bifurcated and recorded at fair value, had been converted. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the nine months ended September 30, 2013 in the amount of $644. The Company recorded expense resulting from the change in the fair value of the compound embedded derivatives during the three and nine months ended September 30, 2012 in the amount of $39,257 and $56,989, respectively.

The Monte Carlo Simulation (“MCS”) technique was used to calculate the fair value of the compound embedded derivatives because it provides for the necessary assumptions and inputs. The MCS technique, which is an option-based model, is a generally accepted valuation technique for valuing embedded conversion features in hybrid convertible notes, because it is an open-ended valuation model that embodies all significant assumption types, and ranges of assumption inputs that the Company agrees would likely be considered in connection with the arms-length negotiation related to the transference of the instrument by market participants. In addition to the typical assumptions in a closed-end option model, such as volatility and a risk free rate, MCS incorporates assumptions for interest risk, credit risk and redemption behavior. In addition, MCS breaks down the time to expiration into potentially a large population of time intervals and steps. However, there may be other circumstances or considerations, other than those addressed herein, that relate to both internal and external factors that would be considered by market participants as it relates specifically to the Company and the subject financial instruments. The effects, if any, of these considerations cannot be reasonably measured, quantified or qualified.

The following table shows the summary calculations arriving at the compound embedded derivative value as of December 31, 2012 and on the final conversion date of February 4, 2013. See the assumption details for the composition of these calculations.

Compound Embedded Derivative	December 31, 2012		February 4, 2013
Notional amount	$	106,355	$	112,150
Conversion price	0.198		0.145
Linked common shares (1)	537,146		773,983
MCS value per linked common share (2)	0.022		0.016
Total	$	11,817	$	12,461

(1) The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares increased as the trading market price decreased and decreased as the trading market price increased.

(2) The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.

The significant inputs into the Monte Carlo Simulation used to calculate the compound embedded derivative values as of December 31, 2012 and on the final conversion date of February 4, 2013 are as follows:

Monte Carlo Assumptions	December 31, 2012	February 4, 2013 (7)
Fair market value of asset (1)	$0.22	$0.16
Conversion price	$0.20	$0.14
Term (2)	0.09 years	n/a
Implied expected life (3)	0.09 years	n/a
Volatility range of inputs (4)	16.12%--40.17%	n/a
Equivalent volatility (3)	30.7%	n/a
Risk adjusted interest rate range of inputs (5)	10.00%	n/a
Equivalent risk-adjusted interest rate (3)	10.00%	n/a
Credit risk-adjusted interest rate (6)	15.63%	n/a

(1)  The fair market value of the asset was determined by using the Company's closing stock price as reflected in the over-the-counter market.

(2)  The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate.

(3)  The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS.

(4)  The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (2) above.

(5) CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument.

(6) The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

(7) Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

XML

Stockholders' Deficit - Convertible Securities (Details) (USD $)	0 Months Ended			0 Months Ended	12 Months Ended
	Feb. 04, 2013	Sep. 30, 2013	Dec. 31, 2012	Feb. 04, 2013 Senior Secured Promissory Note [Member]	Dec. 31, 2012 Senior Secured Promissory Note [Member]	Feb. 03, 2012 Senior Secured Promissory Note [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt instrument, face amount (in dollars)						$ 550,000
Debt conversion, converted instrument, amount (in dollars)				112,150	437,850
Conversion of notes payable into common stock (shares)	6,903,872			773,983	2,069,439
Debt instrument, convertible, conversion price (per share)				$ 0.145	$ 0.21
Embedded derivative, conversion of notes into common stock					(83,663)
Compound embedded derivative	$ 12,461	$ 0	$ 11,817

XML

Notes Payable - Related Parties (Details) (USD $)	0 Months Ended	3 Months Ended		0 Months Ended		12 Months Ended	0 Months Ended		1 Months Ended	9 Months Ended	0 Months Ended
	Feb. 04, 2013	Sep. 30, 2013	Aug. 15, 2013	Feb. 04, 2013 Senior Secured Promissory Note [Member]	Feb. 03, 2012 Senior Secured Promissory Note [Member]	Dec. 31, 2012 Senior Secured Promissory Note [Member]	May 04, 2012 Convertible Promissory Note [Member] shareholder	Aug. 15, 2013 Convertible Promissory Note [Member] units	Sep. 23, 2013 Common Stock [Member]	Sep. 30, 2013 Common Stock [Member]	Aug. 15, 2013 Common Stock [Member] Convertible Promissory Note - Principal [Member]	Aug. 15, 2013 Common Stock [Member] Convertible Promissory Note - Accrued Interest [Member]	Aug. 15, 2013 Common Stock [Member] Convertible Promissory Note [Member]	Aug. 15, 2013 Common Stock [Member] Director [Member]	Aug. 15, 2013 Common Stock [Member] Director [Member] Unsecured Debt - Principal [Member]	Aug. 15, 2013 Common Stock [Member] Director [Member] Unsecured Debt - Accrued Interest [Member]
Short-term Debt [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			349,464
Debt instrument, face amount (in dollars)					$ 550,000		$ 75,000
Debt instrument, unamortized discount					50,000
Debt instrument, fee amount					3,500
Debt issuance cost					21,800		6,000
Proceeds from debt, net of issuance costs					474,700		69,000
Debt instrument, convertible, conversion percentage (percentage)					90.00%		90.00%
Debt conversion, converted instrument, amount (in dollars)				112,150		437,850
Conversion of notes payable into common stock (shares)	6,903,872			773,983		2,069,439				773,983
Debt instrument, convertible, conversion price (per share)				$ 0.145		$ 0.21	$ 5.00
Debt instrument, maturity period (in days)							30 days
Debt Instrument, Number of Existing Shareholders Issued Promissory Note							2
Number of trading days prior to conversion date (in days)							10 days
Debt instrument, interest rate, stated percentage (percentage)							8.00%
Debt instrument, debt default, percentage (percentage)							18.00%
Induced Conversion of Convertible Debt Expense		93,482
Debt conversion, converted instrument, amount (in dollars)									$ 1,376,618		$ 75,000	$ 12,366			$ 1,270,000	$ 19,252
Conversion of Convertible Securities, Investment Units								3.5
Stock Issued During Period, Shares, Conversion of Convertible Securities									5,506,472				349,464	5,157,008

XML

- Derivative Financial Instruments (Details) (USD $)	0 Months Ended		3 Months Ended		9 Months Ended
	May 31, 2013	Feb. 04, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Aug. 15, 2013	Dec. 31, 2012	Jul. 31, 2011
Linked Common Shares to Derivative Warrants [Roll Forward]
Linked common shares to derivative warrants, beginning balance (shares)									250
Linked common shares to derivative warrants, ending balance (shares)									250
Warrant Liability [Roll Forward]
Warrant liability beginning balance					$ 2,750
Change in fair value of derivative			207,462	10,903	207,682	738,628
Warrant liability ending balance			2,139,967		2,139,967
Linked common shares to promissory notes beginning balance					537,146
Increase (Decrease) in the Number of Shares Linked to Promissory Notes Embedded Derivatives	6,042,000
Conversion of notes payable into common stock (shares)		(6,903,872)
Linked common shares to promissory notes, change in fair value of derivatives (shares)			324,726		324,726
Linked common shares to promissory notes ending balance			0		0
Compound embedded derivative		12,461	0		0			11,817
Compound embedded derviative, issuance of promissory note	0
Compound embedded derivatives,change in fair value of derivatives			644		644
Fair value of convertible notes beginning balance					0		1,586,109
Fair value of convertible notes payable	820,202
Fair value of convertible notes payable, change in derivative fair value			422,554		765,907
Fair value of convertible notes ending balance			0		0		1,586,109
Warrant [Member]
Linked Common Shares to Derivative Warrants [Roll Forward]
Linked common shares to derivative warrants, beginning balance (shares)					128,350
Class of Warrant or Right, Issuance of Warrants to Investors in Private Placement					14,236,472
Issuance of warrants with preferred stock financing					(4,546)
Change in fair value of derivatives					0
Linked common shares to derivative warrants, ending balance (shares)			14,360,276		14,360,276
Warrant Liability [Roll Forward]
Warrant liability beginning balance					2,750
Fair Value of Warrants Issued to Investors in Private Placement					2,344,899
Fair value of warrants issued with preferred stock financing					0
Change in fair value of derivative					(207,682)
Warrant liability ending balance			2,139,967		2,139,967
Convertible Notes Payable [Member]
Warrant Liability [Roll Forward]
Fair value of convertible notes, conversion of notes into common stock			$ (1,586,109)		$ (1,586,109)

XML

Derivative Financial Instruments - Compound Embedded Derivative (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended			0 Months Ended		12 Months Ended		0 Months Ended	12 Months Ended
	Feb. 04, 2013	Sep. 30, 2013	Mar. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Jun. 06, 2012	Feb. 04, 2013 Compound Embedded Derivative [Member] Monte Carlo Simulation Technique [Member]		Dec. 31, 2012 Compound Embedded Derivative [Member] Monte Carlo Simulation Technique [Member]		Feb. 04, 2013 Senior Secured Promissory Note [Member]	Dec. 31, 2012 Senior Secured Promissory Note [Member]	Feb. 03, 2012 Senior Secured Promissory Note [Member]
Derivative [Line Items]
Debt instrument, face amount (in dollars)													$ 550,000
Convertible notes payable						75,000
Debt conversion, converted instrument, amount (in dollars)											112,150	437,850
Conversion of notes payable into common stock (shares)	6,903,872										773,983	2,069,439
Debt instrument, convertible, conversion price (per share)											$ 0.145	$ 0.21
Compound embedded derivatives, change in fair value of derivatives		39,257	(56,989)	(644)
Notional amount							112,150		106,355
Conversion price (per share)							$ 0.145	[1]	$ 0.198
Linked common shares (shares)		0		0	537,146		773,983	[2]	537,146	[2]
MCS value per linked common share (per share)							$ 0.016	[3]	$ 0.022	[3]
Compound embedded derivative	$ 12,461	$ 0		$ 0	$ 11,817		$ 12,461		$ 11,817

[1] Monte Carlo inputs are "n/a" on expiration date of February 4, 2013 since only intrinsic value remains. There is no time value left, so the use of an option model is not necessary.

[2] The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares increased as the trading market price decreased and decreased as the trading market price increased.

[3] The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.

XML

Stockholders' Deficit - Schedule of nonvested stock option activity (Details) (Equity Incentive 2011 Plan [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity Incentive 2011 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Common shares, nonvested beginning of period	308,627	57,516
Common shares, granted	7,640,062	378,293
Common shares, vested	(1,541,284)	(83,429)
Common shares, forfeited	(1,097,577)	(43,753)
Common shares, nonvested end of period	5,309,828	308,627	57,516
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted average grant date fair value, nonvested beginning of period	$ 2.17	$ 2.73
Weighted average grant date fair value, granted	$ 0.20	$ 2.17
Weighted average grant date fair value, vested	$ 0.37	$ 2.26
Weighted average grant date fair value, forfeited	$ 0.21	$ 2.78
Weighted average grant date fair value, nonvested end of period	$ 0.27	$ 2.17	$ 2.73
Weighted average remaining years to vest	3 years 7 months	2 years 11 months	2 years 6 months

XML

Consolidated Unaudited Balance Sheets Parentheticals (USD $)	Sep. 30, 2013	Dec. 31, 2012
Accumulated amortization on deferred finance costs	$ 46,059	$ 25,923
Accumulated amortization on intangible assets	$ 72,776	$ 59,276
Common stock, par value (per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (shares)	100,000,000	100,000,000
Common stock, shares, issued (shares)	22,335,543	6,186,997
Common stock, shares outstanding (shares)	22,335,543	6,186,997
Series A Preferred stock, par value (per share)	$ 0.0001
Series A Preferred stock, shares authorized (shares)	10,000,000
Series A Convertible Preferred Stock [Member]
Series A Preferred stock, par value (per share)	$ 0.0001	$ 0.0001
Series A Preferred stock, shares authorized (shares)	240	240
Series A Preferred stock, shares issued (shares)	5	5
Series A Preferred stock, shares outstanding (shares)	5	5

XML

Subsequent Events

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

Subsequent Events [Text Block]

SUBSEQUENT EVENTS

No material events have occurred since September 30, 2013 that require recognition or disclosure in the financial statements.

XML

Consolidated Unaudited Statement of Stockholders' Deficit (USD $)	Total	Series A Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Beginning balance at Dec. 31, 2012	$ (1,313,449)	$ 0	$ 619	$ 21,489,354	$ (22,803,422)
Beginning Balance (shares) at Dec. 31, 2012		5	6,186,997
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock and conversion of notes payable, net of offering costs (shares)	1,912,244		1,424	1,910,820
Sale of common stock and conversion of notes payable, net of offering costs			14,236,472
Conversion of notes payable into common stock (shares)			773,983
Conversion of notes payable into common stock	124,611		77	124,534
Exchange of warrants for common stock (shares)			5,001
Exchange of warrants for common stock	732		1	731
Fair value of warrants issued	7,209			7,209
Stock issued for payment of services (shares)			1,133,090
Stock issued for payment of services	373,399		113	373,286
Stock-based compensation	359,251			359,251
Net loss	(2,752,602)				(2,752,602)
Ending balance at Sep. 30, 2013	$ (1,288,605)	$ 0	$ 2,234	$ 24,265,185	$ (25,556,024)
Ending Balance (shares) at Sep. 30, 2013		5	22,335,543

XML

Consolidated Unaudited Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current:
Cash and cash equivalents	$ 1,663,688	$ 657,946
Accounts receivable	1,163,664	426,818
Prepaid expenses	127,508	162,565
Prepaid equity financing cost	0	0
Deferred finance costs, net of accumulated amortization of $46,059 and $25,923	13,042	1,877
Other current assets	23,099	11,627
Total current assets	2,991,001	1,260,833
Property and equipment, net	147,813	113,757
Intangible assets, net of accumulated amortization of $72,776 and $59,276	4,500	18,000
Software development costs	244,878	0
Security deposits	7,951	9,048
Total assets	3,396,143	1,401,638
Current liabilities
Accounts payable	741,517	1,163,307
Accrued expenses	472,025	187,868
Unearned revenue	1,260,919	1,140,140
Compound embedded derivative	0	11,817
Current portion of capital lease obligations	40,126	17,638
Current portion of notes payable	0	75,000
Total current liabilities	2,514,587	2,595,770
Capital lease obligations, less current portion	30,194	10,212
Notes payable, less current portion	0	106,355
Warrant liability	2,139,967	2,750
Total liabilities	4,684,748	2,715,087
Stockholders’ deficit:
Common stock, $.0001 par value; 100,000,000 shares authorized; 22,335,543 and 6,186,997 issued and outstanding	2,234	619
Additional paid-in capital	24,265,185	21,489,354
Accumulated deficit	(25,556,024)	(22,803,422)
Total stockholders’ deficit	(1,288,605)	(1,313,449)
Total liabilities and stockholders’ deficit	3,396,143	1,401,638
Series A Convertible Preferred Stock [Member]
Stockholders’ deficit:
Series A convertible preferred stock; $.0001 par value; 240 shares authorized; 5 shares issued and outstanding	$ 0	$ 0

XML

Notes Payable - Bridge Bank Credit Agreement (Details) (Secured Line of Credit Facility [Member], USD $)	0 Months Ended
	Mar. 01, 2013	Sep. 30, 2013
Secured Line of Credit Facility [Member]
Debt Instrument [Line Items]
Eligible securitization percentage of accounts receivable (percentage)	80.00%
Line of credit facility, maximum borrowing capacity	$ 1,500,000
Debt instrument, annual facility fee	7,500
Line of credit facility, commitment fee percentage (percentage)	0.50%
Line of credit facility, annual due dilligence fee	1,000
Debt Instrument, description of variable rate basis	prime rate plus 2%
Debt instrument, description of default rate of interest	prime plus 7%
Line of credit facility, termination fee	18,750
Line of credit facility, early termination credit limit percentage (percentage)	1.00%
Line of credit facility, early termination fee calculation denominator (percentage)	80.00%
Debt issuance cost	31,301
Debt issuance cost amortization period (in years)	1 year
Line of Credit Facility, Amount Outstanding		$ 0

XML

Summary of Significant Accounting Policies - Property and Equipment (Details)	9 Months Ended
	Sep. 30, 2013
Equipment [Member]
Significant Accounting Policies [Line Items]
Property, plant and equipment, useful life (in years)	3 years
Furniture and Fixtures [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Property, plant and equipment, useful life (in years)	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Property, plant and equipment, useful life (in years)	10 years
Software [Member]
Significant Accounting Policies [Line Items]
Property, plant and equipment, useful life (in years)	3 years
Leasehold Improvements [Member]
Significant Accounting Policies [Line Items]
Property, plant and equipment, useful life (in years)	3 years

XML

Stockholders' Deficit - Schedule of Stock Option Activity (Details) (Equity Incentive 2011 Plan [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity Incentive 2011 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Common shares, outstanding beginning of period	391,977	114,445
Common shares, granted	7,640,062	378,293
Common shares, exercises	0	(551)
Common shares, forfeited	(1,111,013)	(100,210)
Common shares, outstanding end of period	6,921,026	391,977	114,445
Common shares, excercisable	1,611,198
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, beginning of period	$ 5.87	$ 17.61
Weighted average exercise price, granted	$ 0.25	$ 5.74
Weighted average exercise price, exercised	$ 0.00	$ 2.00
Weighted average exercise price, forfeited	$ 0.45	$ 18.81
Weighted average exercise price, end of period	$ 0.54	$ 5.87	$ 17.61
Weighted average exercise price, exercisable	$ 0.89
Weighted average remaining life (years), outstanding	8 years 9 months	4 years 4 months	4 years 5 months
Weighted average remaining life (years), exercisable	8 years 10 months

XML

Stockholders' Deficit (Details) (USD $)	Sep. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2013 Series A Preferred Stock [Member]	Jul. 30, 2012 Reverse Stock Split [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (shares)	100,000,000	100,000,000	100,000,000		12,500,000
Series A Preferred stock, shares authorized (shares)	10,000,000			240
Series A Preferred stock, par value (per share)	$ 0.0001

XML

Derivative Financial Instruments - Convertible Notes-Carried at Fair Value (Details) (USD $)	0 Months Ended	9 Months Ended					0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended	9 Months Ended	0 Months Ended	1 Months Ended		0 Months Ended	1 Months Ended	6 Months Ended	0 Months Ended		1 Months Ended				0 Months Ended
	Mar. 01, 2013	Sep. 30, 2013	Aug. 15, 2013	May 31, 2013	Sep. 30, 2013 Binomial Lattice Option Valuation Technique [Member]	May 31, 2013 Binomial Lattice Option Valuation Technique [Member]	May 31, 2013 Binomial Lattice Option Valuation Technique [Member] Common Stock [Member]	Sep. 30, 2013 Binomial Lattice Option Valuation Technique [Member] Common Stock [Member]	May 31, 2013 Binomial Lattice Option Valuation Technique [Member] Warrants - $0.25 exercise price [Member]	Sep. 30, 2013 Binomial Lattice Option Valuation Technique [Member] Warrants - $0.25 exercise price [Member]	May 31, 2013 Binomial Lattice Option Valuation Technique [Member] Warrants - $0.50 exercise price [Member]	Sep. 30, 2013 Binomial Lattice Option Valuation Technique [Member] Warrants - $0.50 exercise price [Member]	Aug. 15, 2013 Unsecured Debt [Member]	May 22, 2013 Unsecured Debt [Member]	Aug. 12, 2013 Unsecured Debt [Member]	Aug. 15, 2013 Restricted Stock Units (RSUs) [Member]	May 22, 2013 Restricted Stock Units (RSUs) [Member]	Jun. 30, 2013 Additional Paid-in Capital [Member] Binomial Lattice Option Valuation Technique [Member] Common Stock [Member]	Aug. 15, 2013 Warrants - $0.25 exercise price [Member]	May 31, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.25 exercise price [Member]	Sep. 30, 2013 Director [Member]	Aug. 12, 2013 Director [Member] Unsecured Debt [Member]	Aug. 15, 2013 Director [Member] Warrants - $0.25 exercise price [Member]	Aug. 15, 2013 Common Stock [Member] Director [Member]
Fair Value of Warrants [Line Items]
Short-term loan														$ 750,000	$ 520,000								$ 1,270,000
Warrants issued to purchase shares														1,000,000
Warrants issued to purchase shares, exercise price (per share)													$ 0.25	$ 0.25
Class of Warrant or Right, Expiration Period																			5 years	5 years	5 years
Additional warrants issued to purchase shares (shares)													3,187,500	3,187,500
Shares granted in period (shares)																1,687,500	1,687,500
Share-based compensation arrangement by share-based payment award, award vesting period (in years)														2 years		2 years
Notes payable carried at fair value		1,586,109		820,202
Debt instrument, convertible, carrying amount of equity component		770,975	523,016	755,227																		559,626
Warrants and restricted stock, reserved for furture issuance, value			1,082,642	1,526,202
Stock Issued During Period, Shares, Conversion of Convertible Securities																									2,092,064
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			349,464																		7,118,236			2,092,064
Number of indexed warrants (in shares)							3,021,000	3,064,944	1,510,500	1,532,472	1,510,500	1,532,472						1,000,000
Number of indexed warrants, fair value per share							$ 0.200	$ 0.350	$ 0.088	$ 0.199	$ 0.055	$ 0.136
Fair value of common stock issued					1,586,109	820,202	604,200	1,072,730	132,924	304,962	83,078	208,417
Debt instrument, interest rate, stated percentage (percentage)															7.00%								7.00%
Debt instrument, default interest rate (percentage)															12.00%								12.00%
Equity, Fair Value Disclosure																		88,000
Fair value of warrants issued	7,209	7,209																280,500
Fair value of stock issued during period																		$ 337,500

XML

Derivative Financial Instruments - Fair Value Measurements (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Aug. 15, 2013	May 31, 2013
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value of convertible notes beginning balance		$ 0	$ 1,586,109
Fair value of convertible notes payable				820,202
Fair value of convertible notes payable, change in derivative fair value	422,554	765,907
Fair value of convertible notes ending balance	$ 0	$ 0	$ 1,586,109

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS & CONTINGENCIES

From time to time, the Company may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is, however, subject to inherent uncertainties, and an adverse result in these or other matters may harm the Company's business.

On October 17, 2012, Blue Calypso, Inc. filed a complaint against the Company in the U.S. District Court for the Eastern District of Texas accusing us ofinfringing patents related to peer-to-peer advertising between mobile communication devices seeking unspecified damages. The Company made a request that the Texascourt transfer the matter to the Middle District of Florida, but no ruling has yet been made on that motion. On October 4, 2013, Blue Calypso, the Company and the other defendants submitted to the Texas court a joint claim construction and prehearing statement containing each parties’ position with regard to the meaning of the disputed claim terms of the patents.  The court has also yet to rule on this matter. At this stage, the Company does not have an estimate of thelikelihood or the amount of any potential exposure to it. The Company believes that there is no merit to this suit and intends to vigorously defend itself.

The Company is currently not aware of any other legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on its operations or financial position.

XML

Notes Payable - Brian Brady Promissory Notes (Details) (USD $)	0 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended			1 Months Ended	0 Months Ended
	Aug. 15, 2013 Restricted Stock Units (RSUs) [Member]	May 22, 2013 Restricted Stock Units (RSUs) [Member]	Aug. 15, 2013 Unsecured Debt [Member]	May 22, 2013 Unsecured Debt [Member]	Aug. 12, 2013 Unsecured Debt [Member]	Aug. 12, 2013 Director [Member] Unsecured Debt [Member]	Sep. 23, 2013 Common Stock [Member]	Aug. 15, 2013 Common Stock [Member] Director [Member]	Aug. 15, 2013 Unsecured Debt - Principal [Member] Common Stock [Member] Director [Member]	Aug. 15, 2013 Unsecured Debt - Accrued Interest [Member] Common Stock [Member] Director [Member]
Short-term Debt [Line Items]
Short-term loan				$ 750,000	$ 520,000	$ 1,270,000
Debt instrument, default interest rate (percentage)					12.00%	12.00%
Debt instrument, interest rate, stated percentage (percentage)					7.00%	7.00%
Warrants issued to purchase shares				1,000,000
Warrants issued to purchase shares, exercise price (per share)			$ 0.25	$ 0.25
Warrant conversion period to purchase shares (in years)				5 years
Additional warrants issued to purchase shares (shares)			3,187,500	3,187,500
Shares granted in period (shares)	1,687,500	1,687,500
Share-based compensation arrangement by share-based payment award, award vesting period (in years)	2 years			2 years
Debt conversion, converted instrument, amount (in dollars)							$ 1,376,618		$ 1,270,000	$ 19,252
Stock Issued During Period, Shares, Conversion of Convertible Securities							5,506,472	5,157,008

XML

Stockholders' Deficit - Warrant Transactions (Details) (USD $)	0 Months Ended		9 Months Ended	0 Months Ended	1 Months Ended		0 Months Ended	1 Months Ended		9 Months Ended	0 Months Ended		1 Months Ended
	Aug. 15, 2013	Mar. 01, 2013	Sep. 30, 2013	Aug. 15, 2013 Restricted Stock Units (RSUs) [Member]	May 22, 2013 Restricted Stock Units (RSUs) [Member]	Mar. 01, 2013 Secured Line of Credit Facility [Member]	Aug. 15, 2013 Unsecured Debt [Member]	May 22, 2013 Unsecured Debt [Member]	Aug. 12, 2013 Unsecured Debt [Member]	Sep. 30, 2013 Private Transaction with Warrant Holders [Member]	Aug. 15, 2013 Warrants - $0.25 exercise price [Member]	May 31, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.25 exercise price [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of warrants with preferred stock financing										5,001
Loss on exchange of warrants (in dollars)			$ (732)
Line of credit facility, maximum borrowing capacity						1,500,000
Warrant issued in financing arrangement, period of maturity (in years)		5 years
Warrant issued not yet exercised		58,139
Warrant issued not yet exercised, value		15,000
Warrant issued not yet exercised (per share)		$ 0.258
Fair value of warrants issued		7,209	7,209
Short-term loan								750,000	520,000
Warrants issued to purchase shares								1,000,000
Warrants issued to purchase shares, exercise price (per share)							$ 0.25	$ 0.25
Warrant conversion period to purchase shares (in years)								5 years
Additional warrants issued to purchase shares (shares)							3,187,500	3,187,500
Class of Warrant or Right, Expiration Period											5 years	5 years	5 years
Shares granted in period (shares)				1,687,500	1,687,500
Share-based compensation arrangement by share-based payment award, award vesting period (in years)				2 years				2 years
Adjustments to Additional Paid in Capital, Warrant Issued	$ 706,000

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Property, Plant and Equipment [Table Text Block]

Depreciation and amortization is computed using the straight-line method and half-year convention over the estimated useful lives of the assets as follows:

Equipment	3 years
Furniture and fixtures	5 - 10 years
Software	3 years
Leasehold improvements	3 years

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The Company used the following assumptions for options granted under the 2011 Equity Incentive Plans during the three and nine months ended September 30, 2013 and 2012:

	Three Months Ended		Nine Months Ended
2011 Equity Incentive Plans Assumptions	September 30, 2013	September 30, 2012	September 30, 2013	September 30, 2012
Expected term	10 years	5 years	9 years	5 years
Weighted average volatility	51.72%	54.46%	52.02%	54.90%
Weighted average risk free interest rate	2.74%	0.65%	2.27%	0.75%
Expected dividends	—	—	—	—

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2013

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

RELATED PARTY TRANSACTIONS

On December 26, 2012, Mitchel J. Laskey was elected to the Company's Board of Directors. He was then appointed as the Chairman of the Board, Chairman of the Audit Committee and as a member of the Compensation and Nominating Committees. Upon his appointment, the Board approved a twelve-month compensation arrangement whereby Mr. Laskey would receive $10,000 cash per month, 60,000 restricted stock units in January 2013, 60,000 restricted stock units in June 2013 and up to 120,000 in additional restricted stock units to be issued at the discretion of the disinterested members of the compensation committee for Mr. Laskey's service as Chairman of the Board. Mr. Laskey resigned from the Company's Board of Directors and all his related positions on April 24, 2013. Upon his resignation, he forfeited the right to receive any further cash or stock compensation.

As discussed in Notes 2 and 3, from April 2013 through August 2013, the Company entered into several unsecured loan agreements with Brian W. Brady, a director of the Company. Pursuant to these agreements, the Company received short-term loans totaling $1,270,000 due on August 31, 2013, as amended. The notes bore interest at 7% per annum with a default rate of interest at 12% based on a 360 day year. On August 15, 2013, Mr. Brady converted the $1,270,000 principal, plus $19,252 of accrued interest, into 5,157,008 shares of common stock on the same terms and conditions as were applicable to the other investors in the 2013 Private Placement.

In connection with the 2013 Private Placement, the Board awarded to Edward Murphy, our President and CEO, a bonus of $50,000 and granted him a stock option to purchase 4,398,978 shares of common stock at an exercise price of $0.25 per share, expiring ten years from the issuance date.

XML

Summary of Significant Accounting Policies (Notes)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Unaudited Interim Financial Information

The accompanying consolidated balance sheet as of September 30, 2013, the consolidated statements of operations for the three and nine months ended September 30, 2013 and 2012, the consolidated statement of stockholders' deficit for the nine months ended September 30, 2013 and the consolidated statements of cash flows for the nine months ended September 30, 2013 and 2012 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of our financial position at such dates and our results of operations and cash flows for the periods then ended in conformity with U.S. generally accepted accounting principles (“US GAAP”). The consolidated balance sheet as of December 31, 2012 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the United States Securities and Exchange Commission ("SEC"), does not include all of the information and notes required by US GAAP for complete financial statements. Operating results for the nine months ended September 30, 2013 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2012 included in the Company's Annual Report on Form 10-K filed with the SEC on March 29, 2013.

Nature of Business and Reverse Merger and Recapitalization

IZEA, Inc. (the "Company"), formerly known as IZEA Holdings, Inc. and before that, Rapid Holdings, Inc., was incorporated in Nevada on March 22, 2010.  On May 12, 2011, the Company completed a share exchange pursuant to which it acquired all of the capital stock of IZEA Innovations, Inc. ("IZEA"), which became its wholly owned subsidiary.  IZEA was incorporated in the state of Florida in February 2006 and was later reincorporated in the state of Delaware in September 2006 and changed its name to IZEA, Inc. from PayPerPost, Inc. on November 2, 2007. In connection with the share exchange, the Company discontinued its former business and continued the social sponsorship business of IZEA as its sole line of business. The Company's headquarters are in Orlando, FL.

The Company is a leading company in the social sponsorship space. The Company currently operates multiple online properties including its premiere platforms, SocialSpark and SponsoredTweets, as well as its legacy platform PayPerPost. In 2012, the Company launched a new platform called Staree and a display-advertising network to use within its platforms called IZEAMedia. Social sponsorship is when a company compensates a social media publisher or influencer such as a blogger or tweeter ("creators") to share sponsored content with their social network audience. This sponsored content is shared within the body of a content stream, a practice known as “native advertising.” The Company generates its revenue primarily through the sale of sponsorship campaigns to its advertisers. The Company fulfills these campaigns through its platforms by utilizing its creators to complete sponsorship opportunities for its advertisers. The Company also generates revenue from the posting of targeted display advertising and from various service fees.

Reverse Stock Split

On July 30, 2012, the Company filed a Certificate of Change with the Secretary of State of Nevada to effect a reverse stock split of the issued and outstanding shares of its common stock at a ratio of one share for every 40 shares outstanding prior to the effective date of the reverse stock split. Additionally, the Company's total authorized shares of common stock were decreased from 500,000,000 shares to 12,500,000 shares and subsequently increased to 100,000,000 shares in February 2013. All current and historical information contained herein related to the share and per share information for the Company's common stock or stock equivalents issued on or after May 12, 2011 reflects the 1-for-40 reverse stock split of the Company's outstanding shares of common stock that became market effective on August 1, 2012.

Principles of Consolidation

The consolidated financial statements include the accounts of IZEA, Inc. as of the date of the reverse merger, and its wholly owned subsidiary, IZEA Innovations, Inc. (collectively, the "Company"). All significant intercompany balances and transactions have been eliminated in consolidation.

Going Concern and Management’s Plans

The opinion of the Company's independent registered public accounting firm on the audited financial statements as of and for the year ended December 31, 2012 contains an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.

The Company has incurred significant losses from operations since inception and has an accumulated deficit of $25,556,024 as of September 30, 2013.  Net losses for the nine months ended September 30, 2013 and for the year ended December 31, 2012 were $2,752,602 and $4,672,638, respectively. The Company's ability to continue as a going concern is dependent upon raising capital from financing transactions. The Company’s financial statements have been prepared on the basis that it is a going concern, which assumes continuity of operations and the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments that might result if the Company was forced to discontinue its operations.

From August 15, 2013 through September 23, 2013, the Company raised $2,182,500 in cash through the sale of 8,730,000 shares of its common stock at a price of $0.25 per share in a 2013 Private Placement (see Note 4). Additionally, as discussed in Note 2, the Company converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of its common stock at an effective price of $0.25 per share. The Company also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes.

On September 30, 2013, the Company entered into an agreement pursuant to which it issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services.

The 2013 Private Placement and payment of services with shares of restricted stock provided us with a positive working capital balance and cash reserves for future periods. However, revenues and cash generated from our operations are not presently sufficient to sustain our operations for more than one year.

The Company's continued operations are dependent on its ability to provide positive cash flow from operations and its ability to raise additional capital from financing transactions. Financing transactions may include the issuance of equity or convertible debt securities, obtaining credit facilities, or other financing alternatives. The volatility and sharp decline in the trading price of the Company's common stock over the past two years could make it more difficult to obtain financing through the issuance of equity or convertible debt securities. There can be no assurance that the Company will be successful in any future financing or that it will be available on terms that are acceptable to us.

Future financings through equity investments are likely to be dilutive to existing stockholders. Also, the terms of securities the Company may issue in future capital transactions may be more favorable for the new investors. Newly issued securities, warrants and restricted stock awards may include preferences, superior voting rights and privileges senior to those of existing holders. Further, the Company may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, legal and accounting fees, printing and distribution expenses and other costs. The Company may also be required to recognize non-cash expenses in connection with certain securities it may issue, such as convertible notes and warrants, which will adversely impact our financial condition. Future financings may be impaired by such factors as the overall level of activity in the capital markets and the Company's history of losses, which could impact the availability or cost of future financings. If the amount of capital the Company is able to raise from financing activities, together with its cash from operations, is not sufficient to satisfy the Company's capital needs, the Company may have to curtail its marketing and development plans and possibly limit operations.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

Accounts Receivable and Concentration of Credit Risk

Accounts receivable are customer obligations due under normal trade terms. Uncollectability of accounts receivable is not significant since most customers are bound by contract and are required to fund the Company for all the costs of an “opportunity,” defined as an order created by an advertiser for a publisher to write about the advertiser’s product. If a portion of the account balance is deemed uncollectible, the Company will either write-off the amount owed or provide a reserve based on the uncollectible portion of the account. Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. The Company does not have a reserve for doubtful accounts as of September 30, 2013 and December 31, 2012. Management believes that this estimate is reasonable, but there can be no assurance that the estimate will not change as a result of a change in economic conditions or business conditions within the industry, the individual customers or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. Bad debt expense was less than 1% of revenue for the nine months ended September 30, 2013 and 2012.

Concentrations of credit risk with respect to accounts receivable are typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. The Company also controls credit risk through credit approvals, credit limits and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. At September 30, 2013, two customers accounted for 38% of total accounts receivable in the aggregate, each of which accounted for more than 10% of the Company’s accounts receivable. At December 31, 2012, the Company had two customers which accounted for 46% of total accounts receivable in the aggregate. The Company had two and one customers that accounted for 33% and 13% of its revenue during the three and nine months ended September 30, 2013, respectively. The Company had no customers that accounted for more than 10% of its revenue during the three and nine months ended September 30, 2012.

Property and Equipment

Depreciation and amortization is computed using the straight-line method and half-year convention over the estimated useful lives of the assets as follows:

Equipment	3 years
Furniture and fixtures	5 - 10 years
Software	3 years
Leasehold improvements	3 years

Major additions and improvements are capitalized, while replacements, maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed as incurred. When assets are retired or otherwise disposed of, related costs and accumulated depreciation and amortization are removed and any gain or loss is reported as other income or expense.

Software Costs

The Company is in the process of developing a new platform called the Native Ad Exchange (NAX). This platform will be utilized both internally and externally to facilitate native advertising campaigns on a greater scale. In accordance with ASC 350-40, Internal Use Software and ASC 985-730, Computer Software Research and Development, research phase costs should be expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs may be capitalized. The Company determined that on April 15, 2013, the project became technologically feasible and the development phase began. The Company capitalized $146,031 and $244,878 in payroll and benefit costs to software development costs in the consolidated balance sheet during the three and nine months ended September 30, 2013, respectively. The platform is expected to be fully implemented in the first quarter of 2014.

Revenue Recognition

The Company derives its revenue from three sources: revenue from an advertiser for the use of the Company's network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators ("Service Fee Revenue"). Sponsored revenue is recognized and considered earned after an advertiser's opportunity is posted on the Company's online platform and their request was completed and content listed, as applicable, by the Company's creators for a requisite period of time. The requisite period ranges from 3 days for an action or tweet to 30 days for a blog. Advertisers may prepay for services by placing a deposit in their account with the Company.  The deposits are typically paid by the advertiser via check, wire transfer or credit card. Deposits are recorded as unearned revenue until earned as described above. Media Revenue is recognized and considered earned when the Company's creators place targeted display advertising in blogs. Service fees charged to advertisers are primarily related to inactivity fees for dormant accounts and fees for additional services outside of sponsored revenue. Service fees charged to creators include upgrade account fees for obtaining greater visibility to advertisers in advertiser searches in our platforms, early cash-out fees if a creator wishes to take proceeds earned for services from their account when the account balance is below certain minimum balance thresholds and inactivity fees for dormant accounts. Service fees are recognized immediately when the maintenance or enhancement service is performed for an advertiser or publisher.   All of the Company's revenue is generated through the rendering of services and is recognized under the general guidelines of SAB Topic 13 A.1 which states that revenue will be recognized when it is realized or realizable and earned. The Company considers its revenue as generally realized or realizable and earned once (i) persuasive evidence of an arrangement exists, (ii) services have been rendered, (iii) the price to the advertiser or customer is fixed (required to be paid at a set amount that is not subject to refund or adjustment) and determinable, and (iv) collectability is reasonably assured. The Company records revenue on the gross amount earned since it generally is the primary obligor in the arrangement, establishes the pricing and determines the service specifications.

Advertising Costs

Advertising costs are charged to expense as they are incurred, including payments to contact creators to promote the Company.  Advertising expense charged to operations for the three months ended September 30, 2013 and 2012 were approximately $12,000 and $60,000, respectively. Advertising expense charged to operations for the nine months ended September 30, 2013 and 2012 were approximately $56,000 and $359,000, respectively. Advertising costs are included in sales and marketing expense in the accompanying consolidated statements of operations.

Income Taxes

The Company has not recorded current income tax expense due to the generation of net operating losses. Deferred income taxes are accounted for using the balance sheet approach which requires recognition of deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the tax basis of assets and liabilities. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.

The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more-likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company’s tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the date of filing.

Convertible Preferred Stock

The Company accounts for its convertible preferred stock under the provisions of Accounting Standards Codification ("ASC") on DistinguishingLiabilities from Equity, which sets forth the standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. The ASC requires an issuer to classify a financial instrument that is within the scope of the ASC as a liability if such financial instrument embodies an unconditional obligation to redeem the instrument at a specified date and/or upon an event certain to occur. The Series A Convertible Preferred Stock of the Company issued in May 2011 does not have a redemption feature. Future changes in the certainty of the Company’s obligation to redeem these instruments could result in a change in classification.

Derivative Financial Instruments

Derivative financial instruments are defined as financial instruments or other contracts that contain a notional amount and one or more underlying (e.g., interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. The Company accounts for derivative instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and equity instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

The Company records a beneficial conversion feature (“BCF”) related to the issuance of convertible debt and equity instruments that have conversion features at fixed rates that are in-the-money when issued, and the fair value of warrants issued in connection with those instruments. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds to warrants, based on their relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature. The discounts recorded in connection with the BCF and warrant valuation are recognized (a) for convertible debt as interest expense over the term of the debt, using the effective interest method or (b) for preferred stock as dividends at the time the stock first becomes convertible.

Fair Value of Financial Instruments

The Company’s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:

• Level 1 – Valuation based on quoted market prices in active markets for identical assets and liabilities.

• Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

• Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The Company does not have any Level 1 or 2 financial assets or liabilities. The Company’s Level 3 financial liabilities measured at fair value consisted of certain notes payable and the warrant liability as of September 30, 2013 (see Note 3).

Significant unobservable inputs used in the fair value measurement of the warrants include the estimated term. Significant increases (decreases) in the estimated remaining period to exercise would result in a significantly higher (lower) fair value measurement.

In developing our credit risk assumption, consideration was made of publicly available bond rates and US Treasury Yields. However, since the Company does not have a formal credit-standing, management estimated its standing among various reported levels and grades for use in the model. During all periods, management estimated that the Company's standing was in the speculative to high-risk grades (BB- to CCC in the Standard and Poor's Rating). A significant increase (decrease) in the risk-adjusted interest rate could result in a significantly lower (higher) fair value measurement.

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. Unless otherwise disclosed, the fair value of the Company’s notes payable and capital lease obligations approximate their carrying value based upon current rates available to the Company.

Certain convertible promissory notes are recorded at the fair value of the hybrid instrument as a whole and are recorded at their common stock equivalent value. Significant unobservable inputs used in the fair value of the hybrid instruments include the estimated number of common shares underlying the promissory notes and the fair value of the common stock to be issued upon conversion. Generally, an increase (decrease) in the estimated number of shares underlying the promissory notes or the fair value of the common stock to be issued upon conversion would result in a (higher) lower fair value measurement.

Stock-Based Compensation

Stock-based compensation cost related to stock options granted under the May 2011 Equity Incentive Plan and August 2011 B Equity Incentive Plan (together, the "2011 Equity Incentive Plans") (see Note 4) is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option-pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock as quoted in the OTCQB marketplace on the date of the agreement.  Prior to April 1, 2012, due to limited trading history and volume, the Company estimated the fair value of its common stock using recent independent valuations or the value paid in equity financing transactions. The Company estimates the volatility of its common stock at the date of grant based on the volatility of comparable peer companies that are publicly traded and have had a longer trading history than itself. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and post-vesting forfeitures. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The Company used the following assumptions for options granted under the 2011 Equity Incentive Plans during the three and nine months ended September 30, 2013 and 2012:

	Three Months Ended		Nine Months Ended
2011 Equity Incentive Plans Assumptions	September 30, 2013	September 30, 2012	September 30, 2013	September 30, 2012
Expected term	10 years	5 years	9 years	5 years
Weighted average volatility	51.72%	54.46%	52.02%	54.90%
Weighted average risk free interest rate	2.74%	0.65%	2.27%	0.75%
Expected dividends	—	—	—	—

The Company estimates forfeitures when recognizing compensation expense and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates.  Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and also impact the amount of unamortized compensation expense to be recognized in future periods.  Current average expected forfeiture rates were 50.21% during the three and nine months ended September 30, 2013 and 2012.

Non-Employee Stock-Based Compensation

The Company's accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505, “Equity-Based Payments to Non-Employees.” The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. The fair value of equity instruments issued to consultants that vest immediately is expensed when issued. The fair value of equity instruments issued to consultants that have future vesting and are subject to forfeiture if performance does not occur is recognized as expense over the vesting period. Fair values for the unvested portion of issued instruments are adjusted each reporting period. The change in fair value is recorded to additional paid-in capital. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or the fair value of the services, whichever is more readily determinable.

Segment Information

The Company does not identify separate operating segments for management reporting purposes. The results of operations are the basis on which management evaluates operations and makes business decisions.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Recent Accounting Pronouncements

There are several new accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") which are not yet effective.  Management does not believe any of these accounting pronouncements will have a material impact on the Company's financial position or operating results.

Reclassifications

Certain items have been reclassified in the 2012 financial statements to conform to the 2013 presentation.

XML

Stockholders' Deficit - Schedule of Nonvested Restricted Stock Outstanding (Details) (Restricted Stock [Member])	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested beginning of period	48,582	0
Granted	1,133,090	312,387
Vested	(1,181,672)	(263,805)
Forfeited	0	0
Nonvested end of period	0	48,582

XML

Derivative Financial Instruments - Warrants Liability (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended							0 Months Ended	9 Months Ended		2 Months Ended	3 Months Ended	9 Months Ended	0 Months Ended	3 Months Ended
	Feb. 04, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Aug. 15, 2013	Dec. 31, 2012	Jun. 30, 2012 warrantholder	Jul. 31, 2011	May 31, 2011 May 2011 Offering [Member]	Sep. 11, 2012 September 2012 Offering [Member]	Sep. 30, 2013 Warrant [Member]	Dec. 31, 2012 Warrant [Member]	Jun. 30, 2012 Private Transaction with Nineteen Warrant Holders [Member]	Sep. 30, 2012 Private Transaction with Nineteen Warrant Holders [Member]	Sep. 30, 2012 Private Transaction with Nineteen Warrant Holders [Member]	Feb. 04, 2013 Private Transaction with a Warrant Holder [Member]	Mar. 31, 2013 Private Transaction with a Warrant Holder [Member]	Sep. 23, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.50 exercise price [Member]
Derivative [Line Items]
Common shares linked to derivative warrants (shares)									250	153,882		14,360,276	128,350
Issuance of warrants, public offering (shares)											110,000
Class of Warrant or Right, Number of Warrant Holders								19
Conversion of notes payable into common stock (shares)	6,903,872													123,052			5,001
Loss on exchange of warrants and debt		$ (93,482)	$ (37,610)	$ (94,214)	$ (802,123)										$ (802,123)	$ (802,123)		$ (732)
Change in fair value of derivative		207,462	10,903	207,682	738,628							(207,682)
Warrant liability		2,139,967		2,139,967			2,750					2,139,967	2,750
Issuance of warrants with preferred stock financing												4,546
Fair value of warrants issued with preferred stock financing												0
Change in fair value of warrant derivatives												$ 0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						349,464													7,118,236	7,118,236
Class of Warrant or Right, Exercise Price of Warrants or Rights																			0.25	0.50

XML

Loss Per Common Share (Tables)

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

Net losses were reported during the three and nine months ended September 30, 2013 and 2012.  As such, the Company excluded the following items from the computation of diluted loss per common share as their effect would be anti-dilutive:

	Three and Nine Months Ended
	September 30, 2013	September 30, 2012
Stock options	6,921,026	393,494
Warrants	18,605,999	128,434
Restricted stock units	1,819,400	—
Potential conversion of Series A convertible preferred stock	3,788	3,788
Potential conversion of promissory notes payable	—	789,142
Total excluded shares	27,350,213	1,314,858

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Reverse Stock Split [Policy Text Block]

Reverse Stock Split

On July 30, 2012, the Company filed a Certificate of Change with the Secretary of State of Nevada to effect a reverse stock split of the issued and outstanding shares of its common stock at a ratio of one share for every 40 shares outstanding prior to the effective date of the reverse stock split. Additionally, the Company's total authorized shares of common stock were decreased from 500,000,000 shares to 12,500,000 shares and subsequently increased to 100,000,000 shares in February 2013.

Consolidation, Policy [Policy Text Block]

Principles of Consolidation

The consolidated financial statements include the accounts of IZEA, Inc. as of the date of the reverse merger, and its wholly owned subsidiary, IZEA Innovations, Inc. (collectively, the "Company"). All significant intercompany balances and transactions have been eliminated in consolidation.

Liquidity Disclosure [Policy Text Block]

Going Concern and Management’s Plans

The opinion of the Company's independent registered public accounting firm on the audited financial statements as of and for the year ended December 31, 2012 contains an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.

The Company has incurred significant losses from operations since inception and has an accumulated deficit of $25,556,024 as of September 30, 2013.  Net losses for the nine months ended September 30, 2013 and for the year ended December 31, 2012 were $2,752,602 and $4,672,638, respectively. The Company's ability to continue as a going concern is dependent upon raising capital from financing transactions. The Company’s financial statements have been prepared on the basis that it is a going concern, which assumes continuity of operations and the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments that might result if the Company was forced to discontinue its operations.

From August 15, 2013 through September 23, 2013, the Company raised $2,182,500 in cash through the sale of 8,730,000 shares of its common stock at a price of $0.25 per share in a 2013 Private Placement (see Note 4). Additionally, as discussed in Note 2, the Company converted notes payable and accrued interest thereon totaling $1,376,618 into 5,506,472 shares of its common stock at an effective price of $0.25 per share. The Company also issued fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.25 per share and fully-exercisable, five-year warrants to purchase 7,118,236 shares of its common stock at an exercise price of $0.50 per share. The net proceeds received from the 2013 Private Placement are being used for general working capital purposes.

On September 30, 2013, the Company entered into an agreement pursuant to which it issued 823,090 shares of restricted common stock, at an effective price of $0.35 per share, to settle a $288,081 balance owed for legal services.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

Receivables, Policy [Policy Text Block]

Accounts Receivable and Concentration of Credit Risk

Accounts receivable are customer obligations due under normal trade terms. Uncollectability of accounts receivable is not significant since most customers are bound by contract and are required to fund the Company for all the costs of an “opportunity,” defined as an order created by an advertiser for a publisher to write about the advertiser’s product. If a portion of the account balance is deemed uncollectible, the Company will either write-off the amount owed or provide a reserve based on the uncollectible portion of the account. Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. The Company does not have a reserve for doubtful accounts as of September 30, 2013 and December 31, 2012. Management believes that this estimate is reasonable, but there can be no assurance that the estimate will not change as a result of a change in economic conditions or business conditions within the industry, the individual customers or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. Bad debt expense was less than 1% of revenue for the nine months ended September 30, 2013 and 2012.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentrations of credit risk with respect to accounts receivable are typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. The Company also controls credit risk through credit approvals, credit limits and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. At September 30, 2013, two customers accounted for 38% of total accounts receivable in the aggregate, each of which accounted for more than 10% of the Company’s accounts receivable. At December 31, 2012, the Company had two customers which accounted for 46% of total accounts receivable in the aggregate. The Company had two and one customers that accounted for 33% and 13% of its revenue during the three and nine months ended September 30, 2013, respectively. The Company had no customers that accounted for more than 10% of its revenue during the three and nine months ended September 30, 2012.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Depreciation and amortization is computed using the straight-line method and half-year convention over the estimated useful lives of the assets as follows:

Equipment	3 years
Furniture and fixtures	5 - 10 years
Software	3 years
Leasehold improvements	3 years

Major additions and improvements are capitalized, while replacements, maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed as incurred. When assets are retired or otherwise disposed of, related costs and accumulated depreciation and amortization are removed and any gain or loss is reported as other income or expense.

Research, Development, and Computer Software, Policy [Policy Text Block]

Software Costs

The Company is in the process of developing a new platform called the Native Ad Exchange (NAX). This platform will be utilized both internally and externally to facilitate native advertising campaigns on a greater scale. In accordance with ASC 350-40, Internal Use Software and ASC 985-730, Computer Software Research and Development, research phase costs should be expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs may be capitalized. The Company determined that on April 15, 2013, the project became technologically feasible and the development phase began. The Company capitalized $146,031 and $244,878 in payroll and benefit costs to software development costs in the consolidated balance sheet during the three and nine months ended September 30, 2013, respectively.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

The Company derives its revenue from three sources: revenue from an advertiser for the use of the Company's network of social media content creators to fulfill advertiser sponsor requests for a blog post, tweet, click or action ("Sponsored Revenue"), revenue from the posting of targeted display advertising ("Media Revenue") and revenue derived from various service fees charged to advertisers and creators ("Service Fee Revenue"). Sponsored revenue is recognized and considered earned after an advertiser's opportunity is posted on the Company's online platform and their request was completed and content listed, as applicable, by the Company's creators for a requisite period of time. The requisite period ranges from 3 days for an action or tweet to 30 days for a blog. Advertisers may prepay for services by placing a deposit in their account with the Company.  The deposits are typically paid by the advertiser via check, wire transfer or credit card. Deposits are recorded as unearned revenue until earned as described above. Media Revenue is recognized and considered earned when the Company's creators place targeted display advertising in blogs. Service fees charged to advertisers are primarily related to inactivity fees for dormant accounts and fees for additional services outside of sponsored revenue. Service fees charged to creators include upgrade account fees for obtaining greater visibility to advertisers in advertiser searches in our platforms, early cash-out fees if a creator wishes to take proceeds earned for services from their account when the account balance is below certain minimum balance thresholds and inactivity fees for dormant accounts. Service fees are recognized immediately when the maintenance or enhancement service is performed for an advertiser or publisher.   All of the Company's revenue is generated through the rendering of services and is recognized under the general guidelines of SAB Topic 13 A.1 which states that revenue will be recognized when it is realized or realizable and earned. The Company considers its revenue as generally realized or realizable and earned once (i) persuasive evidence of an arrangement exists, (ii) services have been rendered, (iii) the price to the advertiser or customer is fixed (required to be paid at a set amount that is not subject to refund or adjustment) and determinable, and (iv) collectability is reasonably assured. The Company records revenue on the gross amount earned since it generally is the primary obligor in the arrangement, establishes the pricing and determines the service specifications.

Advertising Cost, Policy, Expensed Advertising Cost [Policy Text Block]

Advertising Costs

Advertising costs are charged to expense as they are incurred, including payments to contact creators to promote the Company.  Advertising expense charged to operations for the three months ended September 30, 2013 and 2012 were approximately $12,000 and $60,000, respectively. Advertising expense charged to operations for the nine months ended September 30, 2013 and 2012 were approximately $56,000 and $359,000, respectively. Advertising costs are included in sales and marketing expense in the accompanying consolidated statements of operations.

Income Tax, Policy [Policy Text Block]

Income Taxes

The Company has not recorded current income tax expense due to the generation of net operating losses. Deferred income taxes are accounted for using the balance sheet approach which requires recognition of deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the tax basis of assets and liabilities. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized.

The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more-likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company’s tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the date of filing.

Convertible Preferred Stock [Policy Text Block]

Convertible Preferred Stock

The Company accounts for its convertible preferred stock under the provisions of Accounting Standards Codification ("ASC") on DistinguishingLiabilities from Equity, which sets forth the standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. The ASC requires an issuer to classify a financial instrument that is within the scope of the ASC as a liability if such financial instrument embodies an unconditional obligation to redeem the instrument at a specified date and/or upon an event certain to occur. The Series A Convertible Preferred Stock of the Company issued in May 2011 does not have a redemption feature. Future changes in the certainty of the Company’s obligation to redeem these instruments could result in a change in classification.

Derivatives, Policy [Policy Text Block]

Derivative Financial Instruments

Derivative financial instruments are defined as financial instruments or other contracts that contain a notional amount and one or more underlying (e.g., interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. The Company accounts for derivative instruments in accordance with ASC 815, Derivatives and Hedging (“ASC 815”), which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and equity instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract, and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

The Company’s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:

• Level 1 – Valuation based on quoted market prices in active markets for identical assets and liabilities.

• Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

• Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The Company does not have any Level 1 or 2 financial assets or liabilities. The Company’s Level 3 financial liabilities measured at fair value consisted of certain notes payable and the warrant liability as of September 30, 2013 (see Note 3).

Significant unobservable inputs used in the fair value measurement of the warrants include the estimated term. Significant increases (decreases) in the estimated remaining period to exercise would result in a significantly higher (lower) fair value measurement.

In developing our credit risk assumption, consideration was made of publicly available bond rates and US Treasury Yields. However, since the Company does not have a formal credit-standing, management estimated its standing among various reported levels and grades for use in the model. During all periods, management estimated that the Company's standing was in the speculative to high-risk grades (BB- to CCC in the Standard and Poor's Rating). A significant increase (decrease) in the risk-adjusted interest rate could result in a significantly lower (higher) fair value measurement.

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses. Unless otherwise disclosed, the fair value of the Company’s notes payable and capital lease obligations approximate their carrying value based upon current rates available to the Company.

Certain convertible promissory notes are recorded at the fair value of the hybrid instrument as a whole and are recorded at their common stock equivalent value. Significant unobservable inputs used in the fair value of the hybrid instruments include the estimated number of common shares underlying the promissory notes and the fair value of the common stock to be issued upon conversion. Generally, an increase (decrease) in the estimated number of shares underlying the promissory notes or the fair value of the common stock to be issued upon conversion would result in a (higher) lower fair value measurement.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock-Based Compensation

Stock-based compensation cost related to stock options granted under the May 2011 Equity Incentive Plan and August 2011 B Equity Incentive Plan (together, the "2011 Equity Incentive Plans") (see Note 4) is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period.  The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option-pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock as quoted in the OTCQB marketplace on the date of the agreement.  Prior to April 1, 2012, due to limited trading history and volume, the Company estimated the fair value of its common stock using recent independent valuations or the value paid in equity financing transactions. The Company estimates the volatility of its common stock at the date of grant based on the volatility of comparable peer companies that are publicly traded and have had a longer trading history than itself. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and post-vesting forfeitures. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The Company used the following assumptions for options granted under the 2011 Equity Incentive Plans during the three and nine months ended September 30, 2013 and 2012:

	Three Months Ended		Nine Months Ended
2011 Equity Incentive Plans Assumptions	September 30, 2013	September 30, 2012	September 30, 2013	September 30, 2012
Expected term	10 years	5 years	9 years	5 years
Weighted average volatility	51.72%	54.46%	52.02%	54.90%
Weighted average risk free interest rate	2.74%	0.65%	2.27%	0.75%
Expected dividends	—	—	—	—

The Company estimates forfeitures when recognizing compensation expense and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates.  Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and also impact the amount of unamortized compensation expense to be recognized in future periods.  Current average expected forfeiture rates were 50.21% during the three and nine months ended September 30, 2013 and 2012.

Non-Employee Stock-Based Compensation [Policy Text Block]

Non-Employee Stock-Based Compensation

The Company's accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505, “Equity-Based Payments to Non-Employees.” The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. The fair value of equity instruments issued to consultants that vest immediately is expensed when issued. The fair value of equity instruments issued to consultants that have future vesting and are subject to forfeiture if performance does not occur is recognized as expense over the vesting period. Fair values for the unvested portion of issued instruments are adjusted each reporting period. The change in fair value is recorded to additional paid-in capital. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or the fair value of the services, whichever is more readily determinable.

Segment Reporting, Policy [Policy Text Block]

Segment Information

The Company does not identify separate operating segments for management reporting purposes. The results of operations are the basis on which management evaluates operations and makes business decisions.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

There are several new accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") which are not yet effective.  Management does not believe any of these accounting pronouncements will have a material impact on the Company's financial position or operating results.

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain items have been reclassified in the 2012 financial statements to conform to the 2013 presentation.

XML

Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013 customer	Mar. 31, 2012 customer	Sep. 30, 2013 customer	Dec. 31, 2012 customer
Accounting Policies [Abstract]
Accounts receivable, number of major customers (customers)	2		2	2
Accounts receivable, major customer (percentage)	38.00%		38.00%	46.00%
Revenue, number of major customer (customers)	2	0	1
Revenue, major customer (percentage)	33.00%		13.00%

XML

Summary of Significant Accounting Policies - Reverse Stock Split (Details)	0 Months Ended
	Jul. 30, 2012	Sep. 30, 2013	Mar. 31, 2013	Dec. 31, 2012
Significant Accounting Policies [Line Items]
Stockholders' Equity Note, Stock Split, Conversion Ratio	40
Common stock, shares authorized (shares)		100,000,000	100,000,000	100,000,000
Stockholders' equity, reverse stock split	All current and historical information contained herein related to the share and per share information for the Company's common stock or stock equivalents issued on or after May 12, 2011 reflects the 1-for-40 reverse stock split of the Company's outstanding shares of common stock that became market effective on August 1, 2012.
Scenario, Previously Reported [Member]
Significant Accounting Policies [Line Items]
Common stock, shares authorized (shares)	500,000,000
Reverse Stock Split [Member]
Significant Accounting Policies [Line Items]
Common stock, shares authorized (shares)	12,500,000

XML

Document and Entity Information Document (USD $)	9 Months Ended
	Sep. 30, 2013	Nov. 01, 2013	Jun. 30, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	IZEA, INC.
Entity Central Index Key	0001495231
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		22,389,331
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 1,506,252

XML

Summary of Significant Accounting Policies - Going Concern and Management's Plan (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended		1 Months Ended	0 Months Ended		1 Months Ended		0 Months Ended
	Sep. 30, 2013	Sep. 23, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Aug. 15, 2013	Sep. 23, 2013 Common Stock [Member]	Aug. 15, 2013 Warrants - $0.25 exercise price [Member]	May 31, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.25 exercise price [Member]	Sep. 23, 2013 Warrants - $0.50 exercise price [Member]	Sep. 30, 2013 Restricted Stock [Member]	May 16, 2013 Restricted Stock [Member]	Jan. 03, 2013 Restricted Stock [Member]	Jul. 02, 2012 Restricted Stock [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Expiration Period										5 years	5 years	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								349,464				7,118,236	7,118,236
Class of Warrant or Right, Exercise Price of Warrants or Rights												0.25	0.50
Stock Issued during period, shares, issued for services														823,090	30,000	20,000	71,221
Share Price, Restricted Stock Granted for Services, Per Share														$ 0.35
Legal Fees Reduction, Settled by Issuance of Restricted Stock	$ 288,081
Stock Issued During Period, Shares, New Issues									8,730,000
Share Price									$ 0.25
Debt conversion, converted instrument, amount (in dollars)									1,376,618
Conversion of notes payable into common stock (shares)									5,506,472
Period Where There Has Been Volatility In Trading Price of Stock					2 years
Accumulated deficit	25,556,024		25,556,024		25,556,024		22,803,422
Net loss			975,302	951,570	2,752,602	3,708,149	4,672,638
Proceeds from Issuance of Private Placement		$ 2,182,500